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Notation Index 
 
 
 
ANCOVA   Analysis of covariance 
ANOVA   Analysis of variance  
AOAC   Association of official analytical chemists 
aPHB   Amorphous poly-β-hydroxybutyrate 
AWCD  Average well colour development 
BW   Body weight 
CFU    Colony forming unit  
CLPP   Community-level physiological profiling 
CP   Component principle 
cPHB   crystalline poly-β-hydroxybutyrate 
DAC   Days after challenge 
DAH   Days after hatching 
DHA   Docosahexaenoic acid 
DMSO   Dimethyl sulfoxide 
dpf   Days post fertilization 
dpv   Days post vaccination 
DSU   Diversity of substrate utilization 
DW    Dry weight 
EPA   Eicosapentaenoic acid 
EPA   Environmental Protection Agency 
Notation index 
 
ii 
 
ESC   Enteric septicaemia 
FA   Fatty acid 
FAME   Fatty acid methyl ester 
FAO    Food and Agriculture Organization 
FCR    Food conversion ratio 
GC    Gas chromatography 
GI    Gastrointestinal 
HPLC   High performance liquid chromatography  
HUFA   Highly unsaturated fatty acid 
MC   Microbial community 
NL   Neutral lipid 
OD    Optical density 
PCA   Principal Component Analysis 
PHB   Poly-β-hydroxybutyrate 
PL   Polar lipid 
PUFA   Polyunsaturated fatty acid 
RPS   Relative percentage of survival 
SCFA   Short chain fatty acid 
SD    Standard Deviation 
SGR    Specific growth rate 
SIA   Stable isotope analysis  
β-HB   β-hydroxybutyrate  
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Chapter 1 
Use of poly-β-hydroxybutyrate for growth and health promotion 
in aquaculture practices: General introduction 
 
 
  
Chapter 1. General introduction 
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Status of the world’s aquaculture production 
It is anticipated that the global human population will rise to 9 billion by 2050 
(United Nations, 2011). Beveridge et al. (2013) emphasized that satisfying the food 
and nutrition needs of the growing population will require a profound change in 
what and how much is eaten, and where and how food is produced. A failure to do 
so could profoundly affect the biosphere through biodiversity loss, changes in 
ecosystem services supply and exacerbated global warming and as such 
compromise the Earth as a life-support system (Battisti and Naylor, 2009; Foley et 
al., 2011; Phalan et al., 2011). In the last five decades, global fish production has 
grown steadily with increasing food fish supply at an average annual rate of 3.2 %, 
outpacing world population growth at 1.6 % (FAO, 2014). The world per capita 
apparent fish consumption increased from an average of 9.9 kg in the 1960s to 19.2 
kg in 2012 (FAO, 2014). 
The global wild fish catches have for some time been at or near the limits of what 
aquatic ecosystems can be expected to provide naturally. Meeting the world's 
demand for fisheries products has thus depended on the growth of the aquaculture 
industry, being one of the fastest-growing food producing sectors in the world. In 
2012 the aquaculture industry set another all-time high in production as it 
contributed up to 42 % of the total global fisheries production (Figure 1.1). This 
share is projected to rise to 47 % of the total global fisheries production in 2022, 
then up to 62 % by 2030, as catches from wild capture fisheries are levelling off 
while the demand will substantially increase. In terms of fish destined for human 
consumption, aquaculture should surpass 50 % of the total fish production by 2015 
and reach 53 % by 2022. Developing countries will continue to account for about 67 
% of world exports of fish for human consumption, with Asian countries 
accounting for 54 % of the total (FAO, 2014). 
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Figure 1.1. Total landings from capture fisheries and aquaculture destined for food 
and non-food uses and the trends of per capita supply (reproduced 
from Tacon and Metian, 2015; data from FAO, 2014). Note: Production 
includes, fish, crustaceans, and molluscs, but excludes aquatic plants.   
 
Importance and potential of tilapia species 
It is estimated that more than 600 species of aquatic animals are cultured 
worldwide in a large variety of farming systems, facilities and culture conditions. 
Aquaculture has allowed the increased consumption of aquatic products by 
inducing a shift from products being primarily wild-caught to being primarily 
aquaculture-produced. This has resulted in a raised availability of products such as 
for shrimp, salmon, bivalves, catfish and tilapia, and a strong increase in their 
commercialization, thus a decrease in their prices (Beveridge et al., 2013; FAO, 
2014). At the global level, looking across fish species, the fastest growth in supply 
has been observed for tilapia, together with pangasius and Atlantic salmon (Fig. 
1.2).  
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Figure 1.2. Cumulative change in production (metric tonnes) of several major 
aquaculture fish species from 2002 to 2012 (Nystoyl and Tveteras, 2012). 
 
FAO has recorded farmed tilapia production statistics for 135 countries and 
territories on all continents (FAO, 2014). Tilapia production is expanding in Asia, 
South America and Africa (Fig. 1.3), with new supply targeting domestic and 
regional consumers rather than international markets (FAO, 2014).  
 
Figure 1.3. Contribution to the total farmed production of 4.85 million tonnes of 
tilapia per country in 2014 (FAO, 2014) 
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Several factors have contributed to the rapid global growth of tilapias. Tilapias are 
easily cultured due to their high reproductive capacity and adaptability to a wide 
range of environmental conditions such as salinity, dissolved oxygen, temperature, 
pH, and ammonia levels than most cultured freshwater fishes can (Hussain, 2004). 
It presents rusticity, good growth rate, and adaptability to confinement, producing 
a tasty white meat (Oliveira Filho et al., 2010). Tilapia is an omnivorous species and 
occupies a wide variety of habitats like rivers, lakes and irrigation channels. Tilapia 
and other farmed aquatic species of low trophic level, i.e. species feeding 
wildly/naturally lower in the aquatic food chain (including most herbivorous 
cyprinids, and omnivorous catfish species – all freshwater fish species; Fig. 1.4), are 
more flexible in terms of feed ingredient use as they can rely on food items from 
different trophic levels to a varying extent and therefore are less dependent upon 
the dietary use of fishmeal and fish oil (Tacon and Metian, 2015). Fishmeal and fish 
oil are continued to be used as the major sources of dietary protein and lipid within 
compound aquafeeds for the higher trophic level fish and crustacean species 
(Tacon et al., 2011) (Fig. 1.5). It is expected that, although the strong demand for 
fishmeal and fish oil in aquaculture diets will continue, the production volumes are 
likely to remain static or decrease (Tacon and Metian, 2008). Also, there is a 
growing demand for fishmeal for direct human consumption, and fish oil for direct 
use in human supplements and pharmaceutical medicines. This market is likely to 
be able to pay more for fishmeal and fish oil, resulting in aquaculture having to 
reduce its usage due to the scarcity of these commodities and their increasing 
prices (Tacon et al., 2012). Tilapia feeds generally contain less than 15 % fish meal, 
with soybean meal or other alternate protein sources providing the bulk of dietary 
protein (Luquet, 1991). Thus, increased production of tilapia is also partly due to 
lower feed prices as compared with those for marine, mostly carnivorous, fish 
species (Tacon et al., 2009; Tacon et al., 2011).  
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Figure 1.4. Trophic level range for a selection of fish species, including several 
major aquaculture fish species (Kaushik and Troell, 2010). 
 
 
Figure 1.5. Total global consumption of fishmeal and fish oil by major aquaculture 
species group in 2008 (Tacon et al., 2011) 
 
Chapter 1. General introduction 
7 
 
When raised in optimal conditions, it takes 6-12 months to obtain market-sized 
tilapia. Out of a total of about 70 tilapia species, nine are used in aquaculture 
worldwide (FAO, 2002). Nile tilapia (Oreochromis niloticus) comprises 83 % of the 
global production of tilapia and is responsible for the huge expansion of tilapia in 
recent decades (Table 1.1). The large size at first maturity, which affects the harvest 
time and thus the market size, and rapid growth rate justify the predominance of 
the Nile tilapia in their global production (Gupta and Acosta, 2004). 
Table 1.1. Total global production of tilapias in 2010 (Tacon et al., 2011) 
Species 
Production 
(tonnes) 
Percent 
Total value 
(US$) 
Value 
(US$  
per kg) 
Tilapias (Family Cichlidae) 2,797,819  4,021,164 1.44 
Nile tilapia (Oreochromis niloticus) 2,334,432 83.4 3,208,561 1.37 
Tilapias nei (Oreochromis spp.) 419,982 15.0 766,946 1.83 
Java tilapia (O. mossambicus) 38,140 1.4 32,476 0.85 
Blue tilapia (O. aureus) 2,687 0.1 5,798 2.16 
Three spotted tilapia (O. andersonii) 1,996 0.1 5,749 2.88 
Longfin tilapia (O. macrochir) 187 < 0.1 538.6 2.88 
Redbreast tilapia (Tilapia rendalli) 160 < 0.1 352 2.20 
Redbelly tilapia (T. zillii) 130 < 0.1 325 2.50 
Sabaki tilapia (O. spilurus) 105 < 0.1 420 4.00 
 
Nutrition in tilapia culture 
In general, fish meat is an excellent source of high quality protein, essential fatty 
acids - especially long-chain polyunsaturated fatty acids (PUFAs) - and 
micronutrients (Kawarazuka and Béné, 2011). The United States Department of 
Agriculture reported that raw tilapia fillet contains about 20 % protein and 1.7 % 
fat (USDA, 1987). Fish fatty acids composition, especially essential fatty acids, is 
also important for human health. Essential fatty acids are unsaturated fatty acids 
(FAs) that are essential to human health but cannot be synthesized de novo in the 
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body, and thus must be supplied in a ready-made form within the diet (Tacon, 
1990). Human consumption of the long chain (n-3) FAs eicosapentaenoic acid 
(20:5n-3; EPA) and docosahexaenoic acid (22:6n-3; DHA) has been shown to have 
numerous health benefits, including reduced incidence of heart disease (Hu et al., 
2003), improved clinical outcomes in inflammatory diseases such as rheumatoid 
arthritis (Calder, 2006), and improved outcomes in depression (Freeman et al., 
2006). Fish is considered as the major source of (n-3) FAs in the human diet. 
Although tilapia has a much lower level of the long-chain (n-3) fatty acids as 
compared to fatty fish such as salmon, they can be considered a good source of 
these fatty acids relative to beef and chicken. It is well established that many 
freshwater fish can readily convert linolenic acid (18:3n-3; LLA) to EPA and DHA 
using metabolic pathways similar to those occurring in higher vertebrates 
(Anderson and Arthington, 1992). Muinde et al. (2013) reported that Nile tilapia 
have the ability to bioconvert stearic acid, oleic acid, and other FAs which belong to 
group C:18 FAs, to highly unsaturated FAs; hence, Nile tilapia is classified as an 
excellent source of (n-3) PUFAs and being suitable for production of (n-3) 
supplements.  
Intensification of fish production methods increases reliance on nutritionally 
complete feeds (Tacon and Metian, 2015). Hence, relevant qualitative information 
on the nutritional requirement of tilapia is critical to adequately supply the 
required nutrients in the formulated diet for an optimum fish performance. In 
general, early juvenile tilapia (up to 10 g) require a diet high in protein, lipids, 
vitamins and minerals and lower in carbohydrates. Sub-adult tilapia (10-25 g) 
require more energy from lipids and carbohydrates for metabolism and a lower 
proportion of protein for growth while adult tilapia (> 25 g) require even less 
dietary protein for growth and can utilize even higher levels of carbohydrates as a 
source of energy (Tacon and Metian, 2008). 
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Proteins  
Dietary proteins are used continuously by fish for maintenance, growth, and 
reproduction functions. When fed in excess, protein may be used as energy. 
However, the latter function is not desirable because of the cost of proteins. Several 
factors including fish size or age, dietary protein quality, energy content of the diet, 
water quality and culture conditions have been reported to affect protein 
requirements of tilapia. Many studies have indicated that the protein requirement 
for maximum performance of tilapia during larval stages is relatively high (35 % to 
more than 50 %), and decreases with increasing fish size (El-Sayed and Teshima, 
1992; Jauncey and Ross, 1982; Siddiqui et al., 1988; Winfree and Stickney, 1981). For 
tilapia juveniles, the protein requirement ranges from 30–40 %, while adults require 
20–30 % dietary protein for optimum performance (El-Sayed and Teshima, 1991). 
Tilapia broodstock require 35–45 % dietary protein for optimum reproduction, 
spawning efficiency, and larval growth and survival (El-Sayed et al., 2003; 
Gunasekera et al., 1996a; Gunasekera et al., 1996b; Siddiqui et al., 1998).  
The profile of dietary protein is important when formulating diets for tilapia. As 
for other tropical fish, tilapia require essential amino acids that need to be supplied 
by the diet (NRC, 1983) (Table 1.2). Essential amino acid requirements can be met 
by the use of a balance of both plant and animal proteins, and if necessary, by the 
inclusion of synthetic amino acids in the complete feed. Several feeding studies 
reported the benefit of dietary supplementation with free amino acids on feeding 
intake and growth of tilapia (El-Saidy and Gaber, 2002; Yacoob et al., 2001).  
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Table 1.2. Essential amino acid requirements of O. mossambicus and O. niloticus as 
% of dietary protein and of total diet (in parenthesis). 
Amino Acid Requirement 
O. mossambicus1  O. mossambicus2 O. niloticus3 O. niloticus4 
Lysine   4.05 (1.62) 3.78 (1.51) 5.12 (1.43) na  
Arginine 3.80 (1.52) 2.82 (1.13) 4.20 (1.18) 4.1 
Histidine na 1.05 (0.42) 1.72 (0.48) 1.5 
Threonine na 2.93 (1.17) 3.75 (1.05) 3.3 
Valine na 2.20 (0.88) 2.80 (0.78) 3.0 
Leucine na 3.40 (1.35) 3.39 (0.95) 4.3 
Isoleucine na 2.01 (0.80) 3.11 (0.87) 2.6 
Methionine 1.33 (0.53) 0.99 (0.40) 2.68 (0.75) 1.3 
Cystine na na 0.53 2.1 
Phenylalanine na 2.50 (1.00) 3.75 (1.05) 3.2 
Tyrosine na na 1.79 1.6 
Tryptophan na 0.43 (0.17) 1.00 (0.28) 0.6 
‘na’ indicates data is not available. 
1Jackson and Capper (1982);  2Jauncey et al. (1983), 3Santiago and Lovell (1988); 4Fagbenro (2000).  
 
Carbohydrates 
Carbohydrates represent a broad group of substances which include sugars, 
starches, gums and celluloses. Carbohydrates make up three-fourths of the biomass 
of plants but are present only in small quantities in the animal body as glycogen, 
sugars and their derivatives. Carbohydrates present an inexpensive energy source 
that would “spare” the catabolism of other components such as non-essential 
amino acids and fatty acids for energetic purposes (Dupree and Hunter, 1984). 
Warm water fish are known for their ability to use higher amounts of dietary 
carbohydrate than cold water and marine species (NRC, 1983). The utilization of 
carbohydrate by tilapia appears to differ depending on the complexity of these 
carbohydrates. Starch or dextrin (partially hydrolysed starch) is used more 
efficiently by tilapia than sugars such as glucose or sucrose (Edwin and Meng, 
1996). Although tilapias use carbohydrate effectively, there is no dietary 
requirement for carbohydrate. 
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Lipids 
Dietary lipids provide a major source of energy, facilitate the absorption of fat 
soluble vitamins, play an important role in membrane structure and function, serve 
as precursors for steroid hormones and prostaglandins, and serve as metabolizable 
sources of essential FAs. Lipids are also considered important in the flavour and 
textural properties of the feed consumed by fish (NRC, 1983). The type and amount 
of lipid used in tilapia diets are based on essential FAs requirements, economic 
constraints of feed manufacture and quality of fish flesh desired (Eyo, 2002). 
Jauncey (2000) suggested that to maximize protein utilization, dietary fat 
concentration should be between 8 and 12 % for tilapia with size <25 g, and 
between 6 to 8 % for larger fish (>25 g). As with most fish, tilapia has the 
requirement for (n-6) FAs, and to a lesser extent, a requirement for (n-3) FAs. 
Dietary lipids should supply (n-6) FAs at 0.5 – 1 % dry feed weight (Teshima et al., 
1982). Farmed fish have become very important in providing health-promoting (n-
3) polyunsaturated fatty acids (PUFA) for the consumers. Generally, wild tilapias 
have more (n-3) FAs, higher (n-3)/(n-6) PUFA ratios, with lower proportions of 
18:2n-6 than farmed tilapias (Karapanagiotidis et al., 2006), but diet adjustments 
can alter the body composition of the domesticated variety (Young, 2009). It is 
reported that the amount and composition of external feed used, which indicate the 
intensity of the fish production methods, affects fish lipid content and composition 
(Karapanagiotidis et al., 2006; Weaver et al., 2008).  
Feed additives as feeding and growth enhancer 
Significant price increases have occurred during the past years for major aquafeed 
ingredients, including fishmeal and fish oils (Tacon and Metian, 2008). In the 
aquaculture sector, the combined efforts of industry and academic institutes 
resulted in the development of a wide range of additives to improve nutrient 
utilization and reduce feed formulation costs. Various types of feed additives, 
including exogenous enzymes and feeding stimulants, are used to enhance the 
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digestibility and/or utilization efficiency of nutrients (Drew et al., 2005; Farhangi 
and Carter, 2007; Lin et al., 2007). The use of enzyme products as animal feed 
supplements is of considerable interest to feed manufacturers and animal 
producers as a means to improve animal performance and reduce feed costs (Felix 
and Selvaraj, 2004; Feord, 1996; Forster et al., 1999; Lin et al., 2007). Goda et al. 
(2012) reported that the use of a mixture of exogenous digestive enzymes enhanced 
the growth of Nile tilapia fingerling with up to 30 %, increased the nutrient 
utilization, i.e. lower feed conversion ratio (FCR) and higher protein efficiency ratio 
(PER), and improved some hematological parameters including increase in total 
plasma protein (TPP) and total plasma globulin (TPG) level. The higher TPP and 
TPG levels of 2.8-3.6 g dL-1 and 1.5-2.2 g dL-1, respectively, were observed in fish 
fed different diets (supplemented with mixture of pepsin, papain and α-amylase at 
different concentrations), compared to 2.7 g dL-1 and 1.4 g dL-1, respectively, in fish 
fed the control diet. Various studies suggested that the addition of phytase into 
tilapia diets can improve growth performances by protecting amino acids from 
degrading, by decreasing the leaching of water soluble components and by 
improving the digestibility and utilization of dietary protein and phosphorous  
(Heindl et al., 2004; Liebert and Portz, 2004; Phromkunthong et al., 2004; Riche et 
al., 2001). Other types of feed additives including immunostimulants and pro-
/prebiotics have also been studied and used to stimulate fish growth and digestion, 
along with their application in disease management (Balca´zar et al., 2006; Bricknell 
and Dalmo, 2005; Kesarcodi-Watson et al., 2008; Nayak, 2010; Sakai, 1999; Tinh et 
al., 2008; Verschuere et al., 2000; Villamil and Novoa, 2009). 
Diseases in tilapia culture 
As aquaculture becomes more intensive, new diseases are likely to emerge, and old 
diseases will appear in new locations. In intensive aquaculture systems, 
environmental and microbial conditions deteriorate rapidly causing significant 
stress to the aquatic animals (Conte, 2004; Subasinghe, 2005). Infectious diseases are 
by far the main reason for mortality of farmed fishes. An outbreak often wipes out 
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an entire stock and it requires costly decontamination of the associated facilities 
and equipment to restore the situation (Pillay and Kutty, 2005). Diseases can be 
considered a significant limiting factor to aquaculture production. Several diseases 
have been reported to affect tilapia culture during different stages of the farming 
cycle (Fig. 1.6). 
 
Figure 1.6.  Main disease causative agents affecting tilapia during the farming 
cycle. Importance of the disease is roughly in proportion to the size of 
the arrow bars (Komar, 2008). 
 
Bacterial diseases 
Tilapia have long been considered a species that is ideal for use in aquaculture due 
to its hardy nature, fast growth, tolerance of suboptimal water quality and disease 
resistance (Little et al., 2008). However, tilapia also suffer from diseases that are not 
always new problems, but old problems that are re-emerging due to intensive 
production practices. Bacterial diseases are the main cause of mortality in tilapia 
culture, often resulting from an infection with a secondary or opportunistic agent 
combined with an infection by parasites. Some bacterial diseases have a seasonal 
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pattern, while others are not necessarily related to climatic factors or may occur 
throughout the whole cycle (Komar, 2008; Noga, 2011; Shoemaker and Klesius, 
1997). Streptococcosis and francisellosis are examples of seasonal bacterial diseases, 
primarily related to water temperature. Streptococcosis, also known as infectious 
meningoencephalitis caused by Gram-positive Streptococcus agalactiae, and to a 
lesser extent S. iniae, has been responsible for significant losses in intensive tilapia 
culture. As a typical feature the disease can occur during a period in which the 
water temperature is above 26 °C (Perera et al., 1994; Shoemaker and Klesius, 1997). 
Affected fish are described as having erratic swimming patterns, pericarditis, and 
chronic inflammatory reaction, hemorrhagic meningitis, polyserositis, or fibrosis. 
Francisellosis, also known as visceral granulomatosis, is caused by Francisella 
noatunensis and outbreaks particularly occur in periods with water temperature 
below 24 °C (Jeffery et al., 2010). 
Columnaris disease is another important cause of mortality in tilapia rearing and is 
responsible for large economic losses worldwide. It is caused by Flavobacterium 
columnare, resulting in skin lesions, fin erosion and gill necrosis, with a high degree 
of mortality (Decostere et al., 1998). F. columnare infection is highly influenced by 
fish culture management (Declercq et al., 2013). Abrupt variations in water 
temperature are likely to induce and accelerate the progression of this disease. Poor 
water quality, inadequate diet, handling and overcrowding are also stress factors 
likely to induce an outbreak (Pilarski et al., 2008; Sebastião et al., 2010). Septicemia 
diseases can also strike tilapias, due to a variety of pathogens including Aeromonas 
hydrophila (Gado, 1998; Plumb and Hanson, 2011), Pseudomonas sp. (El-Attar and 
Moustafa, 1996; Miyazaki et al., 1984; Soto-Rodriguez et al., 2013) and Edwardsiella 
sp., namely E. tarda (Clavijo et al., 2002; Iregui et al., 2012; Miyashita, 1984) and E. 
ictaluri (Situmorang et al., 2014; Soto et al., 2012; Soto et al., 2013). These are 
facultative pathogens (i.e. pathogenicity appears to be related to the stress of a 
weakened hosts) that can be controlled by good aquaculture management (Danner 
and Merrill, 2006; Komar, 2008; Plumb and Hanson, 2011).  
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Fungal diseases 
Fungal diseases in tilapia, particularly saprolegniasis, can be found throughout all 
stages of tilapia production (Aly and El-Ashram, 2000; El-Sayed, 2006; Noor et al., 
2010; Zaki et al., 2008). Saprolegnia is dermatotropic as it affects the skin and can 
penetrate to the dermal stratum compactum. Another fungal disease that affects 
tilapia is aspergillomycosis, which is primarily seen in animals that have been fed 
pellets that are already contaminated by the fungus and can result in high 
mortality (Olufemi et al., 1983; Olufemi and Roberts, 1986; Refai et al., 2010). 
Fungal diseases (mycosis) used to be considered a primary disease, but currently 
can be considered secondary to management practices, particularly during transfer 
or handling of the fish. 
Parasitic diseases  
Several external parasites, including protozoan Trichodina, metazoan Gyrodactylus 
and dinoflagellate Amyloodinium have been identified as major disease pathogens 
in tilapia culture (Shoemaker et al., 2006). Parasites commonly cause problems in 
young fish stocked at high numbers in eutrophic waters (Klesius and Rogers, 1995; 
Shoemaker et al., 2006). Several studies suggested that parasites are able to vector 
viral and bacterial diseases of fish, increasing the transmission efficiency of 
pathogens by creating portals of entry and/or by having the ability to transfer 
pathogens directly from fish to fish (Bandilla et al., 2006; Cusack and Cone, 1986; 
Evans et al., 2007; Kanno et al., 1990; Pylkkö et al., 2006). Other studies suggest 
different mechanisms that increase host susceptibility; for example, parasitism has 
been shown to result in increased stress responses believed to be linked to 
decreased disease resistance (Bowers et al., 2000; Tully and Nolan, 2001). 
Viral diseases 
Iridovirus is the only documented viral disease in tilapia. A Bohle iridovirus case in 
tilapia was reported in Australia (Ariel and Owens, 1997). A disease outbreak due 
to the iridovirus has also been found in Canada in tilapia fingerlings imported from 
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the USA (McGrogan et al., 1998). Iridovirus infection may cause immuno-
suppression, therefore facilitating other diseases caused by other pathogens.  
Management of diseases in tilapia culture 
Hygienic prevention strategies 
The best way to control infectious diseases is to avoid their introduction. Several 
ways to avoid the introduction of fish pathogens are (1) using fishes free from 
pathogens (i.e. specific pathogen free or SPF fish), (2) using foods free of pathogens 
(live foods can be vectors for fish pathogens), (3) application of prophylactic 
treatments with therapeutic agents via static baths, parental drug administration, 
or orally via medicated feed to remove external parasites, treat a diagnosed disease, 
or reduce shedding of pathogenic agents, and (4) filtration and disinfection of 
incoming water to the main system by use of for example ultraviolet light 
sterilization or ozonation (Kent et al., 2009). 
Disinfection procedures of culture water and equipment have been widely applied 
to prevent the introduction and spread of infectious disease (Danner and Merrill, 
2006). Commonly used chemical disinfectants in aquaculture are inorganic chlorine 
products (bleach, as sodium hypochlorite or calcium hypochlorite), buffered 
potassium monopersulphate (e.g. Virkon® Aquatic), surfactants (e.g. quaternary 
ammonium compounds), biguanides (e.g. chlorhexidine), alcohols (e.g. ethanol, 
isopropyl alcohol), iodophors (e.g. Betadine®), carboxylic acids (e.g. citric or acetic 
acids), oxidizing agents (e.g. hydrogen peroxide), phenol derivatives (e.g. Lysol®), 
and formaldehyde (Danner and Merrill, 2006; Noga, 2011; Somga et al., 2012). 
Chemical disinfectants are useful against specific disease organisms, although their 
effectiveness might vary depending on specific doses and/or contact times (Yanong 
and Erlacher-Reid, 2012). 
Typical water treatment systems make use of high efficiency sand filters to clarify 
the water before treatment with ultraviolet (UV) light or ozone (O3). The 
effectiveness and cost of such a system will depend on many factors including the 
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volume of water to be treated, the targeted disease(s), and the contact time of the 
treatment (Pietrak et al., 2010). UV irradiation intends to destroy the DNA of 
microorganisms, causing death or inactivation (Liltved, 2002). The dose of UV 
irradiation necessary to inactivate different microorganisms depends on the 
irradiation intensity and exposure time. For example, Saprolegnia requires UV doses 
that are 4 to 10 fold higher than the level needed for bacteria in order to achieve 
inactivation (Sharrer et al., 2005). UV irradiation has been found to be the cheapest 
method of sterilizing the water, especially for egg incubation systems (Bhujel, 
2014). However, the turbidity caused by organic products is a major problem for 
efficient penetration of UV irradiation in the water. Another problem associated 
with this technique is that it does not only target the pathogens but also the 
beneficial bacteria (Summerfelt, 2003). 
Ozonation is another option for disinfecting water by destroying the outer 
membranes of bacterial and fungal pathogens in aquatic systems (Graslund and 
Bengtsson, 2001) and can also inactivate viruses. Ozone also enhances water clarity 
by breaking down dissolved and particulate organics that discolour the water and 
that could clog the mechanical and biological filters or could provide a food source 
for undesirable bacteria and other pathogens (Yanong and Erlacher-Reid, 2012). 
Summerfelt et al. (2009) reported that a daily application of ozone with a dose of 
0.34-0.39 mg L-1 decreases the total cultivable heterotrophic bacteria to almost zero. 
However, ozonation is relatively costly and its by-products including bromate and 
other brominated compounds are considered toxic for fish and humans (Bhujel, 
2014; Tango and Gagnon, 2003). Similar with UV irradiation technique, the risk of 
elimination of beneficial bacteria is a major concern with the ozonation technique 
(Liltved, 2002; Summerfelt, 2003). 
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Prevention strategies acting at the host immunity level 
Vaccination 
The use of antimicrobials may be significantly reduced by the use of vaccines, 
when possible (Gudding, 2012). These are products that are directly or indirectly 
produced from pathogen biomass and administered to the animal to elicit a specific 
immune response for the prevention of a range of mainly bacterial and viral 
diseases. Vaccinations can be supplied as immersion, oral or by injection 
preparations and can minimize the effects of disease, which in turn minimizes 
morbidity and mortality, promotes optimum growth and improves feed conversion 
(Sommerset et al., 2005). A number of factors are known to influence the ability of 
vaccines to protect fish. These include environmental factors such as temperature 
and pollutants; host factors such as age and general health; husbandry factors such 
as handling, stress, diet and antibiotics; and vaccine-related factors such as dose, 
nature of antigen, route of administration and presence of adjuvants (Karunasagar 
and Karunasagar, 1999). In tilapia culture specifically, vaccination has offered 
protection to bacterial diseases (Table 1.3).  
Unlike the successful bacterial vaccines which are now routinely used in 
aquaculture, only very few anti-viral vaccines are available (mostly for salmonids) 
(Christie, 1997; Dhar and Allnutt, 2011; Lorenzen et al., 1998; Winton, 1997). 
Furthermore, although parasites cause significant problems in the aquaculture 
industry, there are no commercial vaccines for parasitic infections (Karunasagar, 
2012). Vaccines may be developed against parasites (Vercruysse et al., 2007) or 
fungal diseases (Minor et al., 2014), but not in the near future. Development of such 
vaccines will allow antibiotics and chemotherapeutants to be reserved for 
emergencies.  
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Immunostimulants 
An immunostimulant is a naturally occurring compound that modulates the 
immune system by increasing the host’s resistance against diseases that in most 
circumstances are caused by pathogens (Bricknell and Dalmo, 2005). 
Immunostimulants can be divided into several groups depending on their sources: 
bacterial, algae-derived, animal-derived, nutritional factors and 
hormones/cytokines (Sakai, 1999). The enhancement of phagocytic cells activity, 
lymphocytes, complement activity and antibody production by immunostimulants 
has been reported in several studies (Aakre et al., 1994; Hardie et al., 1991; Sakai et 
al., 1993; Siwicki et al., 1996). There are numerous studies on immunostimulants on 
tilapia culture, and most of them report improved resistance to challenge by 
various bacterial pathogens, with observed growth modulation in several studies 
(Table 1.4).  
In fish larviculture, delivery of immunostimulants is generally by bath immersion 
or through fish oral administration. Pulse feeding is commonly practiced. Some 
concerns have been raised about the use of immunostimulants in larval fish, in 
which there could be induction of tolerance. Problems also exist with respect to 
delivery system for fish larvae in flow-through systems and the effect on biological 
filters in recirculating aquaculture systems. Considering the variability in response 
in different fish species, the interval of feeding in the pulse feeding strategy is 
another issue that needs to be resolved (Bricknell and Dalmo, 2005). 
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Table 1.3.  Use of vaccines for health promotion in Nile tilapia culture 
Vaccine Life stage 
Administration 
procedure 
Effect Reference 
     
Formalin killed cells of  
Aeromonas hydrophila Adult 
Intraperitoneal (i.p.) 
injection at 106 CFU 
fish-1 
 Relative percentage of survival (RPS) of 62 % after 
challenge with virulent A. hydrophila (i.p. injected at 
1.5x104 CFU fish-1) on 7 days post vaccination (dpv)  
Ruangpan et al. (1986) 
     
Live attenuated  
Edwardsiella tarda SPM31 
Fingerling 
i.p. injection at 1 mg 
kg-1 body weight 
 RPS of 100 % after challenge with  virulent E. tarda  
FPC498 (i.p. injected at  at 1 mg kg-1 body weight) 
Igarashi and Iida (2002) 
     
Attenuated  
 Streptococcus  agalactiae 
Adult 
i.p. injection at 106 
CFU fish-1 
 RPS of 40 % after challenge with virulent S. agalactiae  
(i.p. injected at 1.5x104 CFU fish-1 on 90 dpv)  
Pasnik et al. (2006) 
     
Attenuated  
S. iniae ISET0901 
Adult 
i.p. injection at 2x107 
CFU fish-1 
  RPS of 75 % after challenge with virulent S. iniae   
 ISET0901 (i.p. injected at 2x107 CFU fish-1 on 180 dpv)  
Pridgeon and Klesius 
(2011) 
     
Attenuated  
Francisella asiatica 
Adult 
i.p. injection at 104 
CFU fish-1 
 RPS of 90 % after challenge with virulent F. asiatica  
(i.p. injected at 106 CFU fish-1)  
Soto et al. (2011) 
     
Mixture of extracellular 
product and  sonicated cell 
of  Pseudomonas fluorescens 
Adult 
i.p. injection at 8x107 
CFU fish-1 
 RPS of 60 % after challenge with virulent P. fluorescens 
(i.p. injected at 4x108 CFU fish-1 on 42 dpv) 
Attia et al. (2012) 
     
Avirulent F. columnare 
genomovar II mutant; 
developed by rifampicin-
resistance strategy 
Juvenile 
Immersion at 2x106 
CFU ml-1 for 30 min 
 RPS of 87 % after challenge with virulent F. columnare 
ARS-1 (immersion at 5.5x106 CFU mL-1 on 28 dpv) 
Mohammed et al. (2013) 
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Treatment strategies acting at the microbial level 
Antimicrobials 
A number of antimicrobials have been used in the aquaculture industry as curative 
agents of infectious bacterial diseases and for prophylactic purposes (Kesarcodi-Watson 
et al., 2008). The use of various antimicrobial agents in Nile tilapia hatcheries and grow-
out facilities have been reported, mostly in Asian countries, including the use of 
antifungals (e.g. formalin, malachite green, trifuralin, methylene blue), antiparasitics (e.g. 
belzalkonium chloride, copper sulphate, potassium permanganate, sodium chloride) and 
antibiotics (e.g. amoxicillin, doxycycline, erythromycin, enrofloxacin, sulfaquinoxaline, 
trimethoprim-sulfadiazine, florfenicol, norfloxacin, oxytetracycline) (Somga et al., 2012; 
Yuan and Chen, 2012).  
Regular use of antibiotics in aquaculture is not a sustainable practice. There are possible 
adverse effects of the use of antibiotics including significant resistance in target bacteria, 
resulting in ineffective and imprudent treatments (Defoirdt et al., 2007a; Karunasagar, 
2012). Antibiotics are also often used in the wrong way and therefore lead to 
ineffectiveness, for example when applied orally while infected fish display a reduced 
appetite. Their routine prophylactic use, particularly in hatcheries, is often uneconomic 
and unjustifiable with the absence of an accurate diagnosis and the fact that the pathogen 
was often not the primary cause of the disease process (Yuan and Chen, 2012).  
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Table 1.4.  Use of immunostimulants for health and growth promotion in tilapia culture (part 1) 
Antagonist / active compound Life stage / size 
Disease  
causative agent 
Effect Reference 
Algae-derived     
     
Spirulina (Arthrospira platensis) Fry (~1.9 g) Aeromonas hydrophila  Increase in growth 
 Increase in survival with 10 to 70 % 
Abdel-Tawwab and 
Ahmad (2009) 
     
Spirulina platensis Fingerling 
(~50 g) 
A. hydrophila   Increase in phagocytic activity 
 Increase in survival with 40 to 70 % 
Ragap et al. (2012) 
     
S. platensis Fingerling 
(4.0±1.0 g) 
Pseudomonas 
fluorescens 
 Increase in survival with 12 to 25 % 
 Increase in growth 
Ibrahem et al. (2013) 
     
Jade Spirulina® (S. platensis) Fingerling 
(50±5 g) 
Vibrio alginolyticus  Increase in survival with 25 to 55 % Abdel-Latif and Khalil 
(2014) 
     
Fungi/Yeast-derived     
     
Scleroglucan (from fungus Sclerotium rolfsii) Fingerling 
(21.8±3.3 g) 
A. hydrophila   Increase in survival with 70 % Wang and Wang (1997) 
     
Scleroglucan (from fungus Sclerotium rolfsii) Fingerling 
(21.8±3.3 g) 
Edwardsiella tarda  Increase in survival with 80 % Wang and Wang (1997) 
     
Saccharomyces cerevisiae Fingerling 
(21.9±0.3 g) 
A. hydrophila   Increase in survival with 80 %  Rasha et al. (2010) 
     
β-glucan from Saccharomyces cerevisiae Adult 
(80-100 g) 
A. hydrophila   Increase in survival with 55 %  El-Boshy et al. (2010) 
     
Saccharomyces cerevisiae cell wall Adult 
(125.0±1.5 g) 
Streptococcus 
agalactiae 
 Increase in survival with 28 to 38 % Salvador et al. (2012) 
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Table 1.4. Use of immunostimulants for health and growth promotion in tilapia culture (part 2) 
Antagonist / active compound Life stage /size 
Disease  
causative agent 
Effect Reference 
     
Plant-derived      
     
PS-K (protein-bound polysaccharide) extracted from  
mushroom Coriolus versicolor 
Fingerling 
(30–50 g) 
E. tarda  Increase in phagocytic activity 
 Increase in survival with 30 to 100 % 
Park and Jeong (1996) 
     
Indian almond Terminalia catappa extract Egg Fungus  Decrease in fungal infection with 8 % Chitmanat et al. (2005) 
     
Combination of Chinese herbs (Lonicera japonica and 
Ganoderma lucidum)  
Fingerling 
(52.5±3.5 g) 
A. hydrophila   Increase in survival with 37 % 
 
Yin et al. (2008) 
     
Green tea (Camellia sinensis) Fingerling 
(1.5–2.0 g) 
A. hydrophila   Increase in survival with 25 to 70 % 
 Increase in growth 
Abdel-Tawwab et al. (2010) 
     
Coneflower (Echinacea purpurea) Juvenile 
(0.8±0.2 g) 
A. hydrophila   Increase in survival with 25 to 45 % 
 Increase in growth  
Aly and Mohamed (2010) 
     
Garlic (Allium sativum) Juvenile 
(0.8±0.2 g) 
A. hydrophila   Increase in survival with 15 to 35 % 
 Increase in growth  
Aly and Mohamed (2010) 
     
Cinnamon (Cinnamomum zeylanicum) Fingerling 
(10–12 g) 
A. hydrophila   Increase in survival with 77 to 80 % 
 Increase in growth, feed utilization 
Ahmad et al. (2011) 
     
Black cumin seeds (Nigella sativa) Fingerling 
(40±5 g) 
A. hydrophila   Increase in survival with 24 % 
 Increased phagocytic activity by 6 % 
Elkamel and Mosaad (2012) 
     
Jackfruit (Artocarpus integrifolia) seed extract Juvenile S. agalactiae  Increase in survival with 30 % Toazza et al. (2013) 
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Table 1.4. Use of immunostimulants for health and growth promotion in tilapia culture (part 3) 
Antagonist / active compound Life stage / size 
Disease  
causative agent 
Effect Reference 
 
Vitamins and hormones/cytokines 
    
     
Vitamin E (Immunoton®) Fingerling 
(28±5 g) 
A. hydrophila   Increase in survival with 50 % Abdelkhalek et al. 
(2008) 
     
Vitamin C ( Levamisole®)  Fingerling 
(28±5 g) 
A. hydrophila   Increase in survival with 75 % Abdelkhalek et al. 
(2008) 
     
Vitamin C (Rovimix Stay-C® 35 DSM)  
(with β-glucan)  
Fingerling 
 (5.0±0.2 g) 
A. hydrophila   Increase in  survival with 15 to 20 % Barros et al. (2014) 
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Several other reasons for failure of the use of antimicrobial agents as disease 
control are (1) use of antimicrobials without improvement in farming practices / 
environment, (2) insufficient treatment duration, (3) utilization of subtherapeutic 
dosages, (4) use of antimicrobials of unsure/unproven quality, (5) lack of 
information concerning the fish stock (e.g. biomass) and (6) inadequate storage of 
chemicals (Yuan and Chen, 2012). Direct adverse effects resulting from the agent 
being in the environment or in the marketed product must also be considered. The 
emergence of antimicrobial resistant pathogens might pose a further risk to the 
health of human beings due to the ease of resistance-gene transfer between 
bacterial populations (Kesarcodi-Watson et al., 2008; Schwarz et al., 2001). Despite 
a lack of reports on adverse effects on human health from agents in aquaculture 
products, their presence has a major influence on market acceptability and on the 
economics of aquaculture (Karunasagar, 2012; Kesarcodi-Watson et al., 2008). For 
these reasons, nowadays several countries, governments and organizations have 
set tight legislations restricting the use of antibiotics in terrestrial as well as aquatic 
animal feeds. This ranges from certification of some drugs for use as in the case of 
several Asian countries to a total ban on the non-therapeutic use of any drug in the 
production of feed animals as in the case of the European Union (EU) and the 
Norwegian salmon industry (Kesarcodi-Watson et al., 2008). The use of antibiotics 
should only be considered a short-term and emergency type of solution. To avoid 
economic losses due to diseases and the stress of treatments themselves, a 
proactive strategy of prevention is strongly advised. The development of 
alternative treatments should focus on the search for microbial methodologies, 
which are based on natural processes ubiquitous in the environment (De Schryver 
et al., 2010; De Schryver and Vadstein, 2014; Defoirdt et al., 2007a).  
Quorum sensing disruption 
A number of Gram-negative pathogenic bacteria have a quorum sensing system 
that regulates the expression of their virulence (Bruhn et al., 2005). Quorum sensing 
(QS) is a mechanism by which bacteria coordinate the expression of certain genes in 
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response to the presence or absence of small signaling molecules (Defoirdt et al., 
2007a). N-acyl-L-homoserine lactones (AHLs) are commonly produced and used 
by the bacteria as the QS signaling molecules (Antunes et al., 2010; Camilli and 
Bassler, 2006). For example, the production of AHLs was observed by the pathogen 
E. tarda isolated from diseased flounder and turbot (Han et al., 2010; Morohoshi et 
al., 2004) and Pseudomonas sp. isolated from diseased Nile tilapia (Chang et al., 
2012). These findings suggest that some virulence factors of these pathogens are 
regulated by the QS system. 
The disruption of bacterial quorum sensing, called quorum quenching, has been 
proposed as an anti-infective strategy and several techniques that could be used to 
disrupt quorum sensing have been investigated. These techniques comprise (1) the 
inhibition of signal molecule biosynthesis, (2) the application of quorum sensing 
antagonists (including natural occurring as well as synthetic halogenated 
furanones, antagonistic quorum sensing molecules and undefined exudates of 
higher plants and algae), (3) the chemical inactivation of quorum sensing signals by 
oxidised halogen antimicrobials, (4) signal molecule biodegradation by bacterial 
lactonases and by bacteria and eukaryotic acylases and (5) the application of 
quorum sensing agonists (Defoirdt et al., 2004). Chen et al. (2010) reported that 
recombinant AHL-lactonase from Bacillus sp., when co-injected with the fish 
pathogen Aeromonas hydrophila in common carp, decreased the mortality rate and 
delayed the time of death of the fish. Recently, Villamil et al. (2014) reported that 
the extracellular products of Lactobacillus acidophilus showed in vitro antibacterial 
capacity against pathogen A. hydrophila and S. agalactiae in Nile tilapia culture, and 
that viable L. acidophilus was able to disrupt quorum sensing activity by the 
inhibition of violacein production that is closely related to the mechanisms of N-
acyl homoserine lactone disruption and quorum sensing regulation in 
Chromobacterium violaceum (Morohoshi et al., 2008). This suggests that L. acidophilus 
can be regarded as a potential biocontrol agent (Defoirt et al. 2004). Although the 
technique seems very promising, it will take a while before practical applications 
come within reach as very limited knowledge is available on the QS interference 
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(Tinh et al., 2008). Further research should be oriented on the establishment of the 
nature of the molecules responsible for the quorum quenching activity that makes 
it useful as a biocontrol agent. 
Probiotics and prebiotics 
The research of probiotics as an alternative biocontrol strategy is increasing with 
the demand for environment friendly aquaculture. Probiotics are defined as live 
microbial feed supplements that control and antagonist pathogens as well as 
promote the growth of the cultured organisms (Mohapatra et al., 2013; Verschuere 
et al., 2000). The probiotics most frequently used in fish, crustaceans and mollusks 
culture belong to the microaerophilic or facultative anaerobic genera 
Carnobacterium, Bacillus, Lactobacillus, Lactococcus, Pediococcus, Enterococcus 
(Gatesoupe, 2008; Mohapatra et al., 2013; Verschuere et al., 2000; Villamil and 
Novoa, 2009). Applications of several probiotic bacteria have indeed been found to 
improve survival and growth of Nile tilapia culture (Table 1.5). 
The most relevant mechanisms of action of probiotic bacteria in wide aquaculture 
practices are enzymatic contribution to feed digestion / nutrients utilization 
(Merrifield et al., 2010; Musa et al., 2009; Verschuere et al., 2000), competition with 
pathogens (Balca´zar et al., 2006), antimicrobial activity (Picchietti et al., 2007; 
Picchietti et al., 2009; Villamil et al., 2003), quorum sensing disruption (Defoirdt et 
al., 2004) and production of inhibitory substances like bacteriocins and ribosomally 
synthesized antibiotic peptides that constitute one of the most potent weapons to 
fight pathogen infections (Desriac et al., 2010). Several studies also demonstrated 
beneficial effects of probiotics on the immune system (Dimitroglou et al., 2011; 
Nayak, 2010; Perez and Fontanetti, 2011), increase in stress tolerance (Arockia Raj et 
al., 2008; Rollo et al., 2006), as well as fish reproduction (Gioacchini et al., 2012; 
Giorgini et al., 2010) and fish development (Carnevali et al., 2004).  
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 Table 1.5. Use of probiotics for health and growth promotion in tilapia culture 
 
Probiotic Life stage / size 
Disease  
causative agent 
Effect Reference 
     
Synbiotic Streptococcus 
(Enterococcus) faecium –  
Lactobacillus acidophilus 
Juvenile (~0.1g) No disease; normal 
culture 
 Increase in survival with 17 to 20% Lara-Flores et al. (2003) 
     
Lactobacillus rhamnosus Fingerling 
 (60-70 g) 
E. tarda  Increase in survival with 25 to 40% Pirarat et al. (2006) 
     
Synbiotic  Lactobacillus  acidophilus -  
Bacillus subtilis 
Fingerling 
 (20-30 g) 
A. hydrophila    Relative level of  protection (RLP) of 52 % Aly et al. (2008) 
P. fluorescens    RLP of 51 % 
S. iniae   RLP of 41 % 
     
Pediococcus acidilactici Adult  (~175 g) Natural effects  Increase in survival with 12 to 15% Ferguson et al. (2010) 
     
Lactococcus lactis Fingerling 
 (6.8±0.1 g) 
A. hydrophila   Increase in survival with 17 to 20% 
 Also increase in growth 
Zhou et al. (2010) 
     
Bacillus subtilis Fingerling 
(30±5 g) 
Flavobacterium 
columnare 
 Amelioration of lesions Mohamed and Refat 
(2011) 
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Besides probiotics, the applications of prebiotics have also been found to enhance 
growth and the health status of cultured animals. They are non-digestible dietary 
carbohydrates that escape digestion in the upper gastrointestinal tract but alter the 
bacterial composition of the gut by changing the type of substrate provided to the 
existing gut microbiota (Ringø et al., 2010). Compounds which have been shown to 
have prebiotic characteristics in aquaculture are fructo-oligosaccharides / FOS 
(Hui-Yuan et al., 2007), mannan-oligosaccharides / MOS (Dimitroglou et al., 2008; 
Sado et al., 2008), xylo-oligosaccharides (Xu et al., 2009),  transgalacto-
oligosaccharide / TOS, galacto-oligosaccharides (GOS), lactose, and inulin 
(Hoffmann, 2012). As such, prebiotics can be used as unique tools to create a gut 
microbiota with a controlled composition that can eventually be correlated with 
specific physiological conditions. This approach focuses on the beneficial activity of 
microorganisms already available in the aquaculture system, specifically the 
health-promoting microbial species already resident in the gastrointestinal tract of 
the aquatic animals (Ringø et al., 2010), such as Lactobacillus spp. and 
Bifidobacterium spp. (Manning and Gibson, 2004). 
Other beneficial effects of a prebiotic are characterized by (i) a decrease in harmful 
bacteria in the gut of the host; e.g. decrease in growth of pathogenic A. hydrophila, 
P. fluorescens and F. columnare in Nile tilapia culture by the application of the 
commercial prebiotic Bio-Mos® containing MOS extracted from S. cerevisiae yeast 
(Abu-Elala et al., 2013), (ii) changes in digestive enzymes concentrations; e.g. 
increase in amylase, protease and lipase activity in rainbow trout juvenile by the 
application of the commercial prebiotic GroBiotic®-A (Azari et al., 2011), and (iii) 
improvement in host digestive system; e.g. increase in absorptive surface in the 
posterior gut region, microvilli density and microvilli length of rainbow trout, by 
the application of the prebiotic MOS (Dimitroglou et al., 2008) 
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Short Chain Fatty Acids (SCFAs) 
 
Short chain fatty acids (SCFAs) are major end-products of fermentation of dietary 
compounds (Gibson and Roberfroid, 2008; Titus and Ahearn, 1988). In mammals, 
the SCFAs associated with specific antimicrobial activity are either simple 
monocarboxylic acids such as formic, acetic, propionic and butyric acid (Titus and 
Ahearn, 1988), or carboxylic acids bearing an hydroxyl group (usually on the α 
carbon) such as lactic (2-hydroxypropanoic), malic (hydroxybutanedioic), tartaric 
(2,3-dihydroxy-Butanedioic), and citric (2-hydroxy-1,2,3-propanetricarboxylic) acid 
(Dibner and Buttin, 2002; Mortensen and Clausen, 1996). Several investigations 
demonstrate the effect of organic acids on the reduction of bacterial counts in the 
stomach (Kluge et al., 2004) and the duodenum (Kirchgessner and Roth, 1991; 
Hebeler et al., 2000; Hellweg et al., 2006), while acid tolerant beneficial Lactobacillus 
spp. seem to be unaffected or may even be enhanced in numbers (Hellweg et al., 
2006).  
SCFA are known to inhibit the growth of some potentially pathogenic bacteria, 
such as Salmonella spp., Vibrio sp. and Streptococcus sp. (Defoirdt et al., 2007a; Ewing 
and Cole, 1994). The growth inhibitory effect of SCFAs is believed to be caused by 
the undissociated form of the acid which is able to penetrate through the bacterial 
cell membrane. Once inside, the acid releases protons (H+) in the neutral cytoplasm 
decreasing the intracellular pH (De Schryver et al., 2010), forcing bacteria to 
redirect energy towards the efflux of the excess protons, thereby straining the cell 
metabolism leading to lower cell growth and even cell death (Kato et al., 1992) (Fig. 
1.7).  
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Figure 1.7. Mechanism of bacteriostatic activity of SCFAs (Defoirdt et al., 2009). 
 
Even though the antimicrobial effect of organic acids is well understood, the 
explanation for their growth-promoting effects remains speculative (Lückstädt, 
2007; Xie et al., 2003). SCFAs are known as an energy source for epithelial cells in 
the colon of mammals. In herbivorous mammals, i.e. ruminants, SCFAs production 
accounts for as much as 80 % of maintenance energy requirements (Engelhardt and 
Rechkemmer, 1985). Poultry and swine fed organic acid-supplemented diets have 
been reported to show improved feed intake, growth, feed utilization efficiency 
and health (Dibner and Buttin, 2002; Kluge et al., 2006; Partanen et al., 2002). In the 
field of aquaculture, the effects of SCFAs have not been studied to any great extent, 
but it has been shown that these substances can have growth promoting effects in 
several salmonids including Atlantic salmon, rainbow trout, and arctic charr, 
although some results are contradictory (Gislason et al., 1994; Lückstädt, 2007). In 
the case of Nile tilapia, citric acid (10-2 to 10-6 M) and lactic acid (10-2 to 10-5 M) that 
are added to experimental diet had stimulatory effects on the feeding response, as  
recorded by a function recorder (Xie et al., 2003). Another study reported 
potassium diformate (potassium salt of formic acid) as a growth promoter in Nile 
tilapia fingerlings, with an increase in weight gain of about 20 % (Ramli et al., 
2005). Similar results were achieved by Zhou et al. (2008), where an increase in 
growth of up to 11.6 % was observed in hybrid tilapia (O. niloticus x O. aureus) 
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fingerlings (2.7 g initial weight) fed with potassium diformate at different 
concentrations (0 %, 0.3 %, 0.6 %, 0.9 % and 1.2 % dry feed weight) during a 56 days 
trial period. In contrast, Petkam et al. (2008) reported no significant improvement 
in the growth performance of Nile tilapia fingerling fed an acid blend Biotronic® 
A.S. (containing Ca-formate, Ca-propionate, Ca-lactate, Ca-phosphate and citric 
acid) or potassium diformate, respectively, at various dietary levels. Though there 
are only a limited number of published studies on the use of organic acids for 
growth promotion, feed efficiency as well as mineral absorption and disease 
prevention in tilapia aquaculture, results from those studies indicate promising 
potential and compel aqua feed manufacturers to consider using organic acids in 
their diets. However, for the application of FAs in practice, the pH of the intestine 
seems to be a limiting factor as it determines the ratio between the undissociated 
(or active) and the dissociated (or less active) form of the FAs and thus the 
effectiveness of the treatment (Dibner and Buttin, 2002). Furthermore, these FAs are 
water-soluble compounds and thus achieving an efficient uptake of the FAs by the 
treated animals is often problematic. As an alternative, polyhydroxyalkanoates 
(PHAs) are more attractive to be applied due to their water insolubility, thus 
increasing the uptake efficiency. 
Polyhydroxyalkanoates (PHAs): production and degradation 
Several studies have evaluated SCFAs as biocontrol agents in animal production, 
with emphasis on polyhydroxyalkanoates (PHAs), which are polymers of β-
hydroxy SCFAs (De Schryver et al., 2010; Defoirdt et al., 2009). PHAs can be 
depolymerized by many different microorganisms that produce extracellular PHA 
depolymerases. PHAs can also be degraded upon passage through the animal’s 
gastrointestinal tract and consequently might result in biocontrol effects similar to 
those described for SCFAs.  
Polyhydroxyalkanoates (PHAs) are polyesters of various hydroxyalkanoates that 
are synthesized by many Gram-positive and Gram- negative bacteria from at least 
75 different genera mainly under conditions of nutrient limitation and carbon 
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excess (Tian et al., 2009). More than 150 constituents of polyhydroxyalkanoates 
(PHAs) have been identified and characterized (Wang and Liu, 2014). These 
polymers are accumulated intracellularly as / discrete granules to levels as high as 
90 % of the cell dry weight under conditions of nutrient stress and act as a carbon 
and energy reserve (Anderson and Dawes, 1990; Lenz and Marchessault, 2005).  
PHAs producing bacteria can be divided in two groups based on the culture 
conditions required for PHA synthesis (Lee, 1996). The first group requires the 
limitation of an essential nutrient such as nitrogen, phosphorus, magnesium, 
potassium, oxygen or sulphur for the efficient synthesis of PHA from an excess 
carbon source. The second group of bacteria does not require nutrient limitation for 
PHA synthesis and can accumulate polymers during growth. Alcaligenes eutrophus, 
Azotobacter vinelandii and Pseudomonas oleovorans and many other bacteria belong to 
the first group, while some bacteria such as Alcaligenes latus and recombinant E. coli 
and Klebsiella strains harbouring the PHA synthesis genes belong to the second 
group (Defoirdt et al., 2009). 
PHAs can be divided into three subgroups based on the number of carbon atoms in 
the monomer unit incorporated into the polymers. PHAs containing up to five 
carbon atom (C5) monomers are classified as short-chain-length PHA (scl-PHA). 
PHA with C6 - C14 and > C14 monomers are classified as medium-chain-length 
(mcl-PHA) and long-chain-length (lcl-PHA) PHA (Wu et al., 2009) (Fig. 1.8). 
Because of inherent biodegradability, PHAs have attracted the world-wide 
attention of scientists and researchers as an environment-friendly alternative to the 
conventional petroleum-based polymers and applications of PHAs have been 
reported in packaging industry, agriculture, automotive sector, food industry and 
medical implantation devices (Kalia et al., 2011).  
PHAs differ from synthetic polymers because of their biodegradability by 
depolymerase enzymes in bacteria. The PHA degradation pathway in PHA 
accumulating bacteria begins with the depolymerisation of PHA to β-
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hydroxyalkanoate monomers by intracellular PHA depolymerase enzymes 
(Kadouri et al., 2005).  
 
Figure 1.8:  General structure of polyhydroxyalkanoates, R is variable. When X = 1, 
R = CH3, the monomer structure is 3-hydroxybutyrate and the polymer 
is poly-3-hydroxybutyrate (poly-β-hydroxybutyrate) (Wu et al., 2009). 
 
Different aerobic and anaerobic microorganisms isolated from a variety of 
ecosystems are able to degrade extracellular PHAs. Depending on the pH, 
temperature and polymer crystallinity, the degradation of PHAs occur via 
enzymatic or chemical hydrolysis. Characteristics such as stereoregularity, 
crystallinity, monomeric composition and accessibility of the polymer surface affect 
the biodegradability by the microorganisms (Defoirdt et al., 2009). PHAs can also 
be degraded upon passage through the gastrointestinal tract of animals and 
consequently adding these compounds to the feed might result in biocontrol effects 
similar to those described for SCFAs. As PHAs can be degraded into SCFA β-
hydroxy (i.e. β-hydroxybutyrate), the potential of β-hydroxybutyrate and its 
natural polymer poly-β-hydroxybutyrate (PHB) as biocontrol agents in aquaculture 
practices have been intensely investigated. 
β-hydroxybutyrate 
β-hydroxybutyrate (β-HB) has important roles in mammalian health and disease 
(Dedkova and Blatter, 2014). In mammals, β-HB is a metabolic intermediate that 
constitutes up to 70 % of ketone bodies. The term “ketone bodies” refers to three 
molecules: (1) β-HB, (2) its dehydrogenated counterpart acetoacetate (AcAc), and 
(3) the decarboxylated AcAc, acetone. The β-HB is produced in liver mitochondria 
during ketogenesis, the process by which FAs released from adipose tissue are 
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transformed into AcAc and β-HB (Dedkova and Blatter, 2014) (Fig. 1.9). The 
process can occur in response to unavailability of blood glucose (Robinson and 
Williamson, 1980), where the production of ketone bodies is then initiated to make 
available energy primarily from fatty acids. The ketone bodies are then transported 
by the blood to the extrahepatic tissues, where they are oxidized via the 
tricarboxylic acid (TCA) cycle to provide the energy required by tissues such as 
skeletal and heart muscle. Studies with rats indicated that β-HB was shown to be 
one of the main precursors, next to acetate and butyrate, of the de novo synthesis of 
lipids in colonic epithelial cells in rats (Zambell et al., 2003). The net effect is a 
greater potential for ATP production, suggesting β-HB as the most efficient fuel in 
the heart (Dedkova and Blatter, 2014; Kashiwaya et al., 1994; Sato et al., 1995). β-HB 
can also serve as building block for the synthesis of fine chemicals such as vitamins, 
antibiotics, aromatics and pheromones (Chiba and Nakai, 1985; Seebach et al., 
2001). It has been patented as human nutritional and dietary supplement for the 
purpose of seizure control, metabolic disease control, reduction of protein 
catabolism, appetite suppression, increased cardiac efficiency, treatment of 
diabetes, and treatment of effects of neurodegenerative disorders and epilepsy 
(Martin et al., 2000). Recently, Dedkova and Blatter (2014) reported that in 
mammals a mild elevation in β-HB levels can modulate the important signaling 
cascades involved in cell growth, cell proliferation and defense against oxidative 
stress, while its polymer PHB has proved to be involved in regulation of protein 
channels in plasma membrane and mitochondria. 
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Figure 1.9. Synthesis of β-HB in the formation of ketone bodies in liver mitochondria; reproduced 
from Dedkova and Blatter (2014). The synthesis of β-HB begins with the condensation of two 
molecules of acetyl-CoAtoformacetoacetyl-CoA, the parent of the three ketone bodies, by a 
ketothiolase enzyme. In prokaryotes, this intermediate is subsequently reduced with NADPH 
to hydroxybutyryl-CoA by acetoacetyl-CoA reductase, and hydroxybutyryl-CoA may then be 
polymerized to form PHB by the enzyme PHB synthase. In eukaryotes, 3-hydroxy-3-methyl 
glutaryl-CoA synthase (HMG synthase) catalyzes the condensation of acetoacetyl-CoA with a 
third acetyl-CoA to form β-hydroxy-β-methylglutaryl-CoA (HMG-CoA). The enzyme HMG-
CoA lyase then catalyzes the decomposition of HMG-CoA to form acetoacetate and acetyl-
CoA, and acetoacetate is further reduced with NADH by phosphatidylcholine-dependent 
mitochondrial D-β-hydroxybutyrate dehydrogenase to form β-HB. 
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In mammals and other higher vertebrates, during the ketone body metabolism, β-
HB can only be produced from FAs if the enzyme β-HB dehydrogenase (HBDH) is 
available (Fig. 1.9). In fish, activity of HBDH has been detected in freshwater teleost 
species, including the northern brown bullhead Ictalurus nebulosus, northern 
pike Esox lucius, black crappie Pomoxis nigromaculatus, and goldfish Carassius 
auratus, and also marine teleost species, including alewife Alosa pseudoharengus, 
smelt Osmerus mordax, and mummichog Fundulus heteroclitus, with the highest 
activity observed in the liver and kidney of fresh water teleosts and in the brain 
and liver of the marine teleosts (Leblanc and Ballantyne, 1993; 2000). The role of 
cytosolic form of HBDH in mammalian ruminants whose nutrients were obtained 
mostly from plant carbohydrates has been attributed to the use of butyrate from 
microorganisms as a carbon source for ketone body formation (Watson and 
Lindsay, 1972). Consequently, it has been hypothesized that in fishes capable of 
digesting plant carbohydrates, a system similar to that of ruminant mammals may 
prevail (Ballantyne, 2014), and this could be the case for tilapia. β-HB formation 
from butyrate has been demonstrated in liver slices of rainbow trout (Salmo 
gairdneri) and eel (Anguilla australis), contributing to 6 % of the measured total 
ketone bodies (AcAc and β-HB) in the liver slices (Phillips and Hird, 1977). β-HB 
has also been detected in the plasma of the two species at levels similar to those of 
mammals of 60-70 % of total blood ketone bodies (Phillips and Hird, 1977). 
However, further studies are needed to demonstrate the utilization of β-HB and to 
elucidate the role of ketone bodies in fish.  
Poly-β-hydroxybutyrate (PHB) 
Like their petrochemical counterparts, PHAs are moldable, water-insoluble, 
thermoplastic polymers. PHB (also known as poly-β-hydroxybutyrate), the most 
common PHA, is a stiff, high-melting-point aliphatic polyester similar to many 
industrial polyolefins (polyethylenes, polypropylenes), that can be used as an 
alternative source of plastics (Byrom, 1987).  It is a biopolymer consisting of linear 
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chains of β-HB. Three groups of PHB with different numbers of β-HB units and 
with different functions have been discovered: (i) high molecular weight storage 
PHB consists of 10,000 to > 1,000,000 β-HB residues (storage PHB), (ii) low 
molecular weight PHB with medium–chain length consisting of 100–300 residues 
(oligo-PHB), and (iii) short-chain conjugated PHB in which low numbers of β-HB 
residues (≤ 30) are covalently linked to proteins (see Reusch 1992, 2012, 2013 for 
comprehensive reviews). Storage PHB was first discovered in granular inclusion 
bodies (termed carbonosomes) within cytoplasmic granules of Bacillus megaterium 
in 1925, and later in a wide variety of archaea and eubacteria, principally those that 
inhabit soil and water ecosystems (Anderson and Dawes, 1990; Nuti et al., 1972; 
Poli et al., 2011). PHB produced by these prokaryotes when nutrients such as 
nitrogen and phosphorous source are available in limiting concentrations in the 
presence of excess carbon source (Anderson and Dawes, 1990; Reusch, 2012).  
Even though there are more than 250 different microorganisms synthesizing PHAs, 
only several of these, such as Alcaligenes eutrophus (Kim et al., 1994), Alcaligenes 
latus (Yamane et al., 1996), Azotobacter vinelandii (Page and Knosp, 1989), 
methylotrophs (Kim et al., 1996), Pseudomonas oleovorans (Brandl et al., 1988) and 
recombinant Escherichia coli (Lee and Chang, 1994; Lee et al., 1997) are suitable for 
the production of PHAs to a high concentration with high productivity. 
Biodegradable plastics have been available for many years on the market; however, 
their high cost has meant they have not replaced the traditional non-degradable 
plastics. Up until now, researchers continue to work on the optimization of PHB 
production by microorganisms through evaluation of the physical and 
environmental factors that lead to the maximization of PHAs production using 
agro-industrial waste products as cheap carbon sources, and scaling up the product 
as a step to be used in large scale industry for its high economic and commercial 
value and its value as a product that is safe for the environment. 
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Use of PHB as biocontrol agent in aquaculture 
In the early investigation of the potential use of PHB for aquaculture applications, 
Defoirdt et al. (2007b) showed that PHB increased survival and growth of starved 
Artemia nauplii and also protected the nauplii culture from V. campbellii infection. It 
was hypothesized that the higher growth of Artemia nauplii and protection against 
V. campbellii following PHB supplementation is due to the release of β-HB and 
production of ketone bodies (Defoirdt et al., 2007b). In order to evaluate the 
potential use of PHB as growth modulator, De Schryver et al. (2010) replaced 
European sea bass diet partially with PHB at a 2 %, 5 % and 10 % inclusion level. 
Their findings suggested that PHB could serve as an energy source in sea bass 
juveniles (as for a diet with 100 % PHB survival was considerably higher than for 
starved animals) and significantly increased growth rate and decreased FCR when 
present at 2 % and 5 % in the diets. A decrease of the gut pH from 7.7 to 7.2 was 
observed, suggesting that PHB can be degraded in the gut, leading to an increased 
production of acidic compounds, likely β-HB. It is reported that the highest 
bacteria range-weighted richness in the fish intestine was observed in the 2 % and 5 
% PHB treatments, and that higher dietary PHB levels induced larger changes in 
the bacterial community composition (De Schryver et al., 2010). 
Another study by Nhan et al. (2010) investigated the effects of feeding enriched 
Artemia nauplii with PHB and/or highly unsaturated fatty acids (HUFAs) on the 
growth performance of giant freshwater prawn (Macrobrachium rosenbergii) larvae. 
Their results revealed that feeding the larvae with PHB containing Artemia nauplii 
significantly increased survival as well as larval development. Also, PHB 
significantly decreased the number of Vibrio spp. and total bacterial counts when 
compared to a control treatment, indicating that the PHB addition had a growth-
inhibitory influence towards these potentially pathogenic microorganisms. PHB 
was also tested in Siberian sturgeon (Acipenser baerii) fingerlings (Najdegerami et 
al., 2012). In their study, PHB affected the gut microbial species richness and 
diversity; however, unlike studies of European sea bass and giant freshwater 
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prawn, no growth modulation was observed. The effects of feeding Artemia nauplii 
enriched with or without PHB and/or HUFA on sturgeon larvae were also 
investigated (Najdegerami et al., 2013). The results showed that PHB and 
PHB+HUFA supplementation decreased the growth performance of the larvae. In 
addition, PHB decreased the survival when larvae were challenged in different 
salinities and ammonia stress levels. It is suggested that the effects of PHB can be 
species specific and thus the optimal PHB doses for bio-encapsulation into Artemia 
remain to be determined for application at the earliest larval stages of sturgeon.  
Sui et al. (2012) investigated the protective effect of PHB on Chinese mitten crab 
(Eriocheir sinensis) zoea larvae challenged with V. anguillarum at a final 
concentration of 105 CFU mL-1. PHB was delivered to the larvae through rotifer and 
Artemia bioencapsulation, which were added to the culture water 24 h prior to 
challenge, upon challenge and 24 h after challenge. The results illustrated that PHB 
could enhance the survival and growth of unexposed Chinese mitten crab larvae. 
Moreover, PHB protected the larvae from the pathogen as the larvae fed PHB-
enriched live food showed the highest survival and development rate in all 
challenged groups. Furthermore, larval performance was the best when PHB was 
delivered to the larvae 24 h before challenge. These results indicate that PHB can be 
used as part of an effective strategy to protect Chinese mitten crab larvae from V. 
anguillarum infection resulting in higher survival and better growth, especially 
when applied before the challenge.  
More recently, Thai et al. (2014) investigated the effect of administering PHB-
accumulated Alcaligenes eutrophus H16 (containing 10 % or 80 % PHB on dry 
weight) on the culture performance of larvae of the giant freshwater prawn. It was 
found that feeding prawn larvae with Artemia nauplii enriched in a medium 
containing 100 and 1,000 mg L−1 A. eutrophus containing 80 % PHB significantly 
increased the survival with about 15 % and the development of the larvae with a 
larval stage index of about 1 as compared to feeding non-enriched Artemia. The 
survival of the larvae also significantly increased with about 35 % in case of a 
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challenge with V. harveyi. Their findings emphasized that PHB supplemented in a 
bacterial carrier (i.e. amorphous PHB) can increase the larviculture efficiency of 
giant freshwater prawn similar to supplementation of PHB in powdered form (i.e. 
crystalline PHB).  
All previous studies suggest the potential of PHB as a biocontrol agent, which may 
serve as an alternative to antibiotic treatments for a more sustainable aquaculture. 
Furthermore, PHB can be completely degraded aerobically and anaerobically by 
microorganisms (Miller and Williams, 1987; Pişkin, 1995). The biodegradability of 
PHB may thus also be considered as an attractive property of PHB with respect to 
sustainable aquaculture. The biodegradation of PHB and its composites in natural 
ecosystems, such as soil, compost, and bodies of water, was described in a number 
of publications (Iordanskii et al., 2014; Lenz and Marchessault, 2005; Mergaert et 
al., 1992). The end products of PHB biodegradation in aerobic environments are 
carbon dioxide and water, while methane is also produced in anaerobic conditions 
(Song et al., 2009). Unlike in agriculture / livestock production, the production of 
methane gas due to the anaerobic biodegradation of aquaculture waste derived 
from PHB-supplemented system will have very little impact, if any, on the 
environment due to the low level of PHB supplementation in fish diets (ranging 
from 2 to 5 % PHB diet in the previous studies), considering the high cost of PHB 
production (Choi and Lee, 1997; 1999; De Schryver, 2010).  
 
Research objectives  
The general objective of this study was to explore the full potential of PHB as an 
ecologically and economically sustainable alternative as growth modulator and 
anti-infective strategy for aquaculture production. Despite the demonstrated 
growth modulation and protection against bacterial infections in different aquatic 
animals, the mechanisms of action of PHB or its fate within the animal are far from 
understood. Previously, the beneficial effect of PHB on fish culture performances 
has been studied in European sea bass culture – carnivorous; marine cold-water 
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species – and Siberian sturgeon culture – carnivorous; freshwater cold-water 
species –; both are species that are high at the trophic level. PHB has not been 
tested on fish species that feed generally on a low trophic level, and which can rely 
from food items from different trophic levels to a varying extent and thus are more 
flexible in terms of feed ingredient use and might benefit more from dietary PHB 
supplementation. As for this, Nile tilapia – omnivorous; freshwater warm-water 
species – is chosen as the experimental animal in this study. This study evaluates 
the application of PHB and its beneficial effects for tilapia culture at different 
developmental stages of tilapia (juvenile, fingerling), in different culture conditions 
(open system vs. gnotobiotic/closed system) and identifies possible mechanisms of 
action responsible for the beneficial effects of PHB on the fish growth and health 
promotion. Figure 1.10 illustrates how the different chapters in this manuscript 
contribute to knowledge in those two fields. 
 
Thesis outline 
The effects of PHB on growth parameters, fish composition and digestive enzyme 
activities of Nile tilapia juvenile culture are evaluated in Chapter 2. As the gut 
microbial community (MC) is hypothesized to play a significant role in the nutrient 
digestion and metabolism, the effects of PHB on the functional physiological 
profiles of the tilapia gut MC are evaluated in Chapter 3. Using the Biolog 
Ecoplate™ assay, it was targeted to apply the gut microbiota’s functional 
physiological profile to provide an understanding of the mechanism of action of 
PHB on fish growth modulation in terms of microbial nutrient digestion. Chapter 4 
then describes the investigation of the compartmental distribution of PHB 
throughout the fish body after ingestion using the stable isotope 13C as a PHB 
tracer. Based on the obtained results hypotheses were formulated about the PHB 
metabolism / utilization in the fish body and the possible mechanism of action of 
PHB in fish growth modulation in terms of fish physiology. In addition to the 
study of PHB on tilapia growth modulation, the effect of PHB on tilapia disease 
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resistance is evaluated in Chapter 5. The survival performance of fish larvae 
supplemented with PHB was studied in a gnotobiotic bacterial challenge test. Here, 
the effect of PHB on larvae resistance towards pathogen infection is discussed. The 
last chapter (Chapter 6) provides an overview and discussion of the research 
outcomes from previous chapters and formulates recommendations for future 
research. 
 
  
 
 
 
 
PHB 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.10. Overview of possible roles of PHB in the enhancement of aquaculture 
performance and the coverage of these aspects in the chapters of the 
present manuscript. The italic letters indicate information / results 
from other studies (not covered in the thesis). 
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Chapter 2 
Poly-β-hydroxybutyrate supplementation in Nile tilapia juvenile 
culture 
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Abstract 
The contribution of poly-β-hydroxybutyrate (PHB) provided in different 
formulations to the growth stimulation and protection against bacterial infections 
has been studied in several aquatic animal species. This study investigated the 
effect of crystalline PHB, directly included in the formulation of a semi-purified 
diet, on the survival and growth parameters, digestive enzymes activity, and body 
composition of juvenile Nile tilapia (Oreochromis niloticus). Dietary PHB 
supplementation over a 28 days feeding period resulted in no significant difference 
in the mean final body weight (258 to 284 mg), when compared to the control 
group (218 mg). Digestive enzyme lipase activity was increased with about 20 to 40 
% by the dietary PHB supplementation. This higher lipase activity might have led 
to the significant increase in the total lipid content with about 10 % in the PHB 
treatment groups. Dietary PHB resulted in increasing contents of total (n-6) fatty 
acids (FAs), total monounsaturated FAs and total saturated FAs with about 15 % 
DW, 15 % DW and 20 % DW, respectively, as compared to the control. However, 
the composition of the FAs groups in the total lipid was similar among various 
PHB treatments. This study suggests that PHB may potentially improve the growth 
of Nile tilapia, possibly by the stimulation of intestinal lipid digestion, absorption 
and deposition. We hypothesize that the altered lipid utilization may have resulted 
from diet-induced alterations in the GI microbiota composition. Future studies on 
the host microbiota-diet interactions are expected to contribute to a more advanced 
knowledge of the possible mechanisms of action of PHB in the alteration of 
nutrient utilization by the host, which could potentially result in growth 
enhancement in aquaculture practices. 
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Introduction 
The expansion of aquaculture production and intensification of culture systems 
goes hand in hand with an increase in bacterial and parasitic fish disease outbreaks 
(Miranda et al., 2013). Under intensive culture conditions, fish are exposed to 
numerous stressors that can interfere with their immune response and resistance to 
infectious microorganisms in the culture environment. Antibiotics, disinfectants 
and parasiticides have been commonly applied to improve the health status of the 
cultured organisms and to prevent or treat bacterial and parasitic diseases in fish 
and crustacean cultures. However, the excessive use of these antimicrobials leads 
to multiple resistance in pathogens (Defoirdt et al., 2007a) and negatively affects 
animal and human health as well as the aquatic environment (Cabello et al., 2013; 
Rico and Van den Brink, 2014; Sapkota et al., 2008). Therefore, such products are 
being withdrawn from the global market. Consequently, different alternative 
biocontrol measures including the use of probiotics (Nayak, 2010; Tinh et al., 2008; 
Verschuere et al., 2000) and quorum sensing disruption (Defoirdt et al., 2004; 
Defoirdt et al., 2006a; Defoirdt et al., 2011) have been developed to control bacterial 
infections and to achieve an environment friendly sustainable aquaculture 
industry.  
Also short-chain fatty acids (SCFAs) have been suggested as a bio-control measure 
in aquaculture (Defoirdt et al., 2006b; Defoirdt et al., 2007a; Defoirdt et al., 2009). 
However, their main limitation for application in aquaculture is their polar nature 
making them highly soluble and easy to diffuse in the culture water. This results in 
a low uptake efficiency of the SCFAs by the animal and thus demands for higher 
concentrations to be effective at the animal level (Defoirdt et al., 2011). A solution 
has been provided in the form of the bacterial polymer PHB, which is water 
insoluble and biologically degradable (Anderson and Dawes, 1990; Doyle et al., 
1991). It serves as a carbon reserve and intracellular energy source for different 
species of bacteria (De Schryver et al., 2010; Defoirdt et al., 2011; Tokiwa and 
Calabia, 2007). 
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Several studies have confirmed the protective role of PHB in the host against 
bacterial infections (Defoirdt et al., 2007b; Sui et al., 2012; Thai et al., 2014), but 
interestingly enough an increased growth performance in crustaceans and fish has 
also been described. The use of PHB, both in particulate and bacterial form, 
resulted in a significant increase in survival of starved Artemia nauplii (Defoirdt et 
al., 2007b). Nhan et al. (2010), then again, found an increased growth performance 
and survival in giant freshwater prawn (Macrobrachium rosenbergii) larvae fed with 
PHB-enriched Artemia. In another study, Sui et al. (2012) have also found an 
enhanced growth and survival effect of PHB-enriched rotifer and Artemia on the 
larvae of the Chinese mitten crab (Eriocheir sinensis). And most recently, it has been 
described that the supplementation of PHB in a bacterial carrier (i.e. amorphous 
PHB) was found effective to support the growth and development of M. rosenbergii 
larvae (Thai et al., 2014). The beneficial effects of PHB dietary supplementation on 
growth performance have also been described for fish. Examples are European sea 
bass (Dicentrarchus labrax) juveniles and Siberian sturgeon (Acipenser baerii) 
fingerlings (De Schryver et al., 2010; Najdegerami et al., 2012).  
In this study, the effect of amorphous PHB administered via a semi-purified diet to 
Nile tilapia (Oreochromis niloticus) at the early juvenile stage was investigated in 
terms of survival and growth performance, and the digestive enzyme activities. 
Based on the current knowledge and the results of this study, suggestions for 
future studies to further evaluate the mechanisms of action of PHB are made.  
Materials and Methods 
Experimental setting 
Nile tilapia juvenile were produced and reared on commercial diet at the 
Aquaculture and Fisheries Group (AFI) of Wageningen University and Research 
Centre, the Netherlands. Juvenile were collected and acclimated in a 50 L aquarium 
for 14 days prior to stocking. During this period, they were fed the experimental 
basal diet (without PHB supplementation) three times daily to apparent satiation. 
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At the end of the acclimation period, fish with an average weight of 26.4±2.4 mg 
were randomly distributed in 12 rectangular aquaria of 38 L (50 fish per aquarium) 
with a flow-through system supplied with dechlorinated, heated tap water at a 
water renewal rate of 38 L/5 L h-1 hour, results in a hydraulic retention time of 7.2 h. 
During the feeding experiment, water temperature was maintained at the level of 
28±1 °C with pH level ranging from 8.2 to 8.8. NH4+, NO2-, and NO3- level never 
exceed 0.05 mg L-1 NH4-N, 0.5 mg L-1 NO2-N and 2.5 mg L-1 NO3-N, respectively. 
The experiment was carried out under a 16:8 h light:dark light regime. Water flow 
rate was checked and adjusted daily to ensure proper water exchange. In order to 
prevent feed loss during the feeding period by water exchange, the flow through 
system was only activated during the dark period. 
Experimental diets and feeding regime 
A basal semi-purified diet (control diet) was formulated to contain approximately 
450 g kg-1 crude protein (Balarin and Halfer, 1982) and 150 g kg-1 lipid (Ng and 
Chong, 2004) based on the feedstuff values reported in NRC (1993) (Table 2.1). The 
analyzed crude protein level in the basal diet, however, was higher than expected 
(52.4 % DM instead of 45 % DM). The PHB experimental diets were the basal diet 
supplemented with three levels of crystalline PHB (5, 25, and 50 g kg-1 diet; 
Goodfellow Cambridge Limited, Huntingdon, England), at the expense of the -
cellulose. The moist mixture was extruded through a 3-mm diameter meat grinder 
(Hobart Corp., Troy, Idaho, USA). The resulting moist pellets were air-dried at 
room temperature to a moisture content of about 100 g kg-1. Pellets were ground 
into small pieces, sieved to obtain appropriate sizes (300-500 µm) and stored at −20 
°C until used. Fishes were fed daily at a fixed feeding level of 20 % on fish wet 
body weight (BW) (Ng and Romano, 2013) in three equal meals given every 4 hours 
between 09:00 and 17:00. The feed amount was adjusted daily based on mortality 
and weekly based on the average weight of the fish in the tank. Each experimental 
diet was tested in triplicates. 
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Table 2.1.   Formulation of basal semi-purified diet (control diet) for Nile tilapia 
juvenile 
 
Ingredients g kg-1 
Carboxymethyl cellulose (Sigma) 20 
Vitamin C (Stay-C 35 % VDS) 0.6 
L-methionine (Sigma) 5 
Vitamins + Minerals mix (VDS) 12.5 
L-lysine (Sigma) 15 
Choline chloride 1.8 
-cellulose 50 
Corn meal (Bio Planet) 100 
Fish herring meal (VDS) 200 
Corn gluten meal (Sigma) 500 
Fish oil (VDS) 20 
Soybean oil  75 
Vitamin E (95 %)  0.1 
Analyzed nutrient content g kg-1 DM 
DM (g kg-1) 922 
Crude protein 524 
Crude fat 146 
Ash 54 
Total carbohydrates* 276 
*Calculated as follows: total carbohydrates (starch, free sugars 
and NSP) = 1000 - (crude protein + crude fat + ash) 
 
Fish survival and growth parameters 
Six juveniles from each replicate tank were randomly collected every week 
minimally 14 h after the last feeding to monitor the growth performance. The 
average weight gain of the fish in a tank over the 28 days was calculated by 
subtracting the weight of the fish sampled on the final day of the experiment with 
the average weight of the fish as measured at the beginning of the experiment, and 
then taking the average. The specific growth rate (SGR) was calculated as follows:  
SGR (% body weight gain per day)   
     –      
 
  
where W is the average body weight after 28 days, W0 is the average initial body 
weight, and t is experimental period (28 days). The same approach was used to 
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calculate the feed conversion ratio (FCR), expressed as the feed consumption over 
the weight increase of the fish per treatment. Fish survival for individual 
treatments was determined as the number of surviving fish at the end of 
experimental period relative to the number of fish at the beginning of the 
experimental period.  
Fish sampling and analyses  
Assessment of digestive enzymes activity 
Whole-body homogenates were used instead of organ-specific (i.e. intestine) 
homogenates to provide enough wet sample for enzymatic assays due to the small 
size of fish. Fish samples were taken minimally 14 h after the last feeding. Three 
fishes from each replicate tank were randomly sampled, euthanized with an 
overdose of Tricaine mesylate (0.1 % Tricaine methanesulfonate, MS-222; Sigma 
Chemical Co., St Louis, USA) and stored at -80 °C until homogenization. Samples 
were homogenized in 50 mM Tris-HCl buffer at 5:1 ratio (pH 7.5) in an electric 
homogenizer (Heidolph, Instruments Switzerland). All these processes were 
performed on ice. The homogenate was centrifuged at 10,000 g for 20 min at 4 ˚C 
and the supernatants collected and stored in small aliquots (100–200 μL) at −80 °C 
until the spectrophotometric assays of digestive enzyme activities.  Lipase activity 
was quantified using 10 mM p-nitrophenol myristate as a substrate in 0.25 M Tris-
HCl (pH 9.0). After 15 min of incubation at 25 ˚C, the p-nitrophenol released was 
monitored spectrophotometrically at 405 nm, using a standard curve of absorbance 
at wavelength of 405 nm against different p-nitrophenol concentrations (0–500 
μmol). One unit of lipase activity is defined as the amount of substrate (μmol) 
hydrolyzed per minute per mg protein at 25 ˚C (Iijima et al., 1998). Trypsin activity 
was quantified using N-α-benzoyl-dl-arginine p-nitroanilide (BAPNA) as a 
substrate in 50 mM Tris-HCl and 20 mM CaCl2 buffer (pH 8.2). After 15 min of 
incubation at 25 ˚C, the BAPNA released was monitored spectrophotometrically at 
407 nm, using a standard curve of absorbance at wavelength of 407 nm against 
different BAPNA concentrations (0–500 μmol). One unit of trypsin activity 
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represents 1 μmol equivalent liberated BAPNA per min at 25 ˚C (Holm et al., 1988). 
Pepsin activity was quantified using 2 % hemoglobin in 0.06 N HCl as a substrate 
(Cahu and Zambonino Infante, 1994) and tyrosin as a standard. After 10 min of 
incubation at 37 ˚C, the tyrosin released was monitored spectrophotometrically at 
280 nm, using a standard curve of absorbance at wavelength of 280 nm against 
different tyrosin concentrations (0–500 mg L-1). One unit of pepsin activity is 
defined as the amount of enzyme required for the formation of 1 mg of tyrosin per 
min at 25 ˚C. Amylase activity was determined as illustrated by Najdegerami et al. 
(2013) using 0.3 % soluble starch as substrate dissolved in NaH2PO4 buffer (pH 7.4). 
After 30 min of incubation at 37 ˚C, the starch hydrolyzed was monitored 
spectrophotometrically at 540 nm, using a standard curve of absorbance at 
wavelength of 540 nm against different starch concentrations (0–500 mg L-1). One 
unit of amylase activity is defined as the amount of starch (mg) hydrolyzed during 
30 min per mL homogenate at 37 ˚C.  
All assays of digestive enzyme activity were carried out in triplicate using the Bio-
Rad Benchmark Plus microplate spectrophotomer and Falcon flat-bottom 96-well 
microplates (Fisher Scientific). All pH values listed for buffers were measured at 
room temperature, and all reagents were purchased from Sigma-Aldrich Chemical. 
Each enzyme activity was measured in each individual fish, and blanks consisting 
of substrate only and sample only (in buffer) were conducted simultaneously to 
control for background activity (i.e. activity by endogenous substrate and/or 
product in the tissue homogenates and substrate solutions). Background was 
accounted for by substracting the measured OD of the sample with OD of 
background control prior to plotting on the standard curve.  The total protein 
content was measured according to the method of Bradford (1976) using bovine 
serum albumin as standard. The specific activity of measured enzymes is expressed 
as unit enzyme activity per mg protein (U mg protein-1).  
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Total protein and lipid content analyses 
At the end of the experiment, remaining fish from each replicate tank were pooled 
(total wet weight of 2-3 g) and the total protein and lipid content in the whole-fish 
body of each treatment was analysed following the standard methods. Nitrogen 
content was analyzed by the Kjeldahl method (AOAC, 2000) and crude protein 
content was estimated by multiplying nitrogen percentage by 6.25. Lipid content in 
the whole body was analyzed by extraction following the modification of Folch 
method demonstrated by Ways and Hanahan (1964). Fatty acid composition was 
determined by gas chromatography. Fatty acid methyl ester (FAME) analysis was 
performed following a modified procedure of Lepage and Roy (1984).  
 
Statistical analyses 
Normalization of the distribution of the survival and final body weight data were 
done using arcsin and log transformation, respectively. Comparison of the fish 
survival, final body weight and length, SGR, FCR, and digestive enzyme activities 
were done using one-way analysis of variance (ANOVA) analysis. Grouping of 
treatments based on significant differences in mean values was done according to 
Tukey test (0.05 level of confidence). STATISTICA statistical software (version 7.0) 
was used for these statistical analyses. 
Results 
Fish survival and growth parameters 
The initial mean fish body weight was 26.4±2.4 mg which after 28 days of feeding 
increased to 218±101, 284±61, 269±68, and 258±48 mg for the 0, 5, 25, and 50 g kg-1 
PHB treatment, respectively (Table 2.2). Each PHB treatment obtained similar SGR 
value as the control group, with the range of mean SGR of 5.2 to 5.4 % body weight 
(BW) gain per day (Table 2.2). The FCR expresses the amount of feed dry matter 
needed per unit of fish gain. No significant difference was observed in the FCR 
values of the four experimental diet treatments following 4 weeks of feeding, with 
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the range of mean FCR of 0.8 to 1.0 (Table 2.2). Similarly, no significant difference 
(P > 0.05) was observed among the fish fed with different experimental diets in case 
of final body length and survival (Table 2.2). 
Table 2.2.  Survival and growth performance (Mean±SD) of Nile tilapia juvenile fed 
four experimental diets. No significant differences (P > 0.05) were found 
in the fish survival, final body weight and length, and FCR (n = 3; m = 
6).  n = number of replicates; m = number of fish pooled per replicate. 
 
    Different letter within column denote significant differences (P ≤ 0.05). 
 
Digestive enzymes activity 
After 28 days of feeding with the experimental diets, no differences were observed 
for trypsin, amylase and pepsin activity among the various treatments (Table 2.3) 
(P > 0.05). Feeding the fish with higher levels of PHB significantly increased the 
activity of lipase in fish fed the 25 g kg-1 and 50 g kg-1 PHB treatment groups, 
compared to the control group with the lowest lipase activity (Table 2.3). 
Fish body composition 
Similar total protein content was observed among all treatments (P > 0.05), with the 
total protein content of 58.2±1.5, 59.4±1.0, 58.6±1.7 and 59.4±2.1 % dry weight (DW) 
in the control, 5 g kg-1, 25 g kg-1 and 50 g kg-1 PHB treatment groups, respectively. 
Dietary PHB supplementation significantly increased the whole-body total lipid 
content with about 3 % on DW when compared to the control treatment (P ≤ 0.05) 
(Table 2.4). 
Treatment 
Survival 
(%) 
Final body 
weight (mg) 
Final body 
length (cm) 
SGR 
(% BW day-1) 
FCR 
Control 87±2 218±101 2.3±0.4 5.27±0.06ab 1.0±0.3 
5 g kg-1 PHB 74±8 284±61 2.6±0.3 5.40±0.08b 0.9±0.0 
25 g kg-1 PHB 86±10 269±68 2.5±0.4 5.25±0.05a 0.9±0.1 
50 g kg-1 PHB 88±3 258±48 2.5±0.4 5.21±0.03a 0.8±0.1 
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Table 2.3.  Digestive enzyme activities (Mean±SD) of Nile tilapia juvenile following 
4 weeks of feeding with different experimental PHB-supplemented diets 
(n = 3; m = 3).  n = number of replicates; m = number of fish pooled per 
replicate. 
 
Activities are expressed as follows: Lipase as mmole of substrate hydrolyzed min-1 mg protein-1; 
Trypsin activity as hydrolyses mmole of BAPNA min-1 mg protein-1; Amylase mg starch hydrolyzed 
min-1 mg protein-1; Pepsin activity as mmole of tyrosine released min-1 mg protein-1. Different letter 
within column denote significant differences (P ≤ 0.05).  
 
Fish lipid profile 
The fish lipids profile (content and composition) following 28 days of feeding on 
different diets is presented in Table 2.4. In general, the fish fed PHB diets had a 
higher content of saturated, monounsaturated and (n-6) FAs than the fish fed 
control diet. The content of saturated and monounsaturated FAs were higher in the 
5 g kg-1 and 25 g kg-1 PHB treatment groups as compared to the control treatment (P 
≤ 0.05), while a higher content of total (n-6) FAs (P ≤ 0.05) was observed in the 50 g 
kg-1 PHB treatment group. However, PHB did not seem to influence the lipids 
composition as similar values (P > 0.05) were observed among treatments, when 
the FAs are expressed as percentage of the total lipid content. PHB had no 
influence over either the content or composition of C20:5n3 (eicosapentaenoic acid, 
EPA), C22:6n3 (docosahexaenoic acid, DHA), total (n-3) FAs, or the (n-6)/(n-3) ratio 
(P > 0.05).  
Treatment 
Digestive enzyme activities (U mg protein-1) 
Lipase Trypsin Amylase Pepsin 
Control 0.021±0.003a 0.035±0.017 0.457±0.039 0.253±0.010 
  5 g kg-1 PHB 0.025±0.004ab 0.032±0.017 0.533±0.041 0.261±0.021 
25 g kg-1 PHB 0.029±0.004b 0.033±0.014 0.489±0.042 0.272±0.014 
50 g kg-1 PHB 0.029±0.001b 0.047±0.016 0.547±0.043 0.245±0.022 
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Table 2.4.  Effects of dietary PHB supplementation on the whole-body total lipid content (% DW; Mean±SD) and the main group of 
long chain fatty acids composition (C14 to C24) as % DW (Mean±SD) and as % total lipid content (in parenthesis; 
Mean±SD) in Nile tilapia juvenile fed with different PHB experimental diets (n = 3; m = 10). n = number of replicates; m = 
number of fish pooled per replicate for FAME analysis. 
 
        Different letter within column denote significant differences (P ≤ 0.05). 
Treatment Total lipid 
 FA composition 
(n-6)/(n-3) 
ratio Saturated 
Mono- 
Unsaturated 
EPA DHA Total (n-6) Total (n-3) 
Control 25.40±0.33a 7.22 ± 0.16a 5.99 ± 0.16a 0.06 ± 0.03 1.45 ± 0.14 7.18 ± 0.03a 1.91 ± 0.13 3.76±0.25 
  (28.44±0.62) (23.59±0.61) (0.24±0.01) (5.71±0.54) (28.27±0.12) (7.53±0.51)  
         
5 g kg-1 PHB 28.26±0.13b 8.23 ± 0.35bc 6.68 ± 0.23b 0.07 ± 0.06 1.65 ± 0.02 7.61 ± 0.47ab 2.13 ± 0.23 3.58±0.16 
  (29.13±1.25) (23.64±0.80) (0.26±0.02) (5.83±0.08) (26.94±1.67) (7.54±0.80)  
         
25 g kg-1 PHB 27.69±1.06b 8.47 ± 0.17c 6.79 ± 0.25b 0.07 ± 0.08 1.51 ± 0.13 7.32 ± 0.41ab 1.95 ± 0.16 3.76±0.10 
  (30.58±0.60) (24.51±0.89) (0.26±0.03) (5.45±0.48) (26.44±1.48) (7.03±0.56)  
         
50 g kg-1 PHB 27.92±0.13b 7.82 ± 0.24ab 6.36 ± 0.06ab 0.07 ± 0.02 1.63 ± 0.02 8.09 ± 0.23b 2.10 ± 0.03 3.85±0.14 
  (27.99±0.86) (22.78±0.23) (0.27±0.01) (5.82±0.07) (28.95±0.81) (7.52±0.10)  
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Discussion 
Fish growth modulation by dietary PHB supplementation  
Although positive effects of PHB on the growth performance in European sea bass 
juveniles and giant freshwater prawn larvae are reported in the studies by De 
Schryver et al. (2010) and Nhan et al. (2010), in this study no significant difference 
was found between treatment groups. Nevertheless, the similar mean final body 
weights observed in the PHB treatment groups (258 to 284 mg) when compared to 
the control group (218 mg) indicate that PHB does not have negative effect on the 
growth of Nile tilapia juvenile. This result corresponds with the study by 
Najdegerami et al. (2012), where no significant effect of PHB on growth 
performance of Siberian sturgeon fingerling was observed.  
Digestive enzymes activity under dietary PHB supplementation 
Digestive enzyme activities can be used as an indicator of digestive processes and 
fish nutritional conditions (Lazo et al., 2000; Ueberschar, 1988). Various intestinal 
enzymes involved in digestive and absorptive processes have been reported in 
tilapia culture, including amylase, pepsin, trypsin, esterases and alkaline 
phosphatase (Dai et al., 2009; Moriarty, 1973; Tengjaroenkul et al., 2000; Zahran et 
al., 2014). As for other herbivorous fish, tilapia commonly demonstrate a higher 
activity of carbohydrase than protease and a lower lipase activity as compared to 
carnivorous and omnivorous fish (Das and Tripathi, 1991; Opuszynski and 
Shireman, 1995; Tocher, 2003). However, it has been reported that manipulation of 
diets causes immediate changes in activities of digestive enzymes (Mohapatra et 
al., 2012). This specifically holds true for fishes with relatively broad diets (German 
et al., 2004). In this study, PHB dietary supplementation resulted in significantly 
higher lipase activities in the 25 and 50 g kg-1 PHB-fed fish group, while a similar 
activity of trypsin, amylase, and pepsin was observed among all different 
treatments. Lipases are the enzymes which are responsible for the breakdown of 
dietary lipid complexes within the intestinal lumen (Karasov and Hume, 1997). The 
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significant increase in lipase activity in the 25 and 50 g kg-1 PHB treatment groups 
(20-40 % higher than in the control group) suggests that the dietary PHB stimulated 
the dietary lipids digestion, providing more fatty acids available for absorption and 
esterification into complex lipids. Such increase could be physiologically relevant 
as a study by Essa et al. (2010) reported a 35-80 % increase in gut lipase activity in 
Nile tilapia fingerlings (~ 25 g) due to supplementation of probiotic Bacillus subtilis 
and Lactobacillus plantarum (either as single or mixture inoculum), which also 
resulted in better growth and feed utilization obtained in the treatment group. 
Further investigation is needed to confirm the relevance of lipase activity in feed 
utilization (i.e. lipids digestion) by PHB supplementation, e.g. by the use of 
exogenous lipase along with PHB supplementation. 
Dietary PHB supplementation did not affect lipid profile of Nile tilapia juvenile 
It is reported by Najdegerami et al. (2012) that crystalline PHB significantly 
increased the linoleic acid and total (n-6) FAs content in the liver of Siberian 
sturgeon fingerling fed on 5 g kg-1 PHB diet. In another study, crystalline PHB was 
found to increase the total monounsaturated and total (n-3) FAs content of giant 
tiger prawn postlarvae (Ludevese-Pascual, personal communication). Similarly, in 
this study, an increasing trend was observed in the total saturated, total 
monounsaturated FAs and total (n-6) FAs content (% DW) of Nile tilapia juvenile. 
However, PHB did not affect the composition of FAs groups, be it the total 
saturated FAs, monounsaturated FAs, (n-3) FAs (including EPA and DHA), or (n-6) 
FAs, when they are expressed as % total lipid content. The FAME analysis 
procedure performed in this study only measured the long chain fatty acids 
(LCFAs; C14 to C24) and did not provide information on the composition of short 
chain fatty acids (SCFAs; C2 to C6) or medium chain fatty acids (MCFAs; C8 to 
C12). As the degradation of dietary PHB is hypothesized to results in the release of 
SCFA, likely β-HB (De Schryver et al., 2010; Defoirdt et al., 2009), it might be 
interesting to evaluate the effect of PHB on the fish SCFAs profile. 
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Fish total lipid content increased with dietary PHB supplementation 
Although there was no effect of PHB on the FAs profile, PHB was found to increase 
the fish whole-body total lipid content. It was mentioned earlier that the increasing 
trends in lipase activity by the PHB treatment groups might indicate that dietary 
PHB can stimulate lipids digestion, and thus may have been responsible in the 
significant increase in fish total lipid content in the PHB treatment groups when 
compared to the control group. Lipids can be divided into two main classes, i.e. 
polar lipids (PLs) and neutral lipids (NLs). PLs are important constituents of 
membranes and they function as precursors in the eicosanoid metabolism 
(structural / functional fat), while the NLs serve mainly as a depot of lipids used as 
an energy source (depot / storage fat) (Henderson and Tocher, 1987). The 
contribution of PLs and NLs to the total lipid was not determined in this study; 
however, Suloma et al. (2008) suggested that PLs make up about 80 % of the total 
lipid in tilapia.  
Semova et al. (2012) suggested that altered fish fat metabolism and lipid profiles 
could be due to the effects of GI microbiota on: (i) intestinal absorption or 
metabolism of exogenous dietary lipids, or (2) hepatic production or metabolism of 
endogenous lipids. In this study, it can only be hypothesized that the increase of 
fish total lipid content may have resulted from the diet (PHB)-induced alterations 
in the intestinal microbiota composition. Further studies on the microbiota-diet 
interactions are necessary to investigate any potential impact of the PHB on the 
intestinal microbiota composition and its importance in the regulation of dietary 
nutrients (i.e. lipids) digestion and metabolism.  
The observed total lipid content can be favourable for human consumption, as 
lipids play an essential role as energy and FAs source for human, both for 
immediate utilization by the body and in laying down a storage depot (adipose 
tissue) for later utilization when food intake is reduced, and also act as a vehicle for 
the ingestion absorption of fat-soluble vitamins (Medeiros and Wildman, 2013). 
Structural fats are specifically of interest as they are needed inside every cell in 
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human bodies and are especially necessary for the growth of the fetal brain (FAO, 
2010; Uauy et al., 2000). It should thus be verified if the increment of total lipid 
resulting from PHB supplementation led to a higher eicosanoid metabolism which 
may have resulted in more structural fat production, or that it was more neutral fat 
that was accumulated which does not contribute to the quality of the tilapia for 
consumption. 
 
Conclusions 
In general, the findings of this study suggest that PHB do not have negative effect 
on the growth of Nile tilapia juvenile. Eventhough a trend of increasing growth 
was observed in all PHB treatment groups, the increase was not statistically 
significant compared to the control group. Furthermore, lipid digestion and 
deposition seemed to increase by the dietary PHB supplementation. We 
hypothesize that the altered lipid utilization may have resulted from diet-induced 
alterations in the GI microbiota composition. Further research needs to focus on the 
effect of PHB on the modulation of the digestive functionality of the GI MC. 
Studies on the host microbiota-diet interactions (i.e. by making use of physiological 
techniques such as Biolog microplate analysis) are expected to contribute to a more 
advanced knowledge of the possible mechanisms of action of PHB in the alteration 
of nutrient utilization by the host, which could potentially result in growth 
enhancement in aquaculture practices.  
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Abstract 
The bacterial storage polymer poly-β-hydroxybutyrate (PHB) has a high potential 
as a feed additive to promote the growth and health of fish and shrimp. In the 
current study, the effect of crystalline PHB on the growth performance and 
survival of Nile tilapia (Oreochromis niloticus) fingerlings was evaluated. The tilapia 
fingerlings were cultured for 4 weeks with diets containing 6 different PHB levels: 
0 (control), 1, 2.5, 5, 25 and 50 g PHB kg-1 diet. The control and PHB treatment 
groups showed no significant differences in survival while the growth performance 
of the fingerlings was significantly higher when PHB was present in the diet. No 
significant differences in growth were observed between the different PHB 
treatments. The digestive functionality of the gut microbial communities was 
evaluated using the Biolog EcoPlate™ method. This allowed to successfully 
discriminate between the indigenous (mucosa associated) and transient (faeces 
associated) gastrointestinal microbial community (MC). The former showed a 
lower functional diversity and functional evenness but a higher utilization intensity 
as compared to the latter. Based on the 31 substrates included in the Biolog 
EcoPlate™ method, no significant effect of PHB on the functional profiling of the 
gut communities could be detected. Based on the results, it is suggested that 
changes in tilapia fingerlings growth performance resulting from PHB 
supplementation is not necessarily related to a change in the gut microbial 
digestion patterns. Therefore, further studies are needed to make the link between 
PHB supplementation and its growth enhancing effect.  
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Introduction 
The disease controlling effects of PHB have been shown in a number of studies. 
Biodegradation of PHB by microbial enzymes and/or host digestive enzymes, is 
hypothesized to yield β-hydroxybutyrate which is assumed to induce an 
antimicrobial effect (Defoirdt et al., 2007a). The supplementation of PHB, both in 
crystalline and amorphous forms, resulted in a significant protection of Artemia 
nauplii (Defoirdt et al., 2007b), giant freshwater prawn (Thai et al., 2014) and giant 
tiger prawn larvae (Laranja et al., 2014) against vibriosis. Equally interesting, the 
dietary supplementation of PHB to commercial feed resulted in improved growth 
performance and/or survival of European sea bass juveniles (De Schryver et al., 
2010), Siberian sturgeon fingerlings (Najdegerami et al., 2011), Chinese mitten crab 
larvae (Sui et al., 2012), giant freshwater prawn larvae (Nhan et al., 2010; Thai et al., 
2014) and giant tiger prawn larvae (Laranja et al., 2014). An explanation for the 
growth promoting effect of PHB is, however, so far lacking. 
It was highlighted by Tanaka et al. (2004), Ringø et al. (2006), and Yang et al. (2007), 
that the type of food is important for the composition and activity of a fish 
gastrointestinal (GI) microbiota. This microbiota is classified as ‘autochthonous’ or 
‘indigenous’ when it is associated with the host’s gut epithelial surface or as 
‘allochthonous’ or ‘transient’ when it is mainly residing in the lumen and 
associated with the faeces (Denev et al., 2009). It has been shown that dietary PHB 
supplementation modulates the fish gut MC organization in terms of genetic 
diversity, relative abundances, and composition dynamics (De Schryver et al., 
2010). The increased diversity and evenness of the gut microbiota may be a 
valuable contributor to an increased resistance against pathogenic infections (De 
Schryver et al., 2010). In terms of nutrition, many studies indicate that fish gut 
microbiota contribute by an important digestive and nutritional function to the 
intestinal metabolism and absorption of ingested food (Cummings and Englyst, 
1995; Ganguly and Prasad, 2012; Macfarlane and Macfarlane, 2007; Mouchet et al., 
2012; Semova et al., 2012; Stevens and Hume, 1998). More specifically, several 
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studies reported the preponderance of aerobic, microaerophilic and facultative 
anaerobic bacteria in fish digestive process (Ganguly and Prasad, 2012; Nayak, 
2010; Saha et al., 2006). Modulation of the intestinal microbiota may thus also result 
in a modification of gut metabolic activity and feed digestion. Also, several studies 
suggested that certain feed ingredients and/or feeding intensity may affect the 
qualitative and quantitative composition of intestinal microbiota of fish (Pucci et 
al., 2000; Ringo and Olsen, 1999; Skrodenyte-Arbaeiauskiene, 2000; Voverienė et al., 
2002) and thus might change the digestive pattern by the microbiota in the gut.  
In addition to other important factors, including culture systems, water, and diet, 
fish age / developmental stage also influences the gut microbiota composition. 
Tengjaroenkul et al. (2000) reported that the gross intestinal configuration of Nile 
tilapia intestine changes dramatically from a short, straight intestinal tube at hatch 
(day 0) to a very complex, coiling pattern first attained at age 9 weeks old, until it 
reaches the complexly-coiled definitive form as found in adult fish at age 12 weeks 
old. It is suggested that at younger age (< 12 weeks old) tilapia is considered to 
have rather simpler gut that would favour colonization of aerobic, microaerophilic 
or facultative anaerobs bacteria, while the adults have complexly-coiled definitive 
form that would favour more colonization of anaerobic bacteria (Ferguson et al., 
2010). Several studies reported that microaerophilic and facultative anaerobic 
probionts, including Bacillus sp., and Lactobacillus sp., have been applied to 
promote growth and health of Nile tilapia fingerlings (Aly et al., 2008; Mohamed 
and Refat, 2011; Pirarat et al., 2006; Zhou et al., 2010).  
The aim of the current study was therefore to investigate how supplementation of 
PHB to the diet of Nile tilapia fingerlings changed the functional activity of the 
aerobic / microaerophilic gut MC and if this could be related to the culture 
performance of the fish. Consequently, the effect of different dietary levels of PHB 
(0, 1, 2.5, 5, 25, and 50 g kg-1 diet) on (i) the fish growth and survival performances, 
and (ii) the functional physiological diversity of the indigenous (intestine samples) 
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and the transient (faeces samples) gut MC of Nile tilapia fingerlings using Biolog 
EcoPlate™ method was evaluated. 
Materials and Methods 
Experimental fish and husbandry  
A total of 360 Nile tilapia fingerlings (~ 0.6 g) produced by Til-Aqua International 
(Velden, The Netherlands) were used in the experiment. Upon arrival in the lab, 
the fish were housed for one week in a 500 L cylindrical tank in the experimental 
chamber to acclimatize to the temperature, light regime and experimental semi-
purified diet (control diet without PHB). The fish were fed three times daily to 
apparent satiation. At the end of the acclimation period, the fish (average body 
weight of 0.8±0.1 g) were randomly distributed over 24 tanks of 40 L (6 treatments, 
4 replicates) at a density of 15 fish per tank. During the experiment, a daily water 
renewal of ~30 % of the volume in the tanks was done to maintain NO2- and NH4+ 
below 1 mg NO2--N L-1 and 1 mg NH4+-N L-1, respectively. The culture water was 
continuously aerated with air stones ensuring dissolved oxygen above 5 mg O2 L-1, 
and the photoperiod was maintained on a 16h:8h light:dark schedule. During the 4 
weeks feeding experiment, water temperature was maintained at 27±0.5 °C using 
electrical heaters.  
Feed Formulation and Feeding Design 
A basal semi-purified diet (control diet) was formulated as described in Chapter 2 
(Table 2.1). For the PHB experimental diets, crystalline PHB (± 98 % purity, average 
300 µm size; Goodfellow Cambridge Limited, Huntingdon, England) was 
supplemented to the basal diet at five levels  1, 2.5, 5, 25, and 50 g PHB kg-1 diet  
at the expense of -cellulose. The dry ingredients of each diet were thoroughly 
mixed in a Hobart mixer (Hobart Corp., Troy, Idaho, USA) before liquid and oily 
ingredients were added. The moist mixture was extruded through a 3 mm 
diameter grinder plate in a Hobart meat grinder. The resulting moist pellets were 
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air-dried at room temperature to a moisture content of about 100 g kg-1. Pellets 
were ground into small pieces and sieved to obtain a size of approximately 800 µm 
and stored frozen in plastic bags at −20 °C until fed. The fish were fed at a fixed 
daily feeding level of 6 % on body weight (Ng and Romano, 2013) in three equal 
meals given every 4 hours between 09:00 and 17:00 during the 4 weeks 
experimental period. On a weekly basis the daily feeding quantity for each tank 
was adjusted based on the fish wet weight measured every week. All experimental 
diets were evaluated in 4 replicates.  
Growth and survival parameters 
Every week, five fish from each replicate tank were randomly collected and 
weighted after a 24 h starvation period to monitor the growth performance. The 
average weight gain of the fish in a tank over the 4 weeks was calculated by 
subtracting the weight of the fish sampled on the final day of the experiment with 
the average weight of the fish as measured at the beginning of the experiment, and 
then taking the average. The specific growth rate (SGR) was calculated as described 
in Chapter 2:  
SGR (% body weight gain per day)   
     –      
 
  
where W is the average weight after 4 weeks, W0 is the average initial weight 
(measured at the beginning of the experiment), and t is experiment period (4 
weeks). The same approach was used to calculate the feed conversion ratio (FCR), 
expressed as the feed consumption over the weight increase of the fish per 
treatment. Fish survival of each treatment group was determined at the end of the 
experimental period by computing the number of surviving fish relative to the 
number of fish at the beginning of the experimental period. 
Proximate analysis 
After 4 weeks of feeding with the different foods, the protein and lipid content of 
the whole body of 5 fish per tank was analyzed following the standard methods. 
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Nitrogen content was analyzed by the Kjeldahl method (AOAC, 2000) and crude 
protein content was estimated by multiplying the nitrogen percentage with 6.25. 
The lipid content in the whole body was analyzed by extraction following the Folch 
method illustrated by Ways and Hanahan (1964) in which the fatty acid 
composition was determined by gas chromatography. Fatty acid methyl ester 
(FAME) was prepared following a modified procedure of Lepage and Roy (1984).  
Community-level physiological profiling (CLPP) 
Sample collection  
Fish were sampled for the analysis of the functional diversity of the indigenous and 
transient bacterial communities at the end of the experimental period. From each 
tank, 5 fish were randomly sampled and transferred into a single 4 L tank 
containing clean fresh water for a 24 h starvation period. Then, faecal samples were 
collected from each tank making up a pooled faecal sample for this respective tank. 
Next, the sampled fish were euthanized in an ice-cold 5 g L-1 benzocaine solution 
(Sigma, E-1501) and aseptically dissected for removal of the whole gut. The 
collected intestine was gently squeezed to remove any remaining contents and then 
rinsed gently with 9 g L-1 NaCl sterile saline solution. The intestine tissues from the 
fish from one tank were pooled. 
Analysis of the sampled microbiota – the Biolog EcoPlate assay 
Pooled samples were homogenised with sterile 0.5 mm glass beads in sterile screw-
capped tubes using a bead beater (4 x 15 s, each with 15 s break). Sterile saline 
solution (9 g L-1 NaCl) was used as a homogenization solvent at a ratio of 25 µL for 
every mg of sample. Homogenized samples were then put in a stand for 30 
minutes after which the supernatant was collected carefully not to include any 
particulate matter, and diluted 100 times. The diluted supernatant was then filtered 
using a 100 µm cell strainer (SPL Cell Strainer, SPL Life Sciences) and the filtrate 
was applied in the Biolog assay. Due to higher mortality recorded in some 
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treatment replicates, only three out of four replicates of each treatment were 
analysed in the Biolog assay.  
The Biolog EcoPlate™ (BIOLOG Inc., Hayward, Calif.) assay was used for 
characterizing community-level physiological profiles of the faecal and gut 
microbial communities. The wells on the 96-well plates contain carbon sources and 
a tetrazolium violet redox dye that turns purple if inoculated microorganisms 
utilize these sources. The Biolog EcoPlate™ contains 31 different carbon sources, 
allowing for community-level physiological profiling (CLPP) of heterotrophic 
bacterial assemblages. The Biolog EcoPlate™ that was used in this study has three 
replicates of a set consisting of 31 substrates and one blank well without substrate. 
Each filtrate sample was inoculated into one Biolog EcoPlateTM (150 µL of sample 
homogenate per well) and initial absorbance (0 h) at 590 nm (OD590, absorbance 
peak of tetrazolium) was measured as a reference using a TECAN Infinite 200 
spectrophotometer (Tecan, Switserland). All Biolog EcoPlates were incubated 
aerobically at 28 °C in a dark chamber and the absorbance values of colour 
development in the wells were recorded after 24, 48 and 84 h of incubation. 
Data Management and Analysis 
a.  Biolog Plate assay data 
The raw absorbance values obtained from spectrophotometric readings were first 
blanked against their control wells in each replicate part of the individual plates 
and negative values were rounded to zero (Kamitani et al., 2006; Van Beelen et al., 
2004). 
b. Average Well Colour Development  
To normalize for variations in the amount of bacterial biomass loaded in the wells 
among replicate samples, the average well colour development (AWCD) for 
replicate parts in individual plates was determined. The AWCD was calculated per 
reading time as follows: 
Chapter 3. Physiological profile of gut microbiota 
73 
 
AWCD = 
  C  R 
n
 
, where: C is the OD of an individual well, R is the OD of the control well and n is 
the total number of wells in each part of the EcoPlate (n = 31). Normalization of OD 
data was then carried out by dividing each blank-corrected well by the AWCD of 
that plate, i.e. (CR)/AWCD (Garland and Mills, 1994; Garland, 1996). Statistical 
multivariate comparisons were then carried out on the normalized data.  
c. Diversity of substrate utilisation (DSU) 
DSU was determined by the Shannon-Wiener index (H), which is one of the most 
commonly used diversity indices considering both the number of species and their 
abundance (Muñiz et al., 2014; Tuomisto, 2010). In this case, the H value considers 
the number of used carbon sources and their utilization intensity thus describing 
the ability of the bacterial community to degrade carbon sources resulting in an 
index of physiological diversity of the bacterial community. Microbial communities 
that are able to degrade more substrates and/or to degrade them with a higher 
efficiency would have higher values of H. The index was calculated as follows 
(Tam et al., 2001; Wang et al., 2011): 
H =            
, where    is the normalised value of OD590.   
d. Gini coefficient  
For calculation of the Gini coefficient, the normalized OD590 values from individual 
wells from a homogenate sample were ranked from low to high and the cumulative 
proportion of absorbance (from 0 to 1) was plotted against the cumulative 
normalized number of the wells (from 0 to 1). This can be depicted as the Lorenz 
curve. Perfect equality, achieved only by completely even absorbance in each well 
would result in a diagonal line from the origin to the upper right corner. The Gini 
coefficient represents the degree of deviation from this diagonal, and it is evaluated 
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as twice the area between the diagonal and the Lorenz curve (Ogwang and Rao, 
1996) using the following equation:  
G  1 –                     
 
   
 
 
, where    is the cumulative normalized number of the wells, with    = 0,    = 1; 
and    is the cumulative proportion of absorbance, with    = 0,    = 1. n is the total 
number of carbon sources (31). The Gini coefficient has a minimum value of 0, 
when all wells have equal absorbance and a theoretical maximum of 1.0, in which 
all wells but one have a value of 0.0. 
e. Principal component analysis (PCA) 
PCA was performed to reduce the complex nature of the data (31 variables per 
sample) into smaller and interpretable representative variables in an ordination 
space (Garland and Mills, 1991; Garland and Mills, 1994). Relationships among 
treatments were obtained by plotting the correlation scores of their first two PCs in 
two dimensions. 
Statistical Analyses 
Comparison of the fish survival, BW gain, SGR, and FCR were done using one-way 
analysis of variance (one-way ANOVA). For fish survival, arcsine transformation 
of survival data was used. Correlation analysis (Spearman Rank Order Correlations 
test) between fish survival and weight gain was conducted to investigate whether 
any relationship existed between the parameters. Grouping of treatments based on 
significant differences in mean values was done using a Tukey post-hoc test (0.05 
level of confidence).  
For the community level physiological profiling, PCA was performed on the 
normalised absorbance data at 84 h. Substrate richness was calculated as the 
number of highly utilized substrates (corrected absorbance > AWCD) and the 
percentage of compounds used in each of the substrate classes: polymers (4 
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compounds), carbohydrates (10 compounds), carboxylic acids (7 compounds), 
amino acids (6 compounds), amines (2 compounds) and phenolic (2 compounds). 
For each of the sample types, substrate richness indices and percentages of 
utilization (arcsin square root transformed data) were analysed using one-way 
ANOVA.  
A two-way analysis of covariance (two-way ANCOVA; factors of different PHB 
treatment and incubation time of Biolog EcoPlate) was conducted for the Shannon-
Wiener index and the Gini coefficient of each sample type (intestine and faeces), 
using AWCD as a covariate to remove the effect of differential rates of colour 
development across the plates (Harch et al., 1997). All statistical analyses were 
completed using STATISTICA statistical software (version 7.0).  
Results  
Fish performance 
The effects of the experimental treatments were examined with respect to body 
weight (BW) gain, specific growth rate (SGR), and survival of the fingerling. After 4 
weeks, no significant differences in survival could be observed (P > 0.05; Table 3.1). 
All PHB treatments showed a significantly higher mean body weight gain and 
specific growth rate and a significantly lower FCR than the control group (P ≤ 0.05), 
while no significant differences were detected for these parameters between the 
different PHB treatments (Table 3.1).  
The BW gain after 4 weeks of feeding was equal to 177±10 %, 265±59 %, 296±64 %, 
303±94 %, 296±16 %, and 312±48 % of the initial body weight in the control, 1 g kg-1, 
2.5 g kg-1, 5 g kg-1, 25 g kg-1 and 50 g kg-1 PHB treatment, respectively. All PHB 
treatment groups showed a significantly lower FCR as compared to the control 
group (P ≤ 0.05). A correlation analysis was performed to assess if fish survival and 
weight gain were related to each other. There was no significant correlation 
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between the fish survival and the mean body weight gain in the 6 treatments 
(Spearman Rank Order Correlations test; r²= -0.14, P > 0.05). 
 
Table 3.1.  Survival and growth performance parameters (Mean±SD) of Nile 
tilapia fingerlings fed with different PHB diets for 4 weeks. Different 
letters within the same column denote significant differences (P ≤ 0.05) 
(n = 4; m = 3).  n = number of replicates; m = number of fish pooled per 
replicate. 
        * SGR = specific growth rate. ** FCR = feed conversion ratio 
 
Fish whole body protein and lipid content  
No effect of PHB on the crude protein level or the whole-body lipid content in the 
fingerlings was observed among various treatments (P > 0.05; Fig. 3.1). The fatty 
acid composition of the fingerlings following the 4-week feeding period is 
presented in Table 3.2. Although all values for the main groups of fatty acids were 
higher for PHB treatments than for the control treatment, no significant differences 
among the treatments were observed (P > 0.05). 
 
 
 
 
 
Treatment 
Survival 
(%) 
BW gain (g) 
SGR* 
(% BW day-1) 
FCR** 
Control 71±19 1.42±0.08
a
  3.64±0.13a 1.51±0.17a 
1 g kg-1 PHB 68±27 2.12±0.47
b
  4.59±0.56b 1.07±0.21b 
2.5 g kg-1 PHB 93±5 2.37±0.51
b
  4.87±0.60b 0.92±0.22b 
5 g kg-1 PHB 46±31 2.43±0.75
b
  4.92±0.78b 1.01±0.12b 
25 g kg-1 PHB 60±34 2.37±0.13
b
  4.91±0.15b 0.94±0.04b 
50 g kg-1 PHB 78±8 2.50±0.38
b
  5.04±0.42b 0.89±0.17b 
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Figure 3.1.  Total crude protein and lipid content of whole-body Nile tilapia 
fingerlings following 4 weeks of feeding with different PHB diets. No 
significant differences in either total crude protein or lipid content 
were observed among treatments (P > 0.05) (n = 3; m = 5). n = number 
of replicates; m = number of fish pooled per replicate for analysis.  
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Table 3.2.  Dietary PHB supplementation had no influence on the content of main group of long chain fatty acids (C14 to 
C24) (% DW; Mean±SD) and their composition as % total lipid content (in parenthesis; Mean±SD) in Nile tilapia 
fingerlings fed with different PHB diets (P > 0.05) (n = 4; m = 5). n = number of replicates; m = number of fish 
pooled per replicate for FAME analysis.  
 
 
  
 
 
 
 
 
 
 
 
 
 Saturated 
Mono- 
unsaturated 
DHA EPA Total (n-6) Total (n-3) 
Control 
4.63±0.60 
(23.22±0.62) 
5.68±0.75 
(28.49±0.67) 
1.54±0.11 
(7.77±0.66) 
0.30±0.03 
(1.51±0.22) 
5.85±0.67 
(29.4±0.71) 
2.38±0.16 
(12.00±0.98) 
1 g kg-1 PHB 
5.64±0.48 
(23.20±0.16) 
7.20±0.70 
(29.60±0.60) 
1.67±0.08 
(6.90±0.37) 
0.37±0.06 
(1.51±0.16) 
7.27±0.57 
(29.9±0.71) 
2.71±0.22 
(11.14±0.38) 
2.5 g kg-1 PHB 
5.62±0.30 
(22.30±3.10) 
6.77±0.33 
(26.87±3.83) 
1.60±0.05 
(6.37±0.99) 
0.31±0.01 
(1.24±0.21) 
7.00±0.23 
(27.8±4.05) 
2.49±0.08 
(9.91±1.56) 
5 g kg-1 PHB 
5.69±0.57 
(22.64±0.12) 
6.74±0.82 
(29.62±0.21) 
1.61±0.13 
(7.31±0.51) 
0.35±0.04 
(1.67±0.10) 
7.00±0.71 
(29.5±0.02) 
2.47±0.22 
(12.02±0.41) 
25 g kg-1 PHB 
5.21±0.80 
(23.16±0.44) 
6.71±1.36 
(29.61±1.24) 
1.63±0.21 
(7.29±0.57) 
0.37±0.05 
(1.63±0.12) 
6.62±1.10 
(29.4±0.25) 
2.61±0.33 
(11.67±0.90) 
50 g kg-1 PHB 
5.35±0.68 
(22.50±0.69) 
6.66±0.95 
(27.97±0.82) 
1.67±0.18 
(7.03±0.35) 
0.34±0.06 
(1.43±0.07) 
6.88±0.96 
(28.9±0.18) 
2.61±0.31 
(10.97±0.43) 
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Community-level physiological profiling (CLPP) 
AWCD, Shannon-Wiener Index and Gini coefficient 
Two-ways ANCOVA was performed on the Shannon-Wiener index (H) and the 
Gini coefficient (G) data to evaluate the incubation time effect (24, 48, 84 h) and 
PHB treatment effect (control, 1, 2.5, 5, 25, and 50 g PHB kg-1 diet) in the intestine 
and faeces samples, separately. In general, a lower Gini coefficient and higher 
Shannon-index were observed in the intestine samples. However, no significant 
difference was found among the various treatments for all parameters (Table 3.3).  
Principal Component Analysis (PCA) 
PCA was used to separate the microbial samples based on their utilization of all 
31 different carbon sources. In general, PCA of both intestine and faeces samples 
did not reveal any distinctive patterns between the treatment groups (Fig. 3.2). 
For both sample types, different PHB treatments are close to each other on the 
sphere and their projections are very close to the correlation circle thus it can be 
ascertained that the variables / different treatment groups are highly correlated, 
i. e., similar to each other. The first two principal components (PCs) accounted 
for 92.7 % and 3.6 %, respectively, of the total data variation for the intestine 
samples and 83.5 % and 8.6 %, respectively, of the total data variation for the 
faeces sample. In the intestine samples, variability in the first PC was explained 
by a contrast among utilization of amine, phenolic compound, carboxylic acids, 
while in the faecal samples, variability in the first PC was explained by a 
contrast among utilization of amine, carboxylic acids, phenolid compound and 
mixed utilization (both high and low) of amino acids and carbohydrates (Tabel 
3.4). Both PCAs could not separate the various treatment groups due to similar 
levels of utilization of carbon sources. 
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Table 3.3.  Results for the incubation time effect (24, 48, 84 h) and PHB treatment effect (control, 1 g kg-1, 2.5 g kg-1, 5 g kg-1, 
25 g kg-1, and 50 g kg-1 PHB diet) from two-way ANCOVA of the Shannon-Wiener index (H) and the Gini 
coefficient (G) for both intestine and faeces samples. No significant difference (P > 0.05) was found among 
different incubation times or various treatments for both parameters (n = 3, m = 5). n = number of replicates; m = 
number of fish sampled per replicate for analysis.  
 
 
 
  
Variables for analysis 
Incubation time  Treatment 
24 h 48 h 84 h  Control  
1 g kg-1 
PHB  
2.5 g kg-1 
PHB   
5 g kg-1 
PHB 
25 g kg-1 
PHB  
50 g kg-1 
PHB   
Intestine           
Shannon-Wiener index (H)  3.025  3.157  3.198   3.096  3.151  3.113  3.167  3.090  3.144  
Gini coefficient (G)  0.479  0.361  0.335   0.414  0.374  0.392  0.367  0.416  0.385  
           
Faeces           
Shannon-Wiener index (H)  3.164  3.325  3.380   3.275  3.278  3.305  3.273  3.305  3.294  
Gini coefficient (G)  0.390  0.240  0.165   0.278  0.284  0.254  0.287  0.246  0.255  
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Figure 3.2. Principle component analysis of Biolog assay data for the gut 
microbiota of tilapia fed with different PHB experimental diets for 4 
weeks (n = 3, m = 5). n = number of replicates; m = number of fish 
sampled per replicate for analysis. The correlation circles for the 
intestine samples (upper graph) and faeces samples (lower graph) are 
shown. 
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Table 3.4. Carbon sources most heavily loaded on first two principal components (PC) in analysis of gut MC characteristics from 
intestine or faeces sample of 6 dietary PHB treatments. When no value is given, the loading was <0.15 and >-0.15. Carbon 
sources with asterisk (*) indicate most heavily loaded carbon sources observed in both intestine and faeces sample analysis. 
 
 
        Intestine sample                      Faeces sample 
  PC1 PC2   PC1 PC2 
 Amine     Amine   
Phenylethylamine* 0.27 0.16  Phenylethylamine* 0.33 -0.18 
 Amino Acids     Amino Acids   
L-Arginin 0.20 -0.17        L-Asparagine* 0.15  
L-Asparagine* 0.18   L-Phenylalanine* -0.25 -0.22 
L-Phenylalanine* -0.20 -0.19  L-Threonine -0.23 -0.25 
 Carbohydrates     Carbohydrates   
α-D-Lactose* -0.17 0.45        α-D-Lactose* 0.16  
D-Mannitol 0.19   i-Erythritol* -0.31 0.42 
i-Erythritol* -0.35   Glucose-1-Phosphate* -0.15 -0.16 
Glucose-1-Phosphate*  0.42        D-Xylose* 0.31  
D-Xylose* 0.17 0.36        D,L-α-Glycerol Phosphate* -0.46  
D-Galactonic Acid γ-Lactone -0.29 -0.30  Carboxylic Acids   
N-Acetyl-D-Glucosamine 0.16         α-Ketobutyric Acid -0.22  
D,L-α-Glycerol Phosphate* -0.22   D-Glucosaminic Acid* -0.25 0.39 
 Carboxylic Acids          D-Malic Acid   -0.36 
D-Glucosaminic Acid* -0.35   Itaconic Acid*  0.37 
Itaconic Acid*  0.18  γ-Hydroxybutyric Acid* -0.24  
γ-Hydroxybutyric Acid* -0.15   Phenolic compound   
 Polymers          2-Hydroxy Benzoic Acid* 0.19  
Tween 40 0.21         4-Hydroxy Benzoic Acid* 0.20  
Tween 80 0.18      
α-Cyclodextrin -0.27 -0.27     
Glycogen 0.22      
 Phenolic compound       
2-Hydroxy Benzoic Acid*  0.29     
4-Hydroxy Benzoic Acid* 0.20      
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Substrate richness 
Similar values of the mean number of intensively used carbon sources (blanked 
absorbance > AWCD) were shown by the samples from all treatments (Fig. 3.3). 
The mean percentage of compounds used in each of the substrate classes (amines, 
amino acids, carbohydrates, carboxylic acids, polymers and phenolic compounds) 
for both intestine and faeces samples are shown in Fig. 3.4. Similar utilization of 
about 60 %, 60 %, 50 %, 40 %, 80 % and 80 % of amine, amino acid, carbohydrate, 
carboxylic acid, polymers, and phenolic compound, respectively, was observed in 
the intestine sample of all treatment groups; while about 60 %, 50 %, 60 %, 40 %, 90 
% and 100 % utilization of amine, amino acid, carbohydrate, carboxylic acid, 
polymers, and phenolic compound, respectively, was observed in the faeces 
sample of all treatment groups. Both intestine and faeces samples did not show any 
significant difference in either the mean number of carbon sources utilized or the 
mean percentages of compounds used in each of the substrate classes between 
treatment groups. 
 
 
 
Figure 3.3. Substrate richness: number of intensively used substrates (blanked 
absorbance > AWCD) of both intestine and faeces samples from the different 
PHB treatment groups. The bars represent the mean values and error bars 
represent standard deviation. No significant difference in the number of 
intensively utilized substrates was detected among the various PHB 
treatments (P > 0.05) (n = 3, m = 5). n = number of replicates; m = number of 
fish sampled per replicate for analysis.  
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Figure 3.4. Percentage of intensively used substrates (blanked absorbance > AWCD) 
among biochemically similar substrate classes for intestine sample (upper 
graph) and faeces sample (lower graph). The bars represent the mean 
values and error bars represent standard deviation. No significant 
difference in the substrate utilization was detected among the various 
PHB treatments (P > 0.05) (n = 3, m = 5). n = number of replicates; m = 
number of fish sampled per replicate for analysis.  
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Discussion 
Fish performance 
In general, the PHB-supplemented diets tested in this study improved the average 
body weight gain of Nile tilapia fingerlings relative to the control group. Several 
studies have reported a similar growth promoting effect of PHB in aquaculture 
animals when supplemented at different dietary levels (De Schryver et al., 2010; 
Defoirdt et al., 2007b; Halet et al., 2007; Nhan et al., 2010). De Schryver et al. (2010) 
found increases in average body weights of European sea bass juveniles when PHB 
was dosed in the diet at levels of 20 and 50 g PHB kg-1 diet. In this study, the lowest 
PHB supplementation level of 1 g PHB kg-1 diet induced similar results as the 
higher supplementation levels up to 50 g PHB kg-1 diet. This indicates that a low 
level of PHB supplementation can already provide beneficial growth promoting 
effects, although this seems to be species specific. This should be highlighted 
because the use of PHB as a feed supplement does not only depend on the 
beneficial effects it provides in the animal cultures, but also on its cost 
effectiveness.  
Apart from its beneficial growth promoting effects, PHB had no substantial effect 
on fish composition as no significant differences were found in the whole body 
total crude protein and lipid content. Although a trend of increased content in main 
fatty acid groups was noted, which can be of biological importance (Patterson et al., 
2014), also here no significant differences were observed. A previously similar 
experiment using smaller fish (Nile tilapia juvenile of ~250 mg) showed slightly 
different results, where dietary PHB increased the whole body total lipid content, 
but not the crude protein level or fatty acids profile (Situmorang et al., unpublished 
data). Differences in the influence PHB has on the lipid metabolism at different fish 
ages was also found by Najdegerami et al. (2013). These authors described that 
PHB increased the lipid content in sturgeon larvae while a reduction was observed 
in sturgeon fingerlings. It was suggested that the difference in mode of action of 
PHB in larvae and fingerlings was different and that this may be related to a 
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different functionality of the microbiota in the fish gut at different life stages. In this 
study, it was therefore hypothesized that the growth modulation effect of PHB for 
the tilapia fingerlings was related to its effect on the functionality of the gut 
microbiota and a resulting altered feed digestion and nutrients metabolism. 
Community-level physiological profile 
Distribution of microbial community substrate utilizations 
It is widely accepted now that the fish diet modulates the fish intestinal microbiota 
composition (Austin, 2006; De Schryver et al., 2010; Merrifield et al., 2010; 
Najdegerami et al., 2012; Neuman et al., 2014; Ringø et al., 1995). Recently, Bolnick 
et al. (2014) reported that diet-induced changes in intestinal microbiota 
composition coincided with changes in relative abundance of gene ontology 
functions involved in digestive system, energy and  nucleotide metabolism, and 
carbohydrate metabolism and transcription. The authors then suggested that 
dietary changes in intestinal microbiota probably alter metagenomic function and 
may have consequences for host metabolism and digestion. In this study, the 
higher Shannon-Wiener index value and lower Gini coefficient for the intestine 
samples indicate a more diverse metabolic functionality and more equal use of the 
different substrates by the resident gut MC as compared to the faecal samples that 
represent the transient gut MC. However, PHB did not seem to have a significant 
effect on the metabolic properties of neither the resident nor the transient gut MC. 
Principal Component Analysis (PCA) 
An overlap in coordinate scores was mainly seen for many of the substrates 
indicating a lesser distinctive pattern between treatments. That is, the more the 
samples are similar, the more they close to each other in an ordination axes and 
vice versa (Garland and Mills, 1994). Similar to the previous findings, PCA was not 
able to reveal distinctive patterns between PHB treatments, as all treatments were 
found to be highly correlated / similar with each other. Thus, based on the 
relatively equal levels of utilization of substrates in Biolog EcoPlate, it is suggested 
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that dietary PHB did not affect fish gut MC, with respect to their functional abilities 
of utilization of specific substrates. 
Substrate richness 
CLPP measures functional potential rather than in situ activity (Garland et al., 
1997). It was, therefore, hazardous to interpret Biolog profiles strictly as a reflection 
of in situ carbon source metabolism. It has nevertheless been reported that a 
positive response reflects the presence of specific strains capable of using a 
particular substrate, while a negative response typically indicates the absence of 
individuals capable of degrading that substrate (Haack et al., 1995). Thus, 
variations in substrate richness and the number of intensively used substrates per 
biochemical class are indicative for differences in metabolic diversity of the gut MC 
between treatments. In this study, as for the other parameters, bacterial 
populations did not appear to be affected by dietary PHB with respect to their 
functional abilities to utilized specific biochemical substrate classes. It thus gives 
the full impression that PHB did not specifically stimulate (some members of) the 
gut MC to change the digestion pattern of the feed.  
In the Biolog EcoPlate method, the extent of substrate utilization can have a direct 
correlation to substrate selectivity for inoculated microbial communities (Christian 
and Lind, 2006). However, it should also be taken into consideration that, as like 
the other culture-dependent techniques, this method detects only the 
microorganisms capable of growing on specific, selective media. A proportion of 
the bacterial population will remain undetected. It might be possible that PHB, 
irrespective of its doses, changed sub-populations of the microbiota, but that the 
use of the 31 EcoPlate substrates was not adequate to reveal these changes. In that a 
functional profiling based on a larger diversity of substrates may be advised. The 
optimum number and kinds of carbon sources required to profile functional 
diversities among aquatic microbial communities should further be assessed, e. g., 
using Biolog GN-/ GP-Microplates or Biolog MT plates.  
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Conclusions 
In general, the current study showed that the addition of PHB in the diet of Nile 
tilapia fingerlings induced an increased body weight gain of the fish. The CLPP 
analysis using the Biolog EcoPlateTM method can differentiate the resident (mucosa 
associated) and the transient (faeces associated) gut MC but it could not detect any 
differences in either the resident or the transient gut MC functional physiological 
profile between control and PHB treatment groups. Thus, it can be suggested that 
the growth promoting effect of PHB was not necessarily related to changes in the 
functional gut MC profile or its feed digestion pattern. As a consequence, further 
studies on making the link between PHB supplementation and its growth 
performing effect remain necessary. Alternatively, CLPP analysis using Biolog 
MicroplateTM containing 95 different substrates might allow better differentiation 
between control and PHB treatments. Based on this study, it is hypothesized that 
the growth promoting effect of PHB might be related to the morphological and/or 
physiological response of the fish, instead of its intestinal microbiota. As for this, 
advance knowledge on the metabolic fate of PHB in the fish body, e.g. based on 
isotope tracer study, is critical to elucidate the exact mechanisms of action 
responsible for the growth promoting effect of PHB. 
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Abstract 
The biopolymer poly-β-hydroxybutyrate (PHB) is suggested as growth promoter 
and disease controlling agent for different species of aquaculture organisms. 
However, the mechanisms of action of PHB and its fate within an animal after 
ingestion are far from understood. In this study, PHB contained in the bacterium 
Ralstonia eutropha DSM545 was labelled with 13C and dosed in the diet of Nile 
tilapia (Oreochromis niloticus) juveniles during a period of 22 days. The 13C isotopic 
signature of different tissues (intestine, liver, kidney, heart, spleen, blood, brain, 
muscle) and the faeces was determined in a time series. Varying δ13C values among 
tissues (P ≤ 0.05) could be detected within 4 h after labelled PHB feeding, reflecting 
high differences in tissue turnover rates for the compound and/or its degradation 
product(s). In general, the higher response in isotopic incorporation of PHB in 
intestine and liver, as well as kidney and spleen, indicate their primary action as 
metabolically active organs (‘source tissues’) in PHB uptake and metabolism. The 
heart rather acts as an ‘assimilator tissue’, while the blood acts as the ‘carrier 
tissue’, and the brain and muscle as the ‘sink tissues’. The combination of intestine 
and liver being important in PHB metabolism and of the fatty acid nature of PHB 
suggests an association of PHB with the lipid and fatty acid metabolism.  
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Introduction 
Despite all the evidence on the beneficial effects of PHB in growth promotion in 
aquaculture production (De Schryver et al., 2010; Defoirdt et al., 2007b; Laranja et 
al., 2014; Najdegerami et al., 2012; Nhan et al., 2010; Sui et al., 2012; Thai et al., 
2014), detailed knowledge about the compound’s actual mechanism of action 
remains very limited. In order to understand how PHB stimulates growth and to 
optimize future PHB application, one should know how PHB distributes in the 
body once it is ingested. Improved knowledge on the PHB metabolism in the 
animal body is specifically needed to adequately design future nutritional 
experiments on PHB. Pure isotope tracers can be applied to evaluate the metabolic 
fate of specific dietary ingredients in an animal’s body under normal feeding and 
environmental conditions (Viegas et al., 2013). By sampling different tissues in a 
single individual, stable isotope analysis permits to explore the allocation of the 
tracer among tissues (Dalerum and Angerbjorn, 2005) while  information on the 
time course of the compound’s isotopic signature in the different tissues allows to 
determine the temporal distribution in the body (Newsome et al., 2007; Phillips and 
Eldrige, 2006).  
The use of stable isotope analysis has been applied in various aquaculture nutrition 
studies, including the monitoring of the incorporation of live food or compound 
diet in animal tissue during larviculture production (Schlechtriem et al., 2004; 
2005). In this study, PHB contained within the bacterium Ralstonia eutropha DSM545 
was labelled with the stable isotope 13C and used as a tracer in the diet of Nile 
tilapia juvenile. The total carbon and δ13C values of different tissues and the faeces 
was measured in function of time to trace the carbon originating from the 13C-
labelled PHB diet and to determine the compartmental distribution of PHB 
throughout the fish body after ingestion. The information on the compartmental 
distribution of PHB is expected to allow to hypothesize about the transfer kinetics 
of carbon originating from PHB throughout the body as well as about the 
metabolization of PHB. 
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Materials and methods 
Production of non-labelled and 13C labelled R. eutropha DSM545 
R. eutropha DSM 545 (also known as Cupriavidus necator) was used as the 
experimental microorganism. According to the DSMZ website (www.dsmz.de), 
this strain, a mutant of C. necator DSM 529, constitutively expresses glucose-6-
phosphate dehydrogenase. A stock culture of R. eutropha DSM 545 was stored at -80 
°C in 2 mL cryovials containing 0.5 mL of 80 % glycerol (Merck, Germany) and 1 
mL of a late exponential-phase liquid culture in Lennox broth (LB) medium 
(Invitrogen, Life Technologies Europe B.V., Belgium). A 200 µL aliquot of this stock 
culture was inoculated into 5 mL of LB medium in 15-mL test tubes and cultivated 
in an orbital shaker (Innova 42, Eppendorf, USA) for 24 h at 30 °C and 200 rpm. 
Subsequently, 2 mL of this culture was sub-cultured for 24 h at 30 °C and 180 rpm 
in 100 mL of seeding medium in 500-mL baffled flasks. The seed medium 
contained 10 g L-1 glucose, 3 g L-1 (NH4)2SO4, 1.5 g L-1 KH2PO4, 4.47 g L-1 
Na2HPO4.2H2O, 0.2 g L-1 MgSO4.7H2O, and 1 mL L-1 trace element solution. The 
trace element solution had the following composition: 10 g L-1 FeSO4.7H2O, 2.25 g L-
1 ZnSO4.7H2O, 1 g L-1 CuSO4.5H2O, 0.5 g L-1 MnSO4.5H2O, 2 g L-1 CaC12.2H2O, 0.23 g 
L-1 Na2B4O7.10H2O, 0.1 g L-1 (NH4)6Mo7O24, and 35 % HC1 10 mL L-1 and was filter 
sterilized through a 0.2-µm polyethersulfone filter (Whatman, UK) prior to use. 
Glucose and MgSO4.7H2O were separately autoclaved at 121 °C for 15 minutes. All 
ingredients were aseptically combined after cooling. Finally, 12.5 % (v/v) of the 
seed culture was used to inoculate the bioreactor (3 L, Applikon Biotechnology, the 
Netherlands). The initial working volume of the culture was 700 mL. The pH was 
maintained at 6.80 by a 2 M H2SO4 solution and a 20 % NH4OH solution, which 
was replaced by a 5 M NaOH solution during the period of ammonium limitation. 
The dissolved oxygen (DO) concentration level was regulated at 55 % of air 
saturation during the biomass growth phase to ensure no PHB accumulation from 
glucose occurred due to oxygen limitation. For PHB production, DO was kept at 30 
% of air saturation during a cascade control strategy consisting of the agitation 
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speed (850 up to 1000 rpm) and air flow. The cultivation medium initially consisted 
of 5 g L-1 glucose and 3 g L-1 (NH4)2SO4, 13.3 g L-1 KH2PO4, 1.2 g L-1 MgSO4.7H2O, 
1.87 g L-1 citric acid, and 10 mL L-1 trace element solution and was prepared similar 
to the seed medium. Glucose and ammonium (NH4+-N) were present according to 
the mass balance of R. eutropha DSM545 (Mozumder et al., 2014) to ensure 
simultaneous depletion of both substrates. At that time instance, 18 g L-1 of 13C 
labelled glucose (Euroisotop, France) was added aseptically to the cultivation 
broth. The carbon flux was redirected from biomass to PHB synthesis and the cells 
started to accumulate PHB from 13C labelled glucose. Samples were taken at 
regular time intervals and analyzed for the concentration of glucose, ammonium, 
cell mass (expressed as cell dry mass, CDM) and PHB as previously described 
(Mozumder et al., 2014; Thai et al., 2014). 
Experimental set up 
Nile tilapia fingerling with an average body weight of 9.1±0.6 g were produced and 
reared on commercial diet (500-800 µm; Coppens International, the Netherlands) at 
the Laboratory of Aquaculture & Artemia Reference Center, Ghent University. 
During a one week acclimatization period, 70 fingerlings were housed in a 200 L 
tank supplied with continuous aeration and fed three times a day with a control 
diet (semi-purified diet without PHB; Table 4.1) at a level of 5 % BW day-1 (Ng and 
Romano, 2013). Daily removal of uneaten feed and faeces, together with 30 % water 
renewal was done prior to first feeding. A photoperiod of 14L:10D was applied, 
water temperature was maintained at 26±1 °C and water quality (NO2- and NH4+) 
was maintained below 1 mg NO2--N L-1 and 1 mg NH4+-N L-1, respectively. 
Following the acclimatization period, fish were transferred to individual 10 L tanks 
and fed for 3 weeks at 5 % BW day-1 with an experimental pre-diet. The pre-diet is 
the control diet that was supplemented with 5 g kg-1 PHB at the expense of 
cellulose to prepare the fish to the digestion of PHB (referred to as ‘preparation 
period’). As the PHB was present in the lyophilized bacteria at 75 % on cell dry 
weight the amount of bacteria added in the diet was 6.67 g kg-1. The δ13C value of 
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this pre-diet was -19.4 ‰. Fish were fed 3 times daily (8:00, 14:00 and 20:00). On a 
daily basis, uneaten feed and faeces were removed and water was renewed prior to 
feeding. The physical environmental conditions during this preparation period 
were the same as during the acclimatisation period.  
 
Table 4.1.   Formulation of basal semi-purified diet (control diet) for Nile tilapia 
fingerling with initial BW of 9.1±0.6 g 
 
 
 
 
 
 
 
 
 
Uptake and elimination period 
In a next phase, the fish were fed with the tracer diet, which was a semi-purified 
diet containing 13C-labelled PHB for a period of 528 h (22 days). Due to few 
technical issues (i.e. higher fish growth rate more than expected, and limitation on 
availability of labelled-PHB), the inclusion level of PHB in the labelled diet had to 
be reduced from 5 g PHB kg-1 diet (as applied in the pre-diet during acclimatization 
period) to 3 g PHB kg-1 diet in order to assure enough food amount needed during 
the course of the experiment. As the PHB was present in the lyophilized bacteria at 
75 % on cell dry weight the amount of bacteria added in the diet was 4 g kg-1. The 
δ13C value of this labelled diet was 196.8 ‰. The period of 528 h during which fish 
were fed with the labelled diet is referred to as ‘uptake period’.  
Ingredients g kg-1 
Carboxymethyl cellulose (Sigma) 40 
Vitamin C (StayC 35% VDS) 0.6 
L-methionine (Sigma) 5 
Vit + Min mix (VDS) 12.5 
L-lysine (Sigma) 15 
Choline chloride 1.8 
-cellulose 50 
Corn meal (Bio Planet) 180 
Fish herring meal (VDS) 200 
Corn gluten meal (Sigma) 400 
Fish oil (VDS) 20 
Soybean oil  75 
Vitamin E (95%)  0.1 
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As a last phase, when the 13C-labelled PHB feeding was stopped after 528 h, fish 
feeding was continued using the unlabelled pre-diet, for a period of 192 h (8 days). 
This period when fish were switched back to the unlabelled pre-diet is referred to 
as ‘elimination period’. The daily maintenance and environmental conditions 
during the uptake and elimination period were identical as during the preparation 
period. 
Sampling and feeding regime 
Fish were sampled at specific time points throughout the experiment. The 5 
replicate fish to be sampled at each sampling point were randomly assigned using 
an online random sequence generator (www.random.org). The fish were 
euthanized using an overdose of MS-222 in ice-cold water and dissected using 
scissors and forceps to collect the intestine (cleaned from intestinal content), liver, 
spleen, heart, muscle, kidney, and brain. Between the sampling of each organ, the 
scissors and forceps were thoroughly cleaned with tap water and dried using a 
paper cloth. Blood (0.5-1 mL) was collected from the caudal vein using heparin-
treated disposable syringe and sterile needle (25-gauge; BD PrecisionGlide®; 
Becton, Dickinson and Company, USA). Faeces were collected from the tank after 
dissection of the fish. Each of the samples was dried in a small tin reservoir at 60 °C 
for 24 h (complete dryness) and cooled in a desiccator to room temperature. After 
drying, the samples were homogenized with a pestle, transferred into pre-weighed 
small pressed tin capsules (5 mm x 8 mm; Sercom Ltd, UK) and accurately weighed 
at 1.0±0.6 mg. The top of the capsules was closed after adding the sample, and the 
cups were stored at room temperature until 13C isotope analysis. 
The different sampling points can be assigned to the different experimental 
periods:  
-  Samples from the preparation period: 5 fish were sampled at the end of the 
preparation period, which was just before the start of the uptake period. This 
sampling point was considered as t = 0 h, and yielded the control samples of the 
experiment (i.e. natural steady state). 
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-  Samples from the uptake period: 5 fish were sampled at 2 h, 4 h, 8 h, 12 h, 24 h, 48 h, 
72 h, 96 h, 192 h, 360 h and 528 h relative to the first time being fed with the 
labelled-diet. The feeding regime during the uptake period depended on the 
sampling time:  
* Fish sampled at t = 2 h were given a single feeding (at 09:00 of the first 
sampling day) with the tracer diet at 2 % BW.  
* Fish sampled at t = 4 h were fed two times (at 09:00 and 12:00 of the first 
sampling day) at a total feeding level of 3 % BW.  
*  Fish sampled at t = 8 h were fed three times (at 09:00, 12:00 and 15:00 of the 
first sampling day) at a total feeding level of 4 % BW.  
*  Fish sampled at t = 12 h were fed four times (at 09:00, 12:00, 15:00 and 18:00 
of the first sampling day) at a total feeding level of 5 % BW.  
*  Fish sampled at 24 h, 48 h, 72 h, 96 h, 192 h, 360 h and 528 h were fed 5 times 
daily (at 09:00, 12:00, 15:00, 18:00 and 20:00) at a total feeding level of 6 % 
BW day-1.  
-  Samples from the elimination period: 5 fish were sampled at 24 h and 192 h relative 
to the restart of being fed again with the unlabelled pre-diet.  
The feeding regime during the elimination period was 5 times daily at 09:00, 12:00, 
15:00, 18:00 and 20:00, at a total feeding level of 6 % BW day-1. 
Isotope Ratio Mass Spectrometry  
The samples were analyzed for total carbon and δ13C at the UC Davis Stable 
Isotope Facility (Department of Plant Sciences, University of California, USA). 
Carbon isotope composition analysis was performed by continuous flow isotope 
ratio mass spectrometry (IRMS; 20-20 mass spectrometer, Sercon, Crewe, UK) after 
sample combustion to CO2 at 1000 °C in an elemental analyzer (Sercon GSL). 
Provisional isotope values obtained from the mass spectrometer were corrected 
based on working standards distributed at intervals in each analytical run.  The 
included standards were bovine liver (δ13C = -21.7 ‰, Vienna Pee Dee Belemnite 
(VPDB)), USGS-41 glutamic acid (δ13C = 37.6 ‰, VPDB), Nylon 5 (δ13C = -27.7 ‰, 
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VPDB) and glutamic acid (δ13C = -28.8‰, VPDB). Additionally, elemental totals 
were calculated based on peak area response to calibration standards.  The same 
reference material analyzed over the analysis period was measured with ±0.2 ‰ 
precision for natural materials and ±0.4 ‰ precision for enriched materials. Stable 
isotope ratios were presented in delta notation (δ) in parts per million (‰) and 
calculated as:   
δ13C =   
Rsample
Rstandard
 - 1  x 1000 
, where δ13C is the stable carbon isotope ratio, while Rsample and Rstandard are the molar 
ratio of the heavy/light isotope (13C/12C) of the sample and the international 
reference (VPDB); 0.0112372), respectively.  
The level of isotopic incorporation into each tissue during the uptake period was 
calculated as ∆δ13Cuptake = δ13Ct-uptake – δ13Ct=0, where δ13Ct-uptake is the δ13C value of the 
tissue at time t during the uptake period, and δ13Ct=0 is the δ13C value of the tissue at 
the beginning of the uptake period (t = 0 h). Similarly, the level of isotopic 
elimination from each tissue during the elimination period was calculated as 
∆δ13Celimination = δ13Ct-elimination – δ13Ct=0’, where δ13Ct-elimination is the δ13C value of the 
tissue at time t during the elimination period, and δ13Ct=0’ is the δ13C value of the 
tissue at the beginning of the elimination period, which was the same as the δ13C 
value of the tissue at the end of the uptake period (t = 528 h).  
Statistic analyses 
Two factors repeated measures ANOVA (RM-ANOVA) was used when data were 
represented in a cumulative way to evaluate the changes in isotopic ratio of 
different tissues at multiple time points during the uptake and elimination period. 
Data sphericity was tested prior the RM-ANOVA by means of the Mauchley’s test 
to check for the assumptions that there is no interaction among times and tissues. 
One-way analysis of variance (one-way ANOVA) was further used to describe the 
change-point of each tissue, i.e. the time when the δ13C value of the tissue was 
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significantly changed from its initial level. Furthermore, differences in carbon 
isotope incorporation (∆δ13Cuptake) and elimination (∆δ13Celimination) among tissues at 
multiple time points during the uptake and elimination period, respectively, were 
tested by means of one-way ANOVA. A posteriori comparisons were carried out 
with the Duncan's multiple range test using 95 % confidence limits. All statistical 
analyses were performed using the STATISTICA statistical software (Version 7.0). 
Results 
Isotope ratio of tissues during uptake period 
The mean δ13C values of the different tissues at the start of the experiment reflected 
the δ13C value of the unlabelled pre-diet (-19.4 ‰). Following the start of the uptake 
period, the faeces showed a very high increase in the δ13C values already from 2 h 
onwards. The δ13C value of the faeces was levelling up to the δ13C value of the 
labelled diet (196.8 ‰) at 2 h (Table 4.2). The δ13C values of all tissues also 
significantly increased during the uptake period. It can be observed that the rate at 
which carbon was derived from the PHB diet and was incorporated during the 
uptake period was highly variable among tissues (Fig. 4.1). The overall trend 
showed higher and faster isotope shifting in the intestine, liver, kidney and spleen 
compared to the heart, brain, blood and muscle. The intestine and liver showed a 
fast increase in δ13C value, resulting in an asymptotic like curve which seems to be 
levelling off towards the end of the uptake period (Fig. 4.1.a-b). Similarly, the 
kidney and spleen also showed a fast increase in δ13C content following a curved 
trend but which did not seem to be levelling off yet at the end of the uptake period 
(Fig. 4.1.c-d). A more linearly increase in δ13C values with a rather high slope was 
shown by the heart (Fig. 4.1.e), while a linear response with a lower slope was 
shown by the blood, brain and muscle (Fig. 4.1.f-h).  
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 (a) Intestine   (b) Liver                                                (c) Kidney   
        
 
(d) Spleen (e) Heart (f) Brain 
       
Figure 4.1.  δ13C  values (‰) of different fish tissues (a – i) and faeces during the uptake period (up to 528 h), followed with the elimination period (up to 192 h) – part 1. 
The vertical dashed line separates the two experimental periods. Time is in hours after the first labelled feeding in the uptake period or after the first 
unlabelled pre-diet feeding in the elimination period. Filled circles are data observations; solid line / curve is polynomial trend line of data observations. 
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(g) Blood             (h) Muscle       (i) Faeces 
      
 
Figure 4.1.  δ13C  values (‰) of different fish tissues (a – i) and faeces during the uptake period (up to 528 h), followed with the elimination period (up to 192 h) – part 2. 
The vertical dashed line separates the two experimental periods. Time is in hours after the first labelled feeding in the uptake period or after the first 
unlabelled pre-diet feeding in the elimination period. Filled circles are data observations; solid line / curve is polynomial trend line of data observations. 
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Tissue change-points and isotope incorporation levels during uptake period 
The results of one-way ANOVA on the differences in δ13C values of each tissue 
during the uptake period showed that there are various change-points between 
tissues (Table 4.2). Based on the change-points, different tissues can be categorized 
into four groups: (1) intestine; 12 h, (2) liver, kidney, and spleen; 48 h, (3) heart, 
brain, muscle; 96 h, and (4) blood; 192 h. This suggests that there are differences in 
the isotopic incorporation rate among tissues during the uptake period. 
Furthermore, the results of one-way ANOVA on the temporal differences in the 
isotopic incorporation levels (i.e. ∆δ13C values) among tissues during this uptake 
period, showed that the significant differences in isotopic incorporation levels 
among tissues were already detected from 2 h onwards (Table 4.3). Overall, in 
addition to the earliest change-point (at 12 h), the intestine showed the highest 
∆δ13Cuptake values among all tissues, with significant differences when compared to 
the heart, blood, brain, and muscle (P ≤ 0.05) at all times during the uptake period; 
while the differences with the liver, kidney and spleen were not always significant 
(Table 4.3). In addition to the similar change-point (at 48 h), the liver, kidney and 
spleen also showed similar ∆δ13Cuptake values during most of the uptake period (the 
∆δ13Cuptake value of the spleen were significantly lower than of the liver and kidney 
at time 192 h and 360 h; no significant differences in ∆δ13Cuptake value were found 
between the liver, kidney and spleen at all other time points). A different pattern 
was observed for the heart, brain, and muscle; even though they showed similar 
∆δ13Cuptake values at their change-point (at 96 h) but the ∆δ13Cuptake values of the 
heart were found to be significantly higher than the brain and muscle from 192 h 
onwards. As for the blood, even though it showed the slowest change-point (at 192 
h), its ∆δ13Cuptake values were similar with the brain and muscle during most of the 
uptake period (the ∆δ13Cuptake value of the blood was significantly higher than of the 
muscle at time 48 h; no other significant differences in ∆δ13Cuptake value were found 
between the blood, brain and muscle at all other time points). At the end of the 
uptake period, the highest ∆δ13Cuptake values were obtained by the intestine and 
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kidney, which were higher than the liver and spleen (P > 0.05), and the heart (P ≤ 
0.05). Lastly, the lowest ∆δ13Cuptake values among all tissues were observed in the 
blood, brain, and muscle (P ≤ 0.05) (Table 4.3). 
Tissue isotopic elimination levels during elimination period 
For the elimination period, differences in the isotopic elimination levels 
(∆δ13Celimination) between different tissues were already observed within the first 24 h 
of elimination period. At the end of the elimination period, the highest ∆δ13Celimination 
value was obtained by the intestine. A lower ∆δ13Celimination value was observed in 
the liver and kidney, which then followed by ∆δ13Celimination value of the spleen and 
heart. The lowest ∆δ13Celimination values were observed in the brain and muscle (Table 
4.3). 
 
Chapter 4. Compartmental distribution of PHB 
 
105 
 
 
Table 4.2.  δ13C values of different tissues, as well as faeces, during trace experiment (Mean±SD). Five fish were analyzed at each 
sampling time). Different letters in columns indicate significant difference in δ13C values between sampling times for 
each tissue during the uptake period (one-way ANOVA; P ≤ 0.05) 
 
*This data point is considered as outlier as it does not well correspond with the next sampling point. Sample might be contaminated with 13C-diet 
particle that were not rinsed completely from the intestine tissue during sampling. 
  
Time (h) during 
uptake period 
δ13C (‰)   
Intestine Kidney Liver Spleen Heart Blood Brain Muscle  Faeces 
 
0 -20.0±0.8a -17.6±0.4a -20.3±0.7a -20.0±1.2a -17.7±0.4a -18.0±0.2a -20.1±0.5a -17.7±0.2a 
 
-19.5±0.9a 
2 -9.0±2.6* -16.8±0.4ab -19.9±0.8a -20.1±1.0a -17.1±0.2a -18.2±0.1a -20.1±0.6a -17.7±0.4a  166.6±174.9b 
4 -15.2±2.1ab -16.1±1.8ab -18.5±2.6ab -17.2±1.6ab -17.0±1.1a -17.4±1.2a -19.1±0.6a -17.5±0.3a  256.5±75.9bc 
8 -13.0±0.9ab -15.9±0.3ab -17.8±1.3ab -17.5±1.4ab -16.8±0.3a -17.6±0.2a -20.0±0.8a -17.5±0.5a  350.1±14.4c 
12 -10.2±6.9b -15.3±2.0ab -17.4±3.6ab -16.7±1.5ab -16.6±1.2a -17.6±1.0a -19.6±0.2a -17.4±0.7a  319.1±86.5bc 
24 -12.8±1.7b -14.6±1.6ab -16.4±1.7ab -17.7±1.2ab -17.0±1.1a -17.1±0.5a -19.5±0.8a -17.5±0.8a  354.5±150.9c 
48 -11.5±3.7b -12.3±2.1b -15.2±2.2b -15.1±0.7b -14.8±1.3ab -16.8±0.8a -18.4±1.1a -17.7±0.6a  218.2±104.9bc 
72 -10.1±0.8b -12.1±1.3b -13.9±2.0b -15.4±1.2b -14.4±1.0ab -16.7±0.3a -18.6±0.5a -16.5±0.5a  353.4±192.7c 
96 0.2±7.0c -5.9±3.1c -7.7±2.6c -9.7±2.2c -11.4±4.4b -14.7±0.5ab -16.2±0.8b -14.6±0.3b  230.0±94.4bc 
192 5.1±6.0cd 3.4±0.6d 1.3±2.9d -3.8±2.6d -5.2±0.8c -10.7±2.2bc -13.1±0.9c -11.9±0.6c  311.7±61.4bc 
360 8.9±3.6d 4.0±5.6d 6.0±5.1e -2.2±3.2d -0.5±2.7d -8.3±2.4c -9.3±3.0d -10.4±1.3d  324.1±69.6bc 
528 20.6±9.8e 23.3±8.0e 16.5±6.5f 10.7±5.9e 9.8±6.1e 0.4±4.8d -1.5±3.1e -4.3±2.9e  392.4±70.4c 
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Table 4.3.  ∆δ13C values of different tissues, as well as faeces, during the uptake and elimination period (Mean±SD). Five fish were 
analyzed at each sampling time. Different lower case letters in rows indicate significant difference in ∆δ13Cuptake values among 
tissues at a specific time during the uptake period (one-way ANOVA; P ≤ 0.05). Different upper case letters in rows indicate 
significant difference in ∆δ13Celimination values among tissues (excluding faeces) at a specific time during the elimination period 
(one-way ANOVA; P ≤ 0.05). 
*This data point is considered as outlier as it does not well correspond with the next sampling points. Sample might be contaminated with 13C-diet particle that were not rinsed completely from the 
intestine tissue during sampling 
Time (h) during 
uptake period 
∆δ13Cuptake (‰)   
Intestine Kidney  Liver  Spleen Heart Blood Brain Muscle  Faeces 
2 10.74±2.58* 0.83±0.44a 0.58±0.70ab  0.63±0.75ab  0.61±0.16a  0.00±0.00b  0.23±0.30ab  0.17±0.24ab   186.09±174.92 
4 4.81±2.08a 1.65±1.70bc 2.18±2.03abc   2.79±1.63ab   0.81±0.92bc 0.69±1.12bc 1.09±0.63bc 0.24±0.24c  276.00±75.92 
8 7.00±0.99a 1.79±0.33bc 2.45±1.34b  2.49±1.36b  0.90±0.34cd 0.40±0.24d 0.37±0.46d 0.29±0.34d  369.61±14.37 
12 9.86±6.90a 2.48±1.82b 3.31±2.84b  3.31±1.49ab   1.21±0.87b 0.67±0.55b 0.53±0.21b 0.48±0.49b  338.52±86.51 
24 7.19±1.66a 3.05±1.62b 3.87±1.75b  2.29±1.19bc 0.71±1.03d 0.92±0.53cd   0.63±0.71d 0.46±0.48d  374.00±150.9 
48 8.50±3.73a 5.30±2.05ab 5.06±2.18ab  4.87±0.75ab  2.87±1.31bc  1.21±0.84c 1.69±1.05c  0.26±0.14d  237.67±104.9 
72 9.92±0.75a 5.59±1.35b 6.36±2.00b  4.59±1.15bc  3.27±1.00c 1.32±0.25d  1.54±0.48d  1.20±0.52d  372.89±192.7 
96 19.81±7.03a 11.80±3.12b 12.59±2.65b  10.30±2.17b  6.25±4.40c 3.31±0.50c  3.97±0.79c  3.09±0.29c    249.48±49.36 
192 25.09±6.02a 21.10±0.58a 21.61±2.95a  16.14±2.58b  12.52±0.77c  7.29±2.22d  7.05±0.91d  5.79±0.62d   331.15±61.39 
360 28.92±3.59a 21.64±5.58b 26.29±5.08ab  17.77±3.17c 17.21±2.73c  9.76±2.42d  10.87±3.03d  7.30±1.29d   343.53±69.58 
528 40.63±9.85a 40.93±8.01a 36.80±6.51ab  30.73±5.90ab  27.51±6.08b  18.40±4.81c  18.58±3.07c  13.45±2.93c   411.84±70.42 
           
Time (h) during 
elimination period 
∆δ13Celimination (‰)   
Intestine Kidney Liver Spleen Heart Blood Brain Muscle  Faeces 
24 10.2±7.9A 6.3±2.9AB 6.7±1.8AB 5.7±4.4AB 2.2±2.0B 2.7±2.4B 1.3±0.6B 1.3±1.5B  -394.55±6.04 
196 21.0±0.6A 17.1±3.3B 13.7±3.5BC 12.0±2.3C 7.9±1.5CD 4.4±1.5DE 1.1±1.0E 1.3±0.9E  -427.04±5.19 
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Discussion 
A tracer experiment was used to measure differences among tissues in 13C 
incorporation in Nile tilapia juveniles with the aim of investigating the 
compartmental distribution of PHB after ingestion. In this study, the labelled PHB 
might have been relatively low digestible, as indicated by the high ∆δ13Cuptake 
values of the faeces at 2 h until the end of the uptake period where the ∆δ13Cuptake 
values reached up to 2.5 times the δ13C value of the labelled diet, which showed 
that high amounts of ingested PHB-C ended up in the faeces and made the faeces 
very highly enriched. Nevertheless, this study succeeded to be the first study that 
shows PHB is actually metabolized as a dietary compound and contributes to 
tissue formation. The overall results showed a faster and higher incorporation of 
PHB-C in the intestine, liver, spleen and kidney as compared to the heart, blood, 
brain and muscle. The turnover rate of a tissue for a specific element (such as 
carbon) gives an indication of the metabolic activity of this organ for that 
compound (Cerling et al., 2007). Highly metabolically active tissues (i.e. splanchnic 
organs including intestine and liver) have high turnover rates reflecting the balance 
between uptake of recent dietary inputs for metabolism and growth and output of 
metabolic products. Other tissues exhibit a much lower turnover rate (i.e. structural 
elements including muscle and red blood cells) reflecting mainly the incorportation 
of dietary inputs in the tissue over longer time periods (Ambrose, 2000; Carleton et 
al., 2008; Dalerum and Angerbjorn, 2005; Gannes et al., 1998; Martinez Del Rio et 
al., 2009; Pearson et al., 2003; Podlesak et al., 2005; Voigt et al., 2003; Waterlow, 
2006). In this study, the exact turnover rate of PHB-C in each tissue could not be 
determined because its incorporation in all tissues was still progressing at the end 
of the trial while an equilibrium level is needed for the calculation of the tissue 
turnover rates (Cerling et al., 2007). However, based on varying change-points and 
isotopic incorporation levels among tissues observed in this study, a simulation can 
be made of the circulation of PHB-C in the body.  
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The observed compartmental distribution of PHB-C is related to the nutrient flow 
in the animal body (Brindley, 1984; Halver and Hardy, 2002) After ingestion of the 
PHB diet, dietary ingredients are digested and absorbed by the intestine (Halver 
and Hardy, 2002). The processes of digestion occur in the intestinal lumen, where 
complex compounds in the diet (lipids, proteins, carbohydrates) are reduced into 
smaller ‘building blocks’ of these compounds (fatty acids, amino acids, 
monosaccharides) (Buddington and Kuz'mina, 2000). The earliest change-point (at 
12 h) and high ∆δ13Cuptake values showed by the intestine indicate a high level of 
intestinal activity in the absorption and digestion of PHB-C during the uptake 
period.  
Digested nutrients absorbed by the intestine are then transported to the blood for 
which there are two routes; the lymphatic vessels of the intestine and the veins of 
the portal system (Brindley, 1984). Substances such as long-chain fatty acids, 
phospholipids and cholesterols are mainly transported by the lymphatic system 
and enter the systemic circulation directly (Sheridan and Friedlander, 1985; Zapata 
et al., 2006). Other substances, including the short-chain fatty acids, 
monosaccharides, and amino acids, are transported via the hepatic portal vein, 
where the spleen is also attached (Buddington and Kuz'mina, 2000), to the liver 
where they undergo metabolic transformation before entering the systemic 
circulation (Brindley, 1984; Halver and Hardy, 2002). The liver plays an important 
role in the lipogenesis and is responsible for the production of bile that emulsifies 
lipid to aid its digestion, as well as storage site of lipid (Ballantyne, 2014; 
Buddington and Kuz'mina, 2000). In this study, the high isotopic incorporation in 
the liver indicates that PHB metabolites are not only metabolized but also taken up 
by the liver. Furthermore, the high metabolic activity of the liver suggests that the 
metabolism of PHB is associated with the fatty acid metabolism. Based on this 
observation, two hypotheses are formulated. Firstly, we hypothesize that PHB is 
metabolized into the short-chain fatty acid, i.e.  butyrate that is one of the common 
FAs used as carbon source in PHB synthesis by PHB-producing bacteria (Hu et al., 
1997; Shimizu et al., 1993). It is reported that although butyrate is greatly 
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metabolized by the intestinal epithelium (Ballantyne, 2014; Bauermeister and 
Sargent, 1979; Buddington and Kuz'mina, 2000; Titus and Ahearn, 1988), a certain 
amount is also absorbed into the portal blood (Velázquez et al., 1997) and taken up 
by the liver in rat in vivo (Bloemen et al., 2009; Demigné et al., 1986). Secondly, we 
hypothesize that PHB metabolism results in the release of ketone body β-
hydroxybutyrate (β-HB). In the liver, fatty acids can also be oxidized into ketone 
bodies (Halver and Hardy, 2002). Ketone bodies formation from butyrate has been 
demonstrated in liver slices of rainbow trout and eel (Phillips and Hird, 1977).  
From the liver, PHB metabolites (i.e. ketone body β-HB) can be diverted to the gall 
bladder followed by secretion into the intestine or alternatively returned back in 
the blood and eliminated by the kidney (Buddington and Kuz'mina, 2000). The 
kidney filters the blood and also acts as the primary excretory organ (Buddington 
and Kuz'mina, 2000). In this study, the high ∆δ13Cuptake values of the kidney indicate 
its high activity in filtering the blood containing PHB-C. The slow change-point 
(only at 192 h) and low isotopic incorporation level of the blood is likely related to 
its function as transport medium of PHB-C, which characterized by a constant 
uptake and release of PHB-C. This suggests that the blood acts as a ‘carrier tissue’ 
for PHB metabolites (i.e. β-HB). Several studies reported that trace amounts of β-
HB were found in blood samples, showing the function of blood in the circulation 
of the ketone body (Hemre et al., 1991; Zammit and Newsholme, 1979). The 
released ketone bodies are then utilized mostly by the heart (Hemre et al., 1991), 
but the brain and muscle are also capable to use ketone bodies as their fuels (Beis et 
al., 1980; Magnoni et al., 2001; Soengas and Aldegunde, 2002). The intermediate 
level of isotopic incorporation in the heart suggests that the heart acts as 
‘assimilator tissue’ that receives and utilizes the PHB metabolites. On the other 
hand, the slow and low isotopic incorporation in the brain and muscle indicate 
their minor response in the uptake of PHB metabolites, suggesting that they rather 
act as ‘sink tissues’, which also receive and utilize the PHB metabolites but at lower 
level. 
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At the end of the elimination period, the intestine, kidney, liver, and spleen showed 
higher isotopic elimination level (higher ∆δ13Celimination values) when compared to 
the heart, blood, brain and muscle. This further emphasizes the primary response 
of these major metabolically active organs for the PHB metabolism. The lower 
isotopic elimination level observed in the heart again indicates its function as an 
‘assimilator tissue’. Furthermore, the low isotopic elimination levels observed in 
the blood, brain and muscle again indicate their low response in PHB metabolism 
due to their suggested function as a ‘carrier tissue’ (i.e. blood) or ‘sink tissues’ (i.e. 
brain and muscle). 
 
Conclusions  
In conclusion, the compartmental distribution of PHB in the fish body can be 
determined through the carbon stable isotope incorporation. The overall results 
suggest that the intestine and liver, as well as kidney and spleen, are the major 
metabolically active organs (‘source tissues’) in PHB uptake and metabolism. It is 
also suggested that the heart rather acts as an ‘assimilator tissue’, while the blood 
acts as the ‘carrier tissue’, with the brain and muscle as the ‘sink tissues’. The 
combination of intestine and liver being important in PHB metabolism and of the 
fatty acid nature of PHB suggests an association of PHB with the lipid and fatty 
acid metabolism. It is hypothesized that once it is ingested, the PHB is digested, 
absorbed, and metabolized, resulting in the release of SCFA and ketone body β-HB 
production. These results are especially of interest for a complete elucidation of the 
PHB metabolic pathway in order to explore the full potential of PHB as an 
ecologically and economically sustainable alternative as growth modulator and 
anti-infective strategy for aquaculture. 
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Chapter 5 
Bacterial challenge test for gnotobiotic Nile tilapia larvae: 
Development and use in poly-β-hydroxybutyrate study 
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Abstract 
The use of PHB in the protection of the host against bacterial infections and in 
increasing the survival and growth performance has been studied in different 
aquatic animals and diet formulations. To study the treatment of infectious 
diseases in Nile tilapia, the availability of a method of experimental infection 
leading to reproducible results in survival is important. In pathogen-screening 
tests, four candidate pathogenic bacterial strains, Edwardsiella ictaluri gly09, E. 
ictaluri gly10, E. tarda LMG2793 and Streptococcus agalactiae LMG15977 were 
individually tested on xenic Nile tilapia larvae. Only Edwardsiella strains delivered 
via Artemia nauplii, with or without additional pathogen delivery via the culture 
water, led to a significant increase in mortality of the fish larvae. Based on an 
antibiotics resistant E. ictaluri gly09R strain, a gnotobiotic Nile tilapia larval model 
system was developed, providing a research tool to investigate the protective effect 
of poly-β-hydroxybutyrate (PHB) under controlled conditions. A double 
disinfection procedure using hydrogen peroxide (2000 mg L-1 for 10 min) and 
sodium hypochlorite solution (75 mg L-1 active chlorine for 2 min) was applied on 
the fish eggs. A cocktail of antibiotics (ampicillin, rifampicin, kanamycin, 
trimethoprim and gentamycin each at 10 mg L-1) and antifungal agents 
(Amphotericin-B and Fluorescent Brightener-28 at 0.5 mg L-1 and 25 mg L-1, 
respectively) were used to maintain gnotobiotic conditions. The feeding of the 
challenged gnotobiotic larvae with PHB-enriched Artemia nauplii resulted in a 20 % 
higher mean survival when compared to the challenged control treatment. This 
indicated that PHB is also effective as an antimicrobial agent for application in Nile 
tilapia larviculture. 
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Introduction 
Tilapia (Oreochromis spp.) are an important group of freshwater aquaculture 
animals due to their ease of culture under a wide range of environmental 
conditions and their relatively high resistance to environmental stressors when 
compared to other cultured finfish species (Welker and Lim, 2011). Under intensive 
culture conditions, however, significant losses can still occur as tilapia can become 
infected with a wide range of viral, parasitic, fungal and especially bacterial 
pathogens. Bacteria of the genus Edwardsiella, including E. ictaluri and E. tarda, have 
been described as strong pathogens that cause severe economic losses in both 
freshwater and marine aquaculture in many countries (Evans et al., 2011; Ewing et 
al., 1965; Hawke et al., 1981). E. ictaluri, the causative agent of enteric septicemia of 
catfish (ESC), is also known to infect and cause mortality in Nile tilapia fingerlings 
(Plumb and Sanchez, 1983; Soto et al., 2012). E. tarda, which is a common bacterium 
in freshwater environments, has been reported to infect and cause disease in red 
tilapia (Iregui et al., 2012). 
The use of antibiotics for the control of bacterial diseases in aquaculture has 
resulted in the development and spread of antibiotic resistance, leading to 
ineffective treatment for some diseases (Defoirdt et al., 2011). This has made 
researchers examine other mechanisms for the control of bacterial diseases in fish.  
Several studies have confirmed the role of PHB in the protection of the host against 
bacterial infections and in increasing the survival and growth performance in 
different aquatic animals and formulations (Defoirdt et al., 2007a; Defoirdt et al., 
2011; Nhan et al., 2010; Sui et al., 2012; Thai et al., 2014). 
Overall, the previous studies of PHB in fish and shrimp culture were done in open 
(or conventional) rearing systems, implying that the composition of the 
gastrointestinal (GI) MC in the animals may be very dynamic. The composition of 
the GI microbiota can be influenced by host genotype (Kostic et al., 2013; Spor et 
al., 2011), environmental conditions and stochastic factors (Fjellheim et al., 2012; 
Verschuere et al., 1999). This often complicates the study of host-microbial 
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interactions, which can be important when the unbiased action of a disease 
treatment is being investigated. Thus, a key strategy in studying host-microbial 
interactions is to first determine interactions under axenic conditions, and then 
further evaluate the effects of a single population or defined populations of 
microbes or specified compounds added under gnotobiotic conditions (Gordon 
and Pesti, 1971). The use of gnotobiotic organisms leads to an increased control of 
variables, enhanced reproducibility of results and more accurate experimental 
designs (Coates, 1975; Marques et al., 2005) and thus is an excellent tool to extend 
the understanding of the mechanisms involved in host-microbe interactions 
(Marques et al., 2006).  
The aims of the present work were to (i) screen candidate pathogenic bacteria 
strains for xenic / conventional Nile tilapia O. niloticus larvae, (ii) develop a 
standardized gnotobiotic Nile tilapia larvae culture system to facilitate the studies 
of host–microbe interactions, (iii) develop a standardized bacterial challenge test 
for gnotobiotic Nile tilapia larvae, and (iv) employ the developed bacterial 
challenge test for gnotobiotic Nile tilapia larvae to evaluate the use of PHB and its 
effects on fish disease resistance. To our knowledge, this is the first study on a 
gnotobiotic food chain consisting of Nile tilapia larvae and Artemia nauplii. 
Materials and Methods 
Pathogen screening test on xenic Nile tilapia larvae 
Larvae production 
Nile tilapia broodstock that ranged from 120 to 150 g wet weight and 21 to 23 cm 
total length were naturally bred in our laboratory to provide tilapia larvae. Three 
days after hatching (DAH) larvae were collected from the mouth of brooding 
females and pooled. Upon collection, the pooled larvae were acclimatized in a 30 L 
aquarium for 6 d at a temperature of 27±1 °C until the start of xenic bacterial 
challenge. Filtered synthetic freshwater containing 96 mg L-1 NaHCO3, 60 mg L-1 
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CaSO4.2H2O, 60 mg L-1 MgSO4 and 4 mg L-1 KCl (EPA, 2002) was used as fish 
culture water.  
Bacterial strains and culture conditions 
Streptococcus agalactiae LMG15977 and two strains of E. ictaluri, referred to as gly09 
and gly10, were tested in the first bacterial pathogen screening test (experiment 1a). 
Another Edwardsiella species, E. tarda LMG2793, was tested along with the 2 E. 
ictaluri strains in a second pathogen screening test (experiment 1b). Both E. ictaluri 
strains were obtained from the Laboratory of Aquaculture & Artemia Reference 
Center, Ghent University, Belgium. These strains were isolated from 
ichthyophthriasis (white spot disease) infected striped catfish (Pangasius 
hypophthalmus). S. agalactiae LMG15977, which was previously isolated from Nile 
tilapia brain, was obtained from the Belgian Coordinated Collections of 
Microorganisms (BCCM/LMG), Laboratory of Microbiology, Ghent University, 
Belgium. Isolate E. tarda LMG2793 was provided by the Laboratory of Veterinary 
Bacteriology and Mycology, Ghent University, Belgium.  This isolate was obtained 
from human faeces. 
The strains were stored in Brain Heart Infusion (BHI) broth (FLUKA, Sigma-
Aldrich, USA) supplemented with 20 % (v/v) glycerol at -80 °C. Edwardsiella strains 
were grown in BHI broth and incubated overnight on a horizontal shaker at 160 
rpm at 27 °C. S. agalactiae LMG15977 was grown in BHI broth and incubated 
overnight on a horizontal shaker at 180 rpm at 37 °C.  
Bacterial challenge procedure for xenic Nile tilapia larvae 
Candidate pathogenic bacteria strains were tested individually in triplicate 1.5 L 
aquaria each of which contained 10 larvae. All aquaria were provided with gentle 
aeration and kept in a heated room (constant air temperature of 29±1 °C), 
maintaining the water temperature at 26±1 °C. Filtered synthetic freshwater was 
used as fish culture water. To maintain the NH4+ and NO2- levels below 0.5 mg 
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NH4+ L-1and 0.2 mg NO2- L-1, respectively, 25 % of the culture water was renewed 
every 3 d during the 12 d experimental period. 
Fish were challenged daily over the experimental period using 3 challenge 
methods: (1) via culture water, (2) via axenic Artemia nauplii, and (3) via both 
culture water and axenic Artemia nauplii. For the culture water challenges, bacterial 
suspensions were harvested by centrifuging at 1000 × g for 10 min and washed 
twice in their respective culture medium followed by 1 time washing using fish 
culture water before addition. The density of the bacterial suspension prior to 
addition was determined based on the McFarland standard (BioMérieux, Marcy 
L’Etoile, France) by measuring the turbidity with a spectrophotometer (Genesys 20, 
Thermospectronic) at 550 nm. For each replicate tank, bacteria were added at a 
density of 106 CFU mL-1. 
For the challenge via axenic Artemia nauplii, axenic Artemia cysts were incubated 
and hatched following the procedure of Marques et al. (2004). Axenic Artemia 
nauplii were harvested after 24 h incubation at 27±1 °C, washed using filtered 
autoclaved synthetic freshwater, and counted. Bacterial suspensions were 
harvested by centrifuging at 1000 × g for 10 min and washed twice using their 
respective culture medium and added to the axenic Artemia culture (100 Artemia 
mL-1) at a density of 108 CFU mL-1. Bacteria loaded Artemia nauplii were harvested 
after 1 h incubation and washed twice using sterile saline solution (9 g L-1 NaCl), 
counted, and added into the tanks at the density of 20 Artemia fish-1. For the 
challenge via both Artemia nauplii and culture water, both challenges were 
conducted as described above.  For all challenge methods, mortality observation 
and dead fish removal were done twice daily. The bacterial load of the Artemia 
nauplii in each treatment was determined by the plate count method. After rinsing 
and counting, subsamples of bacteria loaded Artemia were homogenized according 
to the procedure described by Huys et al. (2001). Subsequently, 50 µL of the 
homogenized Artemia suspension was dilution plated (Spiral platerTM, Spiral 
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Systems, USA) on LB agar. The inoculated plates were incubated overnight at 27±1 
°C and the grown colonies were counted.  
Development of challenge test on gnotobiotic Nile tilapia larvae 
Disinfection protocol to obtain axenic Nile tilapia larvae 
Nile tilapia were naturally bred in our laboratory and 3 d post fertilization (3 dpf) 
eggs were collected and pooled following the procedures described above for the 
xenic pathogen-screening tests. Upon collection, eggs were put on a sterile nylon 
sieve (mesh size 300 µm) and washed 4 times using 250 mL 0.2 µm-filtered 
autoclaved synthetic freshwater at 25±1 °C to remove loose bacteria. Unfertilized 
eggs, dead eggs or eggs with ruptured yolk were discarded prior to the disinfection 
procedure. A double disinfection procedure was applied for the remaining eggs at 
the eyed egg stage (stage 14-15) (Fujimura and Okada, 2007). In the first 
disinfection step, eggs were immersed in diluted 30 % hydrogen peroxide 
(MERCK-Schuchardt 386790) with a final active peroxide concentration of 2000 mg 
L-1 for 10 min at 25±1 °C. During disinfection, eggs were gently agitated to ensure 
that all eggs had equal contact with the disinfecting agent. Subsequently, the eggs 
were rinsed 4 times using 250 mL 0.2 µm-filtered autoclaved synthetic freshwater. 
Next, the eggs were incubated in 0.2 µm-filtered autoclaved synthetic freshwater 
containing 10 mg L-1 each of ampicillin (Sigma-A0166), rifampicin (Sigma-83907), 
trimethoprim (Sigma-T7883) and gentamycin (Sigma-G1264) and the antifungal 
agents Amphotericin-B (Sigma-A9528) and Fluorescent Brightener 28 (Sigma-
F3543) at concentrations of 0.5 mg L-1 and 25 mg L-1, respectively. The second 
disinfection step was done 24 h following the first disinfection. Eggs were first 
rinsed from the culture medium from the first disinfection using 500 mL 0.2 µm-
filtered autoclaved synthetic freshwater. A sodium hypochlorite solution with 75 
mg L-1 active chlorine (Sigma Aldrich 425044) was prepared in 0.2 µm-filtered 
autoclaved synthetic freshwater. Eggs were then immersed in this solution for 2 
min at 25±1 °C. Following disinfection, eggs were rinsed 4 times using 250 mL 0.2 
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µm-filtered autoclaved synthetic freshwater. All disinfection procedures were 
performed in a laminar flow hood. 
Disinfected eggs were aseptically distributed to 500 mL sterile glass bottles 
containing 200 mL 0.2 µm-filtered autoclaved synthetic freshwater at a density of 
500 eggs L-1. Eggs of the control group underwent the same incubation procedure, 
however, they were not surface disinfected or treated with antibiotic and 
antifungal agents. Each incubation bottle was equipped with 2 sterile 0.2 µm filters 
(Sartorius Midisart®, USA) for the aeration in- and outlet to provide gentle sterile 
aeration during incubation. Eggs hatched after 3 days of incubation following the 
disinfection procedure and larvae were maintained in the axenic incubation 
medium throughout the non-feeding larval stage. The effect of the disinfection 
procedure on the egg hatching success was evaluated using the egg hatching 
percentage, which was measured as the proportion of the hatched eggs relative to 
the total eggs incubated regardless of the viability (Komara et al., 2004). The 
hatching percentage was determined 1 DAH. 
Tests for axenity 
Axenity was checked at several crucial steps during the experiments. After 24 h 
following the disinfection procedure, 5 eggs were aseptically sampled from each 
incubation bottle, individually homogenized and plated on Lysogeny broth (LB) 
medium + 15 g L-1 agar (LB Agar; Bacteriological Grade, MP Biomedicals). In 
addition, 1 mL of water from each incubation bottle was added into a sterile tube 
containing 9 mL of LB broth (10 %). The inoculated tubes were incubated at 27±1 °C 
for 96 h and checked for any bacterial / fungal growth.  
At stocking of the larvae (6 DAH) and at the end of the gnotobiotic challenge test, 
the fish larvae from the axenic treatments were checked for bacterial contamination 
using the plate culture method. From each incubation bottle, 2 larvae were 
euthanized using 1 g L1 sterile benzocaine and washed with 1 g L-1 sterile 
benzalkonium chloride before being rinsed with 0.2 µm-filtered autoclaved 
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synthetic freshwater and homogenized in sterile saline solution (9 g L-1 NaCl). 
Subsequently, 50 µL of the homogenate was plated (Spiral platerTM, Spiral Systems, 
USA) on LB agar plates. The inoculated plates were incubated at 27±1 °C for 96 h 
and checked for any bacterial / fungal growth.  
Bacterial challenge procedure on gnotobiotic Nile tilapia larvae 
Along with the antifungal agents (0.5 mg L-1 Amphotericin-B and 25 mg L-1 
Fluorescent Brightener-28), a mixture of antibiotics containing ampicillin, 
rifampicin, kanamycin, trimethoprim and gentamycin (each at 10 mg L-1) was used 
in the larval incubation medium throughout the gnotobiotic challenge tests. 
Therefore, it was necessary to identify antibiotic resistant mutants of the pathogens 
that could be used for challenge. The resistance of E. ictaluri gly09 to the 
different antibiotics was investigated by inoculating an overnight E. ictaluri gly09 
culture into sterile tubes containing BHI broth and one of the 5 antibiotics at a 
concentration of 10 mg L-1. These cultures were incubated overnight on a horizontal 
shaker at 160 rpm at 27±1 °C.  Growth, determined by the increase in turbidity, was 
obtained in the presence of 10 mg L-1 ampicillin, trimethoprim and gentamycin, 
suggesting that E. ictaluri gly09 is intrinsically resistant to these antibiotics. No 
growth occurred in the presence of 10 mg L-1 rifampicin or kanamycin. 
In order to obtain spontaneous rifampicin-resistant and kanamycin-resistant E. 
ictaluri gly09 mutants, the wild type E. ictaluri gly09 strain was cultured separately 
on BHI agar plates containing 2 mg L-1 of each antibiotic. Colonies appearing on the 
BHI-rifampicin and BHI-kanamycin plates after an incubation period ranging from 
48 to 72 h at 27±1 °C were harvested, mixed and transferred into several tubes 
containing BHI broth with 2 mg L-1 of both antibiotics. Cultures were incubated on 
a horizontal shaker at 160 rpm at 27±1 °C overnight, after which 1 mL of culture 
was transferred into new tubes containing 9 mL of BHI broth with a higher 
antibiotics concentration of 5 mg L-1 each. Following overnight incubation, grown 
cultures (cultures with an absorbance level of more than 0.5 at a wavelength of 600 
nm) were then transferred into new tubes containing 9 mL of BHI broth with 
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higher antibiotics concentration of 10 mg L-1. Cultures of E. ictaluri gly09 that were 
resistant to 10 mg L-1 rifampicin and kanamycin were transferred and grown in 
BHI broth containing 10 mg L-1 ampicillin, rifampicin, kanamycin, trimethoprim 
and gentamycin. The resulting E. ictaluri gly09 strain (referred to as E. ictaluri 
gly09R) with multiple antibiotics resistance was used in the gnotobiotic challenge 
tests. E. ictaluri gly09R culture was washed from its culture medium prior to 
enrichment of Artemia nauplii; thus, no nutrient was provided to the bacteria 
during the challenge test. Axenic fish larvae were challenged with E. ictaluri gly09R 
via both axenic Artemia nauplii and culture water following the procedures applied 
in the pathogen-screening test on xenic larvae. The Artemia nauplii were considered 
as the only nutritional sources for the fish larvae.  
The gnotobiotic challenge tests were done in triplicate in 500 mL sterile glass 
bottles containing 200 mL 0.2 µm-filtered autoclaved synthetic freshwater with 10 
fish per bottle. Each incubation bottle was equipped with 2 sterile 0.2 µm air filters 
(Sartorius Midisart®, USA) to provide gentle sterile aeration and a sterile septum 
for aseptic larval feeding during the experimental period. An unchallenged axenic 
fish group was used as the control group for the gnotobiotic system. In order to 
verify that there was no effect of the culture system set-up on the pathogen 
virulence, in experiment 2a the E. ictaluri gly09R strain was also tested on xenic 
larvae using the same culture system set-up but without the 0.2 µm air filtration or 
the use of both antibiotics and antifungal mixtures. To maintain good 
environmental conditions within the experimental system, 25 % of the incubation 
medium with or without antimicrobials was replaced every 3 days. The gnotobiotic 
challenge test was repeated twice (experiment 2a and 2b). In experiment 2a, E. 
ictaluri gly09R strain was tested on both xenic and gnotobiotic fish, while in 
experiment 2b it was only tested on gnotobiotic fish.  
In order to determine larval bacterial load at the end of the challenge test, surviving 
larvae were killed using an overdose of benzocaine, surface-disinfected in a bath of 
1 g L-1 benzalkonium chloride and rinsed with 0.2 µm-filtered autoclaved synthetic 
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freshwater, then homogenized and plated on BHI agar containing 10 mg L-1 
ampicillin, rifampicin, kanamycin, trimethoprim and gentamycin, according to the 
procedure described earlier. The inoculated plates were incubated overnight at 
27±1 °C and the grown colonies were counted.  
Bacterial challenge test for gnotobiotic Nile tilapia larvae supplied with poly-β-
hydroxybutyrate (PHB) 
The developed bacterial challenge procedure on gnotobiotic Nile tilapia larvae was 
further employed to evaluate the effect of PHB on the survival of challenged larvae. 
In this experiment (experiment 3), 160 axenic larvae (DAH 5) were distributed in 4 
treatment groups with four replicates: (1) control group - no PHB supplementation 
and unchallenged, (2) PHB-enriched and unchallenged group, (3) PHB-enriched 
and challenged group, and (4) challenged group without PHB enrichment. The 
bacterial challenge was done daily during the 12 days experimental period via the 
culture water and axenic Artemia nauplii. Bacterial challenge via water culture and 
via Artemia nauplii was done following the procedures applied in the previous 
challenge tests.  
For the fish groups supplied of PHB, Artemia nauplii at a density of 100 Artemia mL-
1 were enriched in a 100 mg L-1 PHB suspension for 1 h, washed with 0.2 µm-
filtered autoclaved synthetic freshwater and added to its respective incubation 
bottles. The feeding level (i. e., the total number of Artemia nauplii consisting of 
non-enriched, pathogen-enriched, and/or PHB-enriched given to each replicate 
bottle) was the same for all treatments. The control group fish were fed with axenic 
non-enriched Artemia nauplii at the density of 20 nauplii per fish. Unchallenged or 
challenged PHB-supplemented fish were fed PHB-enriched Artemia nauplii at the 
density of 10 nauplii per fish with an addition of axenic Artemia nauplii or 
pathogen-enriched Artemia nauplii, respectively, at a density of 10 nauplii per fish. 
The challenged fish without PHB supplementation were fed axenic Artemia nauplii 
and pathogen-enriched Artemia nauplii, each at the density of 10 nauplii per fish. 
Mortality observation and dead fish removal was done daily during the 
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experiment. The experimental designs for bacterial challenge tests on Nile tilapia 
larvae were approved by the ethical committee of Ghent University under the file 
number EC2012/070 for experiment 1a and 1b, EC2013/069 for experiment 2a and 
2b, and EC2014/041 for experiment 3. 
Statistical analysis 
A chi-square test was used to detect significant differences in the hatching 
percentage between the xenic and the disinfected eggs. For the comparison of the 
cumulative mortality of fish larvae, data were arcsine transformed before a one-
way analysis of variance (one-way ANOVA) was performed using STATISTICA 
statistical software (version 7.0). A Duncan test was performed on the transformed 
data for multiple comparisons among means. All analyses were run at a minimum 
level of significance of 5 %. The relative percentage of survival (RPS), which is the 
larval survival after challenge when compared to control fishes (Amend, 1981), was 
calculated to evaluate the efficacy of xenic and gnotobiotic bacterial challenge test 
as follows:  
RPS (%) =  1 -  
% mortality in challenge group
% mortality in control group
    100 
The RPS obtained in the challenge studies were analysed using a chi-square test. 
 
Results 
Pathogen-screening tests on xenic Nile tilapia larvae 
In the first pathogen-screening test (experiment 1a), mortality was first observed in 
the group challenged with E. ictaluri gly09 via Artemia nauplii and in the group 
challenged with E. ictaluri gly10 via the culture water 6 days after challenge (6 
DAC) (Table 5.1). There were no significant differences between treatments 
(challenge routes and control) until 11 DAC when significantly higher levels of 
mortality were seen in the groups challenged with E. ictaluri gly09 via Artemia and 
via both Artemia and culture water when compared to the control and the groups 
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challenged via the culture water. A similar result was observed for E. ictaluri gly10 
with the exception that the group challenged via Artemia had significantly higher 
mortalities than all other treatment groups and the control at 10 DAC. At 11 DAC, 
significantly higher levels of mortality were observed in the groups challenged via 
Artemia and via both Artemia and culture water when compared to the control and 
other groups challenged via culture water (Table 5.1).  
No significant difference in fish mortality was observed between the treatment 
groups challenged with S. agalactiae LMG15977 and the control group. 
Furthermore, significantly lower mortalities were observed when compared the 
groups challenged with S. agalactiae LMG15977 to the groups challenged with E. 
ictaluri strains via Artemia and via both Artemia and culture water (Table 5.1). The 
pathogenicity of both E. ictaluri strains for tilapia larvae was confirmed in 
experiment 1b (Table 2), where the treatment groups challenged with either E. 
ictaluri gly09 or gly10 via Artemia and culture water resulted in significant 
mortalities of 93±11 % and 100±0 %, respectively, as compared to the 40±17 % 
mortality seen in the control group at 9 DAC. A significantly higher larval 
mortality was observed in the group challenged with E. tarda LMG2793 via Artemia 
and culture water when compared to the control group, starting from 7 DAC with 
a final mortality of 93±11 % at 9 DAC (Table 5.2).   
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Table 5.1.  Cumulative mortality (%, Mean±SD) of control and challenged (E. ictaluri gly09, E. ictaluri gly10 and S. agalactiae LMG15977) 
xenic Nile tilapia larvae using different challenge methods in experiment 1a. Different letters within the same row denote 
significant differences (P ≤ 0.05) (n = 3; m=10). n = number of replicates; m = initial number of fish larvae per replicate.  DAC = 
day after challenge.         
 
  
 
Edwardsiella ictaluri gly09 
 
Edwardsiella ictaluri gly10 
   Streptococcus  agalactiae 
LMG15977 
 
 Control 
 via 
culture 
water 
via 
Artemia 
nauplii 
via 
Artemia 
and water 
 via  
culture 
water 
via 
Artemia 
nauplii 
via 
Artemia 
and water 
 via  
culture 
water 
via 
Artemia 
nauplii 
via Artemia 
and water 
6 DAC  0±0a  0±0a 4±6a 0±0a  4±6a 0±0a 0±0a  0±0a 0±0a 0±0a 
7 DAC  0±0a  4±6a 7±6a 0±0a  4±6a 4±6a 0±0a  0±0a 0±0a 4±6a 
8 DAC  0±0a  33±29a 30±17a 18±6a  18±13a 41±28a 33±29a  18±23a 4±6a 15±17a 
9 DAC  26±26a  44±22a 56±11a 52±6a  41±6a 63±28a 74±6a  22±29a 26±28a 37±26a 
10 DAC  37±23a  59±6a 74±13a 81±6a  48±6a 74±17a 85±6b  44±22a 48±28a 63±17a 
11 DAC  48±13a  67±0 a 81±6b 81±6b  70±6a 81±13b 89±0b  67±19a 70±13a 74±6a 
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Table 5.2.  Cumulative mortality (%, Mean±SD) of control and challenged (E. 
ictaluri gly09, E. ictaluri gly10 and E. tarda LMG2793) xenic Nile tilapia 
larvae via both Artemia nauplii and culture water in experiment 1b. 
Different letters within the same row denote significant differences (P ≤ 
0.05) (n = 3; m = 10).  n = number of replicates; m = initial number of fish 
larvae per replicate.  DAC = day after challenge.         
 
 
 
  
 
Eggs disinfection protocol for axenic Nile tilapia larvae 
The effect of the disinfection procedure on the egg hatching success was 
evaluated by measuring the hatching percentage at 1 DAH for the xenic and the 
disinfected eggs. There was no significant effect of the disinfection procedure on 
the hatch percentage in both gnotobiotic experiments (Fig. 5.1). With respect to the 
egg / larvae axenity following the egg disinfection procedure, samples of the 
homogenized eggs that were taken 24 h after disinfection never resulted in growth 
on the LB plates after 96 h incubation. Samples of the incubation medium or 
homogenized larvae at larval stocking also did not show any colonies on the LB 
plates after 96 h incubation. In the course of the experiment, no bacteria were 
detected in the samples of the axenic fish at the end of experiment 2a, as verified by 
fish homogenate plating on the LB plates. A very low level of bacterial 
contamination was observed in the axenic group at the end of experiment 2b, as 
bacteria colonies grew on the LB plates after 96 h incubation at a density of <30 
CFU fish-1. 
 
 
 Control 
E. ictaluri 
 gly09 
E. ictaluri 
gly10 
E. tarda 
LMG2793 
5 DAC 0±0a 3±6a 0±0a 0±0a 
6 DAC 0±0a 17±6a 17±21a 3±6a 
7 DAC 0±0a 37±31ab 47±25b 60±17b 
8 DAC 27±23a 77±6b 100±0c 83±15b 
9 DAC 40±17a 93±11b 100±0b 93±11b 
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Figure 5.1.  Hatch percentage of the disinfected and xenic (not disinfected) eggs in 
gnotobiotic experiments. Bars represent the mean values of three 
treatment replicates; error bars represent standard deviation values. No 
significant difference was observed between the disinfected and not 
disinfected eggs in both experiments (P > 0.05). 
 
Quantification of the bacteria load in Artemia nauplii and Nile tilapia larvae 
In experiment 1a, incubation of axenic Artemia nauplii with E. ictaluri gly09, E. 
ictaluri gly10 and S. agalactiae LMG15977 resulted in a density of 7.8±0.2, 5.2±0.1, 
and 6.5±0.1 × 102 CFU Artemia-1 after 1 h of incubation, respectively. Similar results 
were observed in experiment 1b, where incubation of axenic Artemia nauplii 
resulted in a density of 6.9±0.7, 5.1±0.4, and 7.7±0.2 × 102 CFU Artemia-1 for E. ictaluri 
gly09, E. ictaluri gly10 and E. tarda LMG2793, respectively.  
In the challenge tests using the gnotobiotic system, the E. ictaluri gly09R loaded 
onto the Artemia nauplii resulted in a density of 4.5±0.9 × 103 CFU Artemia-1 and 
8.8±0.5 × 102 CFU Artemia-1 after 1 h incubation in experiment 2a and 2b, 
respectively. At the end of the gnotobiotic challenge test, the density of E. ictaluri 
gly09R inside the surviving fish was 7.9±0.9 × 104 CFU fish-1 and 4.8±0.6 × 103 CFU 
fish-1 in experiment 2a and 2b, respectively.   
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Mortality of the gnotobiotically challenged Nile tilapia larvae 
In both gnotobiotic challenge tests, the mortality of the fish after challenge by E. 
ictaluri gly09R strain was not significantly different (P > 0.05) compared to the 
unchallenged (axenic or xenic) fish until 9 DAC (Table 5.3). From 10 DAC onwards, 
the challenge of the axenic larvae with E. ictaluri gly09R resulted in a significantly 
higher mortality (P ≤ 0.05) as compared to the unchallenged axenic fish in both 
challenge tests. Challenge with the E. ictaluri gly09R strain under xenic conditions 
resulted in a significant mortality (P ≤ 0.05) of 40±10 % as compared to the xenic 
unchallenged group, but no significant differences were observed when compared 
to the gnotobiotically challenged group (12 DAC; experiment 2a). With respect to 
the RPS, there was no significant difference in mortality (P > 0.05) between the 
axenic fish challenged with E. ictaluri gly09R and the xenic fish challenged with E. 
ictaluri gly09R at 12 DAC, with a RPS of 67 and 73 %, respectively. 
Effect of PHB in a bacterial challenge test on gnotobiotic Nile tilapia larvae 
In experiment 3, the enrichment of Artemia nauplii with pathogen E. ictaluri gly09R 
resulted in a bacterial load of 3.1 x 103 CFU Artemia-1. Larval mortality was first 
observed in all treatments on 6 DAC (Table 5.4). While a low level of mortality was 
observed in the unchallenged groups, the mortality level was significantly 
increased in the challenged groups. At the end of the experiment (11 DAC), the 
challenged larve without PHB supplementation showed the highest mortality level 
of 70±8 %, which was significantly higher than the challenged fish with PHB 
supplementation (50±8 %) and the unchallenged fish with or without PHB 
supplementation (20±8 % and 28±10 %, respectively). 
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Table 5.3. Cumulative mortality (%, Mean±SD) of xenic (not challenged or challenged), axenic and gnotobiotically challenged Nile 
tilapia larvae using antibiotics-resistant E. ictaluri gly09R strain via Artemia nauplii and culture water in experiment 2a 
and 2b. Different letters within the same row within 1 experiment denote significant differences (P ≤ 0.05) (n = 3; m = 
10). n = number of replicates; m = initial number of fish larvae per replicate.  DAC = day after challenge.         
 
 
  
 
 
Experiment 2a  Experiment 2b 
 Xenic 
Xenic 
E. ictaluri 
gly09R 
Axenic 
Gnotobiotic 
E. ictaluri 
gly09R 
 
Axenic 
Gnotobiotic  
E. ictaluri 
gly09R 
5 DAC 0±0a 3±6a 0±0a 0±0a  0±0a 0±0a 
6 DAC 3±6a 3±6a 0±0a 0±0a  0±0a 0±0a 
7 DAC 7±6a 3±6a 0±0a 0±0a  0±0a 0±0a 
8 DAC 7±6a 10±10a 0±0a 0±0a  7±6a 10±10a 
9 DAC 7±6a 10±10a 0±0a 3±6a  13±6a 23±11a 
10 DAC 7±6ab 13±6b 0±0a 13±6b  20±0a 53±15b 
11 DAC 7±6a 23±6ab 10±10ab 33±15b  20±0a 60±10b 
12 DAC 13±6a 40±10bc 23±6ab 57±6c  23±6a 63±11b 
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Table 5.4. Cumulative mortality (%, Mean±SD) of gnotobiotically challenged Nile tilapia larvae using antibiotics-resistant 
E. ictaluri gly09R strain via Artemia nauplii and culture water in experiment 3. Different letters within the same 
row denote significant differences (P ≤ 0.05) (n = 4; m=10). n = number of replicates; m = initial number of fish 
larvae per replicate.  DAC = day after challenge.         
   
 Axenic PHB-enriched 
Challenged with E. 
ictaluri gly09R 
PHB-enriched and 
challenged with 
E. ictaluri gly09R 
6 DAC 3±5a 3±5a 3±5a 3±5a 
7 DAC 3±5a 3±5a 10±8a 3±5a 
8 DAC 8±5a 3±5a 13±13a 5±6a 
9 DAC 10±0a 3±5a 30±18b 10±8a 
10 DAC 20±12a 18±10a 60±8c 40±12b 
11 DAC 28±10a 20±8a 70±8c 50±8b 
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Discussion 
Pathogen-screening tests on xenic Nile tilapia larvae 
Streptococcus sp. and Edwardsiella sp. are common genera of bacteria that have been 
reported to infect wild and farmed tilapia (Plumb and Hanson, 2010). E. tarda has 
been reported to infect and cause significant pathology in red tilapia (Iregui et al., 
2012). In the last few years, different strains of E. ictaluri, which are known as 
etiological agents of ESC, have also been reported as the causative agent of 
morbidity and mortality in Nile tilapia fingerlings (Soto et al., 2012). In this study, 
four candidate pathogenic bacterial strains representing the two groups were 
screened for the development of a bacterial challenge test for gnotobiotic Nile 
tilapia larvae: E. ictaluri gly09, E. ictaluri gly10, E. tarda LMG2793 and S. agalactiae 
LMG15977.  
The bacterial strain S. agalactiae LMG15977, which was the only bacterial strain 
actually isolated from tilapia culture, resulted in no significant mortality in tilapia 
larvae. Several studies suggested that the susceptibility of Nile tilapia to S. 
agalactiae infection is temperature dependent (Mereghetti et al., 2008; Rodkhum et 
al., 2011). It is possible that the pathogenicity of S. agalactiae in this experiment was 
affected by the water temperature that was below the optimal growth temperature 
for S. agalactiae culture. 
Unlike S. agalactiae, both E. ictaluri strains can cause significant larval mortalities 
when associated with the larval feed Artemia, with or without additional pathogen 
delivery via the culture water. However, less or non-significant mortality was 
observed when the fish were only exposed to the pathogens via the culture water. 
In a study by Soto et al. (2012), tilapia fingerlings (~15 g) challenged with E. ictaluri 
at 106 CFU mL-1 showed 100 % mortality at 8 d post immersion. The results of the 
current study suggest that bacterial infection via culture water in tilapia larvae 
(immersion challenge) is less likely than infection through feed uptake.  
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Due to the emergent nature of edwardsiellosis in non-ictalurid fish, little is known 
regarding the dynamics of E. ictaluri infection in Nile tilapia culture, especially 
during its larviculture. To our knowledge, this is the first report of E. ictaluri 
induced mortality in Nile tilapia larviculture. With respect to the study by Soto et 
al. (2013) these authors increased our understanding on the pathogenesis of E. 
ictaluri in Nile tilapia fingerlings suggesting that the cutaneous and oral routes 
were the main ports of entry for the bacterium, which then spreads 
hematogenously throughout the fish body, with the spleen and head kidney as the 
main targets of infection. Their observations support the study by Li et al. (2012), 
who suggested that E. ictaluri gains entry through the intestinal epithelium, 
possibly using actin polymerization and receptor-mediated endocytosis as 
mechanisms of invasion. 
In both of the pathogen screening tests, the first fish mortalities in the treatment 
group challenged with E. ictaluri occurred at 5–6 DAC. However, the mortality 
from the challenges via both Artemia and culture water in experiment 1a differed 
when compared to experiment 1b as significant differences in mortality following 
challenge occurred as already at 7 DAC. The differences in the incubation period 
until significant mortalities were observed could be caused by the presence of other 
microorganisms beside the tested pathogens or a difference in pathogen resistance 
between the different larval batches. 
The results of both pathogen-screening tests showed that all Edwardsiella strains 
tested in this study can cause significant mortality in tilapia larvae culture and are 
candidates for use in the development of a bacterial challenge test on gnotobiotic 
Nile tilapia larvae, with the challenge route via Artemia nauplii, with or without 
additional challenge via the culture water, as an effective procedure. 
Eggs disinfection protocol for axenic Nile tilapia larvae 
Compared to the hatch percentage of tilapia eggs that are commonly incubated in 
upwelling fish egg incubators (Rana, 1988), the relatively low hatch percentage 
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obtained in this study could be due to the type of incubation system required to 
maintain the axenic conditions that might not be optimal for egg hatching 
incubation. In order to obtain axenic larvae, artificial incubation of surface-
disinfected eggs in axenic conditions until hatching is crucial. These included the 
need for a gentle motion of the eggs and the need for an axenic closed system with 
easy access for removal of non-developing embryos and also refreshment of sterile 
culture medium.  
In gnotobiotic studies with fish, the common method to obtain axenic larvae is to 
collect fertilized eggs, disinfect them and then incubate them in a cocktail of 
disinfectants and antibiotics. The effectiveness of sodium hypochlorite and 
hydrogen peroxide solutions as egg surface disinfectant has been reported by 
several studies with different fish species using various concentrations and 
exposure times (Barnes et al., 1998; Douillet and Holt, 1994; Marking et al., 1994; 
Mitchell et al., 2009; Pham et al., 2008; Rach et al., 1998; Schreier et al., 1996). In this 
study, the results of the axenity test suggest that the double disinfection using 
hydrogen peroxide (2000 mg L-1 for 10 min) and sodium hypochlorite (75 mg active 
chlorine L-1 for 2 min), followed by incubation in a medium containing antibiotics 
(10 mg L-1 ampicillin, rifampicin, trimethoprim, and gentamycin) and antifungal 
agents (0.5 mg L-1 Amphotericin-B and 25 mg L-1 Fluorescent Brightener 28) was 
effective to obtain axenic Nile tilapia larvae. To our knowledge, this is the first 
published protocol to generate gnotobiotic Nile tilapia larvae. The low bacterial 
contamination observed at the end of experiment 2b could be related to the 
technical complexity of the system (Marques et al., 2006), where handlings and 
manipulations, such as the culture medium exchange and daily feeding involved 
during the experimental period might have resulted into contamination. 
Mortality of the gnotobiotically challenged Nile tilapia larvae 
This laboratory test system relied on antibiotics to maintain gnotobiotic conditions. 
As for this, antibiotic resistant mutants need to be isolated / developed prior to use 
in challenge trials. Such spontaneous mutations have been found in several Gram-
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negative bacteria, including Edwardsiella species (Ingham and Furneaux, 2000; 
Thavasi et al., 2007). It was reported that E. ictaluri strains are naturally resistant to 
rifampicin, macrolides, lincosamides, streptogramins, glycopeptides, fusidic acid, 
oxacillin (Stock and Wiedemann, 2001) and gentamycin (Reger et al., 1993). Several 
studies also reported E. ictaluri isolates displaying acquired resistance to 
trimethoprim, streptomycin, oxytetracycline (Dung et al., 2008), kanamycin (Russo 
et al., 2009), and ampicillin (Russo, 2011). In this study, the multiple antibiotic 
resistance of E. ictaluri gly09R was both intrinsic (for ampicillin, trimethoprim and 
gentamycin) and mutational in nature (for rifampicin and kanamycin).  
When creating antibiotic resistance in a bacterium, either via plasmids or by 
spontaneous mutation, the acquired resistance represents an additional energy cost 
for the strain that can result in a longer generation time and altered metabolic 
activity (Andersson and Levin, 1999; Feng and Rise, 2009; Levin et al., 2000; 
McDermott et al., 2006). This implies that a bacterial strain with introduced 
resistance may behave differentially from the original strain. The E. ictaluri gly09R 
strain used in this study, however, showed similar pathogenicity in the 
gnotobiotically challenged fish as compared to the xenic challenged fish, indicating 
that the bacterial pathogenicity was preserved after the acquisition of antibiotic 
resistance. 
Several studies on gnotobiotic culture systems suggested that the cellular and 
humoral defence systems of axenic animals is underdeveloped hence making them 
more susceptible to diseases when compared to xenic animals (Coates, 1975; 
Marques et al., 2006). Unlike these previous studies, the similar RPS values 
between the gnotobiotic and xenic fish in the gnotobiotic challenge test did not 
indicate that axenic Nile tilapia larvae are more susceptible to pathogen infection 
compared to xenic larvae. The bacterial challenge in a gnotobiotic environment 
thus yields similar results as in a conventional open system, however without 
uncontrolled interference. 
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Effect of PHB in a bacterial challenge test on gnotobiotic Nile tilapia larvae 
The gnotobiotic challenge test was used to investigate if PHB has a beneficial effect 
by protecting the tilapia larvae against E. ictaluri gly09R infection. Similarly to the 
study in prawn larviculture (Thai et al., 2014), this experiment showed that PHB 
supplementation to gnotobiotic Nile tilapia larvae can provide certain protection 
against pathogenic infection. Despite the evidence of the beneficial effects of PHB 
in disease protection, knowledge on the actual protective mechanism(s) of PHB 
remains scarce. It will be of interest to further evaluate the effect of PHB on the 
growth and pathogenicity of E. ictaluri gly09R culture. In addition, the availability 
of the gnotobiotic Nile tilapia challenge test creates the opportunity for a detailed 
investigation of the effects of PHB exposure on pathogen growth and virulence 
under microbiologically controlled conditions in Nile tilapia.  
Conclusions 
This study succeeded in developing a Nile tilapia gnotobiotic challenge system 
using E. ictaluri gly09R as a pathogen. The usefulness of this model was shown for 
PHB which upon application through PHB-loaded Artemia, decreased the 
susceptibility of the larvae to a pathogenic challenge. The gnotobiotic system will 
be a useful tool to extend the understanding of the mechanisms involved in host–
microbe interactions and will as such contribute to the development of biocontrol 
strategies to be applied in aquaculture practices.  
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The routine use of chemical compounds and antibiotics as growth promoters and 
conventional agent of disease control is a matter of debate in the animal farming 
industry. The development of non-antibiotic and environment friendly agents is 
one of the key targets for health management in aquaculture. Consequently, with 
the emerging need for environment friendly aquaculture, the use of alternatives to 
antibiotic growth promoters in fish nutrition is now widely accepted. From the 
findings of this study, it is clear that the application of poly-β-hydroxybutyrate 
(PHB) works beneficially for growth and health promotion in Nile tilapia culture. 
The exact mechanisms of action of PHB, however, require further thorough 
exploration in order to optimally apply PHB at full-scale. In this chapter, the results 
obtained in this PhD research are integrated with the literature and discussed in 
the light of research needs and practice opportunities. 
Evaluation of PHB as a growth promoter in aquaculture 
Effects of dietary PHB on the fish growth 
Many studies have explored the potential of PHB for aquaculture purposes by 
focusing on the beneficial effects at the level of the host. Different aquatic animals 
including Artemia, giant black tiger shrimp, giant freshwater prawn, Chinese 
mitten crab, European sea bass, and Siberian sturgeon have benefited from dietary 
PHB in terms of growth and health improvement (De Schryver et al., 2010; Defoirdt 
et al., 2007; Najdegerami et al., 2012; Nhan et al., 2010; Sui et al., 2012; Thai et al., 
2014). For Nile tilapia culture, it was not yet assessed if dietary PHB has any impact 
on fish performance. It was therefore of importance that in the first step in this 
research it was verified that PHB showed no adverse and preferably beneficial 
growth effects on cultured Nile tilapia, which is a species of major importance in 
aquaculture. As expected, dietary PHB was found to improve the growth of Nile 
tilapia fingerlings (Chapter 3), although this growth promoting effect could not be 
detected in Nile tilapia juveniles (Chapter 2). Difference in growth between the two 
studies may be explained by the difference in age of the experimental fish. The first 
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study (Chapter 2) used tilapia juveniles at the age of 3-7 weeks old, while the 
second study (Chapter 3) used tilapia fingerlings at the age of 7-11 weeks old. 
Tengjaroenkul et al. (2000) reported that a considerable morphological change of 
the fish gut with complex coiling pattern occurs by the age of 9 weeks old, until the 
complexly-coiled definitive form as found in adult fish is obtained at 12 weeks old. 
The author also reported that the rate of increase in intestinal length takes place at 
an accelerating rate as the fish age  where the gut length increases from 90 % to 
410 % of body length during the developmental period  and that the great 
intestinal length provides an advantage to the fish in digestion and absorption of 
nutrients. Thus, the difference in fish growth between the first and second study 
may be explained by the differences in development and performance of digestive 
system, which may have been resulted in different dietary nutrients (e.g. PHB) 
utilization capacities. 
Based on this PhD study it can be suggested that the growth promoting effect of 
PHB is non-linear and varies for different developmental stages, because (1) a low 
PHB concentration of 1 g PHB kg-1 diet led to a similar growth of tilapia fingerlings 
as compare to a higher concentration of 50 g PHB kg-1 diet, and (2) a significant 
increase in growth was found in tilapia fingerlings but not in tilapia juveniles. This 
confirmed the result of a previous study on European sea bass, where dietary PHB 
supplementation at 20 g PHB kg-1 diet and 50 g PHB kg-1 diet resulted in a 
significant increase in growth of sea bass juveniles when compared to the control 
group. A higher concentration of 100 PHB kg-1 diet did, however, not lead to higher 
growth when compared to the lower PHB concentrations (20 g PHB kg-1 diet and 50 
g PHB kg-1) suggesting that the growth promoting effect of PHB is non-linear (De 
Schryver et al., 2010). Furthermore, in another study using Siberian sturgeon 
culture, dietary PHB supplementation at 20 g PHB kg-1 diet and 50 g PHB kg-1 diet 
led to similar growth of sturgeon fingerlings (Najdegerami et al., 2012), while the 
growth of sturgeon larvae when PHB supplemented with PHB through Artemia 
enrichment at 5 g L-1 (Najdegerami et al., 2013) led to reduced growth. In shrimp 
culture, Ludevese-Pascual et al. (personal communication) found no growth 
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stimulation of PHB on giant black tiger shrimp post-larvae. In another study, 
however, it was suggested that Bacillus sp. capable of accumulating PHB can 
provide beneficial effects on the growth performance of giant black tiger shrimp 
post-larvae (Laranja et al., 2014), although further investigations are required to 
verify the PHB effect of the bacterial cultures on the shrimp. Thus, based on the 
results of this current study and also the knowledge from the previous studies, it 
can be stated that the growth promoting effect of PHB is not only non-linear (dose-
dependent), but also species-dependent and varies for different developmental 
stages. Hence, in order to apply certain PHB supplementation levels on targeted 
animal/species at specific age/developmental state, one should consider the 
differences in animal species (i.e. trophic level, feeding behaviour) and also 
developmental status. For each host species, it is worthwhile to first explore the 
optimal developmental stage at which PHB should/can be applied, as well as the 
optimal supplementation level.  
Effects of dietary PHB on the fish lipid metabolism  
Dietary proteins, lipids and carbohydrates are essential nutrients for growth 
(anabolism) and for energy to run the body machinery (catabolism) (Silva and 
Anderson, 1995). Lipids, especially phospholipids, are important for cellular 
structure and the maintenance of membrane flexibility and permeability (Sargent et 
al., 2002). Lipids as the primary energy providing nutrients in fish diets have a 
major protein-sparing effect in many fish species (Sargent et al., 2002; Wilson, 
2002). In this study, the dietary PHB was found to significantly increase the whole-
body total lipid content of Nile tilapia juveniles (Chapter 2). Increasing whole-body 
total lipid content was observed in Nile tilapia fingerlings, but it was not 
statistically different when compared to the control group (Chapter 3). Overall, 
based on the results of lipid analyses described in Chapter 2, it is hypothesized that 
the higher total whole-body lipid content in the PHB treatment groups may be due 
to larger amount of visceral fat, which is deposited in the form of fat (triglycerides).  
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It is suggested that changes in lipid content in fish body could be linked with 
changes in its synthesis and/or deposition rate in the muscle (Fauconneau 1984; 
Abdel-Tawwab et al. 2006). It is often reported that the muscle tissue of intensively 
cultured fish is characterized by increased lipid deposition consisting of mainly 
saturated fatty acid (SFA), monounsaturated fatty acid (MUFA) and linoleic acid 
(LA; 18:2n-6) (Karapanagiotidis et al., 2006). In this study, the increase in total lipid 
content of fish fed with PHB was also accompanied with an increase in the content 
of total SFAs, total MUFAs and total (n-6) FAs (Chapter 2). The composition of 
these FA groups (as proportion of total lipid content), however, remained 
unchanged. This indicates that fish FA profile was not affected by PHB 
supplementation. This is important as excessive deposition of LA is undesirable 
because it will reduce any conversion of alpha-linolenic acid (ALA; 18:3n-3) to 
eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3), 
and will unbalance the production of eicosanoids toward the proinflammatory n-6 
series prostaglandins in both the fish and the human consumer. However, several 
studies reported that fatty acid profiles in cultured fish are not only influenced by 
their dietary uptake and capacity to de novo synthesizes other fatty acids, but also 
by their capacity to bioconvert certain fatty acids (Anderson and Arthington, 1992). 
Maina et al. (2003) reported that tilapia possesses desaturation and elongation 
enzymes that efficiently convert C18 PUFAs to longer chain PUFAs, e.g. the 
capacity of bioconversion of LA (18:2 n-6) into ARA (20:4n-6) and LNA (18:3n-3) 
into EPA (20:5n-3). They also convert EPA into DPA (22:5n-3) and DPA into DHA 
(22:6n-3) (Nishiyama et al., 2014). Hence, in this study, the analyzed fish FA profile 
might reflect the FA profile of the experimental diets as well as the result of 
bioconversion of FA process by the fish.  
The increase in whole-body total lipid content in the PHB treatment groups is also 
accompanied with the increase in lipase activity (Chapter 2). Similarly, the lipase 
activity of Siberian sturgeon fingerling was earlier found to be significantly 
increased by dietary PHB, but only when supplemented at a high level of 50 g kg-1. 
A variety of lipases and colipases are involved in the general digestive process for 
Chapter 6. General discussion  
144 
 
lipids as they play an important role in the extracellular lipid hydrolysis in the 
intestine, stomach, and caecal lumen (Trocher, 2003). Hence, it can be that the 
higher lipase activity resulting from PHB supplementation (Chapter 2) indicates a 
high activity of lipase in the digestion of PHB as a lipid (Chapter 2). Consequently, 
we hypothesize that the growth promoting effect of PHB is due to an improved 
nutrient utilization particularly in lipids digestion and absorption that increased 
lipid deposition in adipose tissue (i.e. triglycerides). It is reported that when the 
triglycerides are mobilized from the fat tissue, their hydrolysis by the lipase results 
in the release of free FAs that can be utilized either directly through β-oxidation 
and serve as fuel mainly for the muscle and also the heart, or indirectly after initial 
conversion to ketone bodies (Leblanc and Ballantyne, 2000; Phillips and Hird, 
1977). Ketone bodies, primarily the β-hydroxybutyrate (β-HB) and its 
dehydrogenated counterpart acetoacetate (AcAc), can be produced in the liver as 
transportable units of fat during conditions of high circulation of free fatty acids 
(Phillips and Hird, 1977). The ketone bodies are transported by the blood to the 
extrahepatic tissues where they are oxidized via the tricarboxylic acid (TCA) cycle 
(Ballantyne, 2014; Dedkova and Blatter, 2014) to provide the energy required by the 
tissues, including the heart (Zammit and Newsholme, 1979), brain and skeletal 
muscle (Beis et al., 1980). In this study, it can also be that the higher lipase activity 
in the PHB treatment groups indicates an increase in the hydrolysis of the 
deposited fat (Chapter 2), which would have provided energy that might have 
contributed in the higher fish growth (Chapter 3), either through β-oxidation or 
ketone bodies production. PHB is a fatty acid polymer and can thus be considered 
to be a typical source of energy (Azain, 2004). In accordance to this, De Schryver et 
al. (2010) reported that the caloric value of the PHB was slightly higher (22.4 kJ g−1) 
than that of the basic feed (19.6 kJ g−1). Because fish feed to meet their energy 
requirements, diets with excessive non-protein energy may result in decreased feed 
intake and reduced weight gain (Ogunji et al., 2008). Other studies suggested that 
excess energy relative to protein content in the diet may result in high lipid 
deposition, which does not equate to faster growth and is an inefficient use of 
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nutrients (Hixson, 2014). Hanley (1991) indicated that tilapia were able to store 
significant quantities of lipid in their carcass and viscera, but could not utilize this 
energy source to improve growth. Overall, the fish lipid content obtained in this 
study (±6 % WW) is much higher than often reported for tilapia juveniles (2.5-4.5 % 
WW) (Chou and Shiau, 1996). In this study, even though the protein to energy (P/E) 
ratio of the experimental diets or the fish was not analysed, PHB supplementation 
by replacing cellulose in the basal diet might have resulted in excessive energy, 
reducing the dietary P/E ratio when compared to the basal / control diet, which 
may have been the reason for the slightly lower (P > 0.05) growth performance in 
the fish group fed with high PHB supplementation (25 g kg-1 diet and 50 g kg-1 diet) 
compared to the control group in the first study (Chapter 2). Significantly higher 
body lipid in fish fed PHB diets may support this speculation. Similar speculation 
might also be applied in the second study (Chapter 3), where similar growth was 
observed for treatment group with high PHB supplementation (25 g kg-1 diet and 
50 g kg-1 diet) compared to the low PHB supplementation (1 g kg-1 diet to 5 g kg-1 
diet). As for this speculation, it is important to account for this nutritional 
parameter in future PHB studies, especially for the interpretation of the effect of 
dietary PHB on fish growth and fish body composition. Further investigation is 
needed to evaluate how the PHB contributes to specific nutritional needs (e.g., 
optimal digestible protein to digestible energy ratios) of tilapia at different life 
stages. Further studies also need to focus on the fish lipid metabolism with PHB 
supplementation, for example using the compound-specific isotope analysis 
(SCIA). Lipids (FAs and sterols) are ideal targets for compound-specific stable 
carbon isotope analysis since they are abundant in higher organisms (Chamberlain 
et al., 2004). In such studies using tilapia fish, it is then important to keep in mind 
that FA δ13C values are not necessarily reflect those of the dietary FAs, and that one 
should be aware of the fish bioconversion of FAs activity when interpreting the 
information on fish FAs profile. 
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Effects of dietary PHB on the fish gut community-level physiological profiling 
As hypothesized earlier, the growth promoting effect of PHB seemed to be 
associated with an improved nutrient utilization, particularly in the lipid 
metabolism (Chapter 2). It is suggested that the regulation of intestinal dietary lipid 
absorption is critical to maintain the host’s growth and energy balance (Musso et 
al., 2011). The intestinal microbiota is suggested to play a role in fish nutrition, 
including differentiation of the fish intestinal epithelium and to contribute by 
enzymes or nutrients, which improve feed digestion and nutrient uptake (Denev et 
al., 2009; Dibner and Buttin, 2002; Ewing and Cole, 1994). Although the microbiota 
can influence dietary nutrient harvest, the diet can also impact gut MC composition 
and functionality (Bolnick et al., 2014). De Schryver et al. (2010) reported that the 
dosage of PHB in the diet of juvenile European sea bass induced a steering effect on 
the gut MC. The alteration of gut MC by dietary PHB was also observed in 
sturgeon fingerlings (Najdegerami et al., 2012). Using a gnotobiotic zebrafish 
model, Semova et al. (2012) hypothesized that diet-induced alterations in gut 
microbiota composition might influence lipid absorption by several possible 
mechanisms: (1) by increasing the bioavailability of FAs through modification of 
the production or composition of bile salts (Swann et al., 2011), (2) by promoting 
FA availability for potential absorption by direct contribution in lumenal lipolytic 
activity (Ringø et al., 1995), (3) by enhancing FA absorption indirectly through 
evoking physiologic responses in the intestinal epithelial cells, and/or (4) by 
reducing rates of FA oxidation in intestinal epithelial cells permitting increased 
storage of FAs. In this study, it was initially hypothesized that the increased whole-
body lipid content of fish fed with PHB (Chapter 2) might be due to a change in GI 
microbiota functionality resulting from PHB supplementation, either in terms of 
intestinal absorption or metabolism of exogenous dietary lipids or in terms of 
hepatic production or metabolism of endogenous lipids. In order to test the 
hypothesis, the study described in Chapter 3 aimed at detecting an effect of PHB on 
the gut microbiota physiological profile. The results could, however, not show any 
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alteration in the gut MC physiological (functional) profile by the dietary PHB based 
on a variety of 31 carbon substrates. Hence, it can be suggested that the growth 
promoting effect of PHB is not necessarily related to changes in the functional gut 
MC profile or its feed digestion pattern. It should be noted, however, that the 
observation is based only on the degradation of the carbon sources by a part of the 
gut MC, namely the aerobic and facultative anaerobic bacteria. The oxidative 
metabolism of the gut microbiota is distributed between anaerobic and aerobic 
respiration, with the intermediate case of the facultative anaerobic respiration 
(Mouchet et al., 2012). Since tilapias are herbivorous / omnivorous and possess a 
relatively long and coiled gastrointestinal tract (Smith et al., 2000) this would 
favour the colonization of anaerobic bacteria (Ferguson et al., 2010). This suggests 
that further study would be needed to evaluate the effect of PHB on the 
community-level physiological profiling by focusing on the gut anaerobic 
microbiota (i.e. by using the Biolog AN MicroPlateTM method).  
Diet-induced alteration in gut MC composition can possibly occur unless the 
communities are resistant (composition remain unaltered), resilient (original 
composition are restored) or functionally redundant (original functions are 
retained) (Berga et al., 2012). Functional redundancy implies that the new 
community that is established may be different in composition but performs the 
same processes as the community prior to modification (Wohl et al., 2004). Allison 
and Martiny (2008) suggested that a community can only be completely altered if 
none of the abovementioned characteristics are present. As for this study, further 
investigation is needed to find out whether the unaltered physiological profile of 
the gut MC upon dietary PHB supplementation (Chapter 3) was due to the gut MC 
that was resistant, resilient or functionally redundant. A plausible explanation for a 
high functional redundancy is given by the multifunctionality of communities 
(Hector and Bagchi, 2007). This concept posits that low to moderate levels of 
species diversity are required to support one function, but higher levels are 
necessary to support all ecosystem functions. Thus, maintaining species sharing a 
similar function in a given ecosystem but with different environmental 
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requirements is one of the main mechanisms supporting assemblage stability and 
resilience by providing substitutes to species lost in fluctuating environments and 
thus acting as insurance against loss of species diversity (Yachi and Loreau, 1999). 
This apparent redundancy may be weaker when considering more functions. For 
example, this study is focusing on the carbon cycle, but the fish gut MC is involved 
in the nitrogen and sulphur cycle as well. We hypothesized that the fish gut MC 
may be less functionally redundant than has been revealed by our limited set of 
carbon sources, when considering (i) a higher number of carbon sources (e.g. 
Biolog GN-/GP-MicroPlateTM with a set of 95 carbon sources), or (ii) several 
nutrient cycles. Overall, the results of this study showed no clear effect of dietary 
PHB towards the fish gut MC physiological / functional profiling. Consequently, 
the potential impact of dietary PHB on the physiological profile of the gut MC 
remains unclear. Advance studies will be required to identify the functional 
relationship between dietary PHB and the gut microbiota of Nile tilapia.  
Biodegradation of PHB and its compartmental distribution in fish body 
Overall, the information gathered in Chapter 2 and 3 suggests that dietary PHB 
increased the growth of Nile tilapia, hypothetically by the improvement of nutrient 
utilization particularly in the lipid digestion, absorption and metabolism which 
is not necessarily associated with the gut MC physiological / functional profile. For 
a complete understanding of the PHB performance in animal a comprehensive 
evaluation of the PHB degradation process is necessary. It is generally accepted 
that biodegradation of PHB both in living systems and in the environment occurs 
via enzymatic and non-enzymatic processes that take place simultaneously under 
natural conditions (Bonartsev et al., 2011; Freier et al., 2002; Marois et al., 1999). The 
degradation rate of PHB is influenced by the characteristics of the polymer, such as 
chemical composition, crystallinity, morphology and molecular weight (Abe and 
Doi, 2002).  
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The examination of hydrolytic degradation of natural PHB in vitro is a very 
important step for understanding PHB biodegradation. The hydrolytic degradation 
of PHB is usually examined under experimental conditions simulating internal 
body fluid, in buffered solutions with pH = 7.4 at 37 °C, although higher 
temperature (55 °C, 70 °C, and more) and other pH values (from 2 to 11) have also 
been selected (Iordanskii et al., 2014). Several studies suggested that the non-
enzymatic hydrolysis of PHB proceeds via random bulk hydrolysis of ester bonds 
in the polymer chain (Bonartsev et al., 2007; Boskhomdzhiev et al., 2010; Koyama 
and Doi, 1995). The examination of enzymatic degradation of PHB in vitro is the 
following important step for understanding of PHB performance in animal. Most 
studies observed degradation of PHB by depolymerases of its own bacterial 
producers (Bonartsev et al., 2007; Koyama and Doi, 1995). Several studies 
suggested that the enzymatic degradation of PHB in vitro occurs in the presence of 
various lipases that act as non-specific esterases (Hoshino and Isono, 2002; Qu et 
al., 2006; Shishatskaya et al., 2005). At the next step it is necessary to observe 
enzymatic degradation of PHB under the conditions that modelled the animal 
tissues and body fluids containing nonspecific esterases. Miller and Williams (1987) 
showed degradation of PHB in the serum and blood, with progressive mass loss of 
PHB sutures of 16 % and 25 %, respectively, after 180 days of incubation. Other 
study showed PHB degradation in crude extracts from animal tissues, including 
liver, kidney, heart, brain and muscle, from 2 to 18 % mass loss of PHB 
microspheres after 17 h incubation at pH 7.5 and 9.5 (Shishatskaya et al., 2005). 
Various studies suggested that lipase can penetrate into pores of PHB film but the 
enzymatic degradation proceeds mainly on the surface of the coarse polymer film 
achievable for lipase. In addition to studies on PHB hydrolysis and enzymatic PHB 
degradation in vitro by lipases, in vivo biodegradation of PHB implant (in the form 
of plates, films, fibers, monofilament threads, and micro- and nanospheres) has 
been studied in various laboratory animals, including rats, mice, rabbits, guinea 
pigs, cats, calves, and sheep (Borkenhagen et al., 1998; Freier et al., 2002; Kunze et 
al., 2006; Kuppan et al., 2011; Malm et al., 1992; Qu et al., 2006). Pişkin (1995) 
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reported that the in vivo biodegradation of PHB is faster than in vitro hydrolysis at 
body temperature, indicating that enzymes existing in vivo catalyze the 
degradation. Very clear data that clarify the tissue response that contributes to 
biodegradation of PHB patch after implantation into the gastrointestinal tract of rat 
was reported by Löbler et al. (2002), where specific genes, namely the vitamin D 
binding protein mRNA and C-reactive protein mRNA were found to be induced 
after 7 and 14 days of contact between PHB and rat stomach tissues. Similarly, a 
specific tissue response induced by an implantation of PHB fiber was reported by 
Shishatskaya et al. (2005), showing the presence of two types of degradation 
enzymes, namely liver serine esterases and kidney esterases, in rat stomach tissues. 
As for tilapia fish, lipase activity has been found in extracts of the pancreas, pyloric 
ceca and anterior intestine (Ballantyne, 2014; Sargent et al., 2002; Tengjaroenkul et 
al., 2000). In this study, we hypothesized that the high lipase activity in fish fed 
with PHB (Chapter 2) demonstrates its high activity in PHB biodegradation. 
To actually show whether dietary PHB is digested (degraded), absorbed and 
metabolized in Nile tilapia body after ingestion, the study described in Chapter 4 
aimed at detecting carbon isotope incorporation from the labelled PHB diet in 
different tissues. As expected, carbon isotope originated from labelled PHB diet 
was compartmentalized in different tissues at different rates, suggesting that PHB 
is being digested, absorbed and metabolized in different tissues. As the isotopic 
incorporation among tissues was found to be fastest in the intestine, followed by 
the isotopic incorporation in the kidney, liver, and spleen, it can be suggested that 
these tissues act as the major metabolically active tissues (‘source tissues’) with 
clear functional responses to isotopic incorporation from the PHB, while the lower 
isotopic incorporation in the heart indicates its response as an ‘assimilator tissue’. 
The lowest isotopic incorporation levels were observed in the blood, brain and 
muscle. The low isotopic incorporation in the blood indicates its function as a 
‘carrier tissue’, which is characterized by a constant uptake and release of C from 
PHB; while for the brain and muscle the low isotopic incorporation indicates their 
response as ‘sink tissues’.  
Chapter 6. General discussion 
 
151 
 
In this study, we related the observed compartmental distribution of C originating 
from PHB with the nutrient flow suggested by Halver and Hardy (2002). We 
further hypothesize the possible metabolic route of PHB in the fish body: that once 
it is ingested, PHB is digested and absorbed by the lipase in the intestine, resulting 
in free fatty acids that are transported to the blood for which there are two possible 
routes; the lymphatic vessels of the intestine and the veins of the portal system. The 
long-chain fatty acids are transported by the lymphatic system (kidney, spleen) and 
enter the systemic circulation directly (Sheridan and Friedlander, 1985; Zapata et 
al., 2006), while short-chain fatty acids are transported to the liver via the hepatic 
portal vein where they are esterified into triglycerides, converted into cholesterol or 
phospholipids, or oxidized into ketone bodies, before entering the systemic 
circulation (Halver and Hardy, 2002). We hypothesize that the produced ketone 
bodies (particularly β-HB) are circulated by the blood (Hemre et al., 1991; Zammit 
and Newsholme, 1979) and further utilized mostly by the heart (Hemre et al., 1991; 
Leblanc and Ballantyne, 2000), and also by the brain and muscle as their energy 
sources (Beis et al., 1980; Magnoni et al., 2001; Soengas and Aldegunde, 2002).   
Possible mode of action of PHB as a growth promoter 
It was first established that PHB improves growth of Nile tilapia fry (Chapter 2) 
and fingerlings (Chapter 3). This coincided with an increase in lipase activity as 
well as with an increase in whole-body lipid deposition (Chapter 2). This suggests 
that PHB is either considered and degraded in the body as a fat or that it influences 
the fat metabolism of the fish. The results from the 13C-PHB incorporation 
experiment (Chapter 4) suggest the important role of intestine in the digestion and 
absorption of PHB as a fat, as well as the important role of the liver in the PHB 
metabolism as a lipid. It was hypothesized earlier that the higher total whole-body 
lipid content in the PHB treatment groups may be due to larger amount of visceral 
fat, which is deposited in the adipose tissue in the form of fat (triglycerides). These 
triglycerides are an enormous reservoir of metabolic fuel. Consequently, we 
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hypothesize that the growth promoting effect of PHB can be due to the high energy 
delivered by the PHB as a lipid. 
PHB supplementation may potentially result in the release of SCFA and so the 
growth promoting effect of PHB might be explained by the benefits associated with 
the availability of SCFA in the gastrointestinal tract. In herbivorous mammals, such 
as ruminants with voluminous large intestines, SCFA production accounts for as 
much as 80 % of maintenance energy requirements (Engelhardt and Rechkemmer, 
1985). The supplementation of sodium butyrate at 30 g kg-1 in the diet of calfs also 
resulted in the improvement of growth and nutrient utilization (Ślusarczyk et al., 
2010). Butyrate was reported to be one of the main precursors, next to acetate, of 
the de novo synthesis of lipids in colonic epithelial cells in rats (Zambell et al., 2003). 
The SCFA butyrate is essential for maintaining the normal metabolism of intestinal 
mucosa and regulating cellular growth / cell membrane synthesis (Kruh et al., 
1994). Thus, we hypothesize that dietary PHB induce SCFA production that 
stimulate the epithelial cell growth in the intestine and increase the uptake 
efficiency of nutrients from the feed, and thereby promoting the fish growth. This, 
however, needs further investigation. 
Furthermore, we further hypothesize that the growth promoting effect of PHB 
could also be due to the production of the intermediate product of PHB 
biodegradation, ketone body β-hydroxybutyrate, and its use as an energy source 
by the muscle, as well as  by the vital organs, such as the heart and brain (Willmott 
et al., 2005).  
Effectiveness and efficiency of PHB application as a growth promoter 
The biodegradation of PHB also depends on the physical properties of the polymer 
(Boskhomdzhiev et al., 2010; Freier et al., 2002; Vroman and Tighzert, 2009). 
Intracelullar PHB granules are insoluble and coated with phospholipids and 
proteins which stabilize it (Wieczorek et al., 1995). There are seven different 
structural proteins (encoded by ‘phasin’; inclusing phasin PhaP1 to PhaP7) that can 
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be detected at the surface of PHB granules during in vivo or in vitro studies, with 
the amount of PhaP1 at the surface of PHB granules by far being the largest in 
comparison to the amounts of other phasins (Pfeiffer and Jendrossek, 2011; 2012; 
Pötter et al., 2004). It is reported that the amorphousness of intracellular PHB 
granules is stabilized by a small amount of water (5-10 %) and these phasins in the 
membrane lipids. The removal of these impurities induce partial crystallization 
which toughens the granules and inhibit extensive molecule degradation and 
granule aggregation (Porter and Yu, 2011). It is reported that these phasins also 
seemed to have a regulatory influence on the degradation of PHB, although the 
exact mechanisms remain unknown. The lack of PhaP1 caused a reduced in vitro 
degradation of native PHB granules (nPHB) in Ralstonia eutropha, while the lack of 
all phasins considerably reduced the degradation of nPHB although the 
degradation was not fully prevented (Eggers and Steinbüchela, 2013; Uchino et al., 
2007). These findings suggest that the cPHB might be degraded differently from the 
amorphous PHB (i.e. less hydrolyzed). In this study, the increase in lipase activity 
(Chapter 2) indicates in vivo cPHB enzymatic biodegradation. The incorporation of 
the 13C stable isotope originating from labelled PHB diet in different Nile tilapia 
tissues, i.e. intestine, liver, kidney, spleen, heart, blood, brain, and muscle (Chapter 
4), also strongly indicated in vivo aPHB biodegradation, which contributed to tissue 
formation. It is hypothesized that the growth modulation effect of PHB observed in 
Nile tilapia fry and fingerling (Chapter 2 and 3) could have been even higher by 
using aPHB instead of cPHB due to the hypothetically higher degradation / 
hydrolysis of aPHB compared to cPHB. However, further investigations are needed 
to confirm the hypothesis. 
In term of cost effectiveness, the use of bacterial cells that contain aPHB can be 
considered as an effective alternative for cPHB particles (Halet et al., 2007). It is 
reported that the extraction of PHB from the cells alone costs about 30 % of the total 
production cost of the pure / crystalline PHB (Mudliar et al., 2008). Consequently, 
the absence for the need of PHB extraction in the application of amorphous PHB 
will considerably decrease the total production costs of PHB. It was estimated that 
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the price of PHB still contained within bacterial cells will be about 40 % lower than 
that of pure extracted crystalline PHB (De Schryver, 2010). Overall, more research 
is needed for an understanding of PHB degradation and metabolism, 
enzymatically or physically, by the fish (host) and/or its associated microbiota, in 
order to effectively and efficiently apply PHB as a growth promoter in aquaculture 
production.   
Evaluation of PHB as a health promoter in aquaculture 
Development of gnotobiotic tilapia larvae system 
In this study, in addition to its growth promoting effect (Chapter 2 and 3), PHB was 
also studied for its health promoting effect (Chapter 5). In order to design efficient 
PHB treatment strategies for addressing health problems in aquaculture, one 
would need an increased understanding of the interactions between dietary PHB, 
host, and gut microbiota. To clarify these different contributing factors / 
interactions that make up the mechanism of action of PHB, it is important to 
exclude any arbitrary influences during the investigations. The use of gnotobiotic 
animal models in which the composition of the bacteria is exactly known allows an 
increased control over the variables and an enhanced reproducibility of results. 
Gnotobiotic animal models have been applied in different categorical studies: (1) 
nutrient requirements, (2) metabolic functions, and (3) complex host–microbe 
interactions (Dierckens et al., 2009; Forberg et al., 2011; Kau et al., 2011; Marques et 
al., 2006; Rawls et al., 2004; Semova et al., 2012; Yossa et al., 2013). Focussing on 
tilapia, as this is the test organism used in this work, the main benefit associated 
with the use of the gnotobiotic tilapia larvae as compared to other gnotobiotic fish 
larvae, i.e. gnotobiotic cod or gnotobiotic seabass larvae, is that these larvae can 
take up either live feed (i.e. Artemia nauplii) or formulated microdiet at first 
feeding. This is important as the use of formulated diet in gnotobiotic system 
allows us to control not only the microbiological, but also the dietary variable 
which might have potential effects on host metabolism. In this study (Chapter 5), 
gnotobiotic tilapia larvae system was obtained by a double egg surface disinfection 
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procedure using hydrogen peroxide (2000 mg L-1 for 10 min) and sodium 
hypochlorite solution (75 mg L-1 active chlorine for 2 min), with the use of a cocktail 
of antibiotic (ampicillin, rifampicin, kanamycin, trimethoprim and gentamycin 
each at 10 mg L-1) and antifungal agents (Amphotericin-B and Fluorescent 
Brightener-28 at 0.5 mg L-1 and 25 mg L-1, respectively) to maintain gnotobiotic 
condition. 
Application of gnotobiotic tilapia system to investigate the protective effect of 
PHB 
Similar to the study with giant freshwater prawn larvae  (Thai et al., 2014), PHB 
also acted as a protecting agent for gnotobiotic Nile tilapia larvae. As illustrated in 
Chapter 5, dietary PHB induced an increase in larval tilapia survival with about 20 
% in a gnotobiotic challenge test with pathogen E. ictaluri gly09R. However, the 
direct effect of PHB on fish morphological / physiological responses is non-
exclusive as the PHB might also have directly affected the pathogen. As for this, it 
will be interesting to use the gnotobiotic tilapia system that has been developed in 
this study to clarify the different possible mechanisms of action of PHB in the 
improvement of the fish disease resistance and overall immune status. For this 
purpose, the gnotobiotic tilapia larvae system can be used (i) to study the 
interactions between dietary PHB and host, (ii) to study the interaction between 
dietary PHB and gut microbiota, (iii) to study the modulation of gut microbiota 
and host metabolic interactions, and (iv) to study to which extent interactions 
between gut microbiota and dietary PHB can affect host physiology and health.  
In Figure 6.1 an overview is provided on the different elements that should make 
up the study on the mechanistic action of PHB using gnotobiotic tilapia larvae as 
test organism. The antimicrobial effect of PHB (and its degradation products; β-
hydroxybutyrate) towards the survival and infection of Edwardsiella ictaluri 
(Edwardsiella spp.; tilapia intracellular pathogens) need to be investigated. A study 
using green fluorescent protein (GFP) showed that both avirulent and virulent 
Edwardsiella sp. are able to adhere to, invade, and replicate in the fish epithelial 
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papilloma (EPC) cell line using host microfilaments and protein tyrosine kinase 
(Ling et al., 2000). Type ІІІ secretion system (T3SS) and type VІ secretion system 
(T6SS) play important roles in adherence, penetration, survival, and replication of 
E. tarda in epithelial cells and phagocytes. The T6SS of E. tarda comprises 16 genes, 
and 13 of the encoded proteins are involved in the secretion of EvpP (E. tarda 
virulence protein) (Zheng and Leung, 2007). T3SS is a multi-protein complex that is 
essential for host and pathogen interaction. In E. tarda, T3SS proteins include the E. 
tarda secretion system apparatus (EsaB and EsaN), effectors (EseB, EseC and EseD), 
chaperones (EscA, EscB and EscC), and regulators (EsrA, EsrB and EsrC) (Wang et 
al., 2010; Zheng et al., 2007). Proteomic studies have revealed that EseB, EseC and 
EseD are the major extracellular protein, and mutations of these genes in E. tarda 
reduce virulence compared to parental E. tarda (Tan et al., 2002). These pathogenic 
genes expression may thus be of interest in the future PHB studies on tilapia 
pathogen Edwardsiella sp.  
At the level of tilapia, the easiest factors to score are survival and growth. Future 
study, however, also needs to focus on the fish immune responses that may 
provide protection against this intracellular bacterial infection. Several immune-
related genes, such as Notch2 and nfatc3b, have shown crucial role in immune 
regulating function in tilapia (Xiao et al., 2015) and thus may be of interest for 
future studies. 
It has been accepted that the intestinal epithelium acts as the major physical barrier 
to pathogen infection, and it is the location of competitive exclusion by the 
autochtonous microbiota, and production of antimicrobials (Cain and Swan, 2011; 
Esteban, 2012). This is of importance as the intestinal tract is considered as the main 
portal of entry to many enteric pathogens, including E. ictaluri (Li et al., 2012; Soto 
et al., 2013), which was used in the challenge tests on gnotobiotic Nile tilapia larvae 
(Chapter 5). Using gnotobiotic tilapia, further study can focus on the effects of PHB 
and its degradation products on the development of the gut by histological and 
stereological analysis (Najdegerami et al., 2013; Rekecki et al., 2009). This may show 
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whether or not the fish morphology is beneficially influenced, which may also 
provide protection against intracellular bacterial infection. The gut volume to body 
volume ratio, the intestinal epithelium height, the specific surface area of the villi , 
the villi number,... are all factors that can be investigated. The use of gnotobiotic 
tilapia larvae is ideal for this future study, as there will be no interference by 
microbiota on the proliferation of gut epithelial cells, as often described in the 
conventional system (Denev et al., 2009).  
The information about the exact mechanisms of action of PHB will provide a better 
understanding of how to extract the full potential of PHB applications for health 
promotion in aquaculture production. However, one must consider that the 
functioning of metabolic processes in axenic / gnotobiotic animals is likely much 
different from their conventional counterparts. Thus, the gathered information 
obtained from gnotobiotic studies on PHB needs to be validated for conventional / 
non-bacteria free animals. 
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Figure 6.1. Proposed research scheme on the mode of action of PHB using the 
gnotobiotic tilapia larvae system (as suggested in De Schryver, 2010). 
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Possible mode of actions of PHB as health promoter 
The effect of PHB at the host level is reported by Suguna et al. (2014), whereas PHB 
increased resistance of Java tilapia against Aeromonas hydrophila infections by 
stimulating both specific immune response (analysed in terms of antibody response 
to sheep red blood cells) and nonspecific immune response (analysed in terms of 
serum lysozyme activity, total peroxidases activity and antiprotease activity) when 
supplemented at a higher dose of 5 g kg-1. Futhermore, PHB may have a direct 
effect on the host, for example in the alteration of morphological and physiological 
responses in the intestinal epithelium, which functions affect the immune system. 
PHB can also work at the level of pathogen. As suggested by De Schryver et al. 
(2010), it is hypothesized that PHB degradation in the intestine results in high 
concentrations of short chain fatty acids like β-hydroxybutyric acid and/or its 
oligomers (Chapter 2). β-hydroxybutyric acid is known to exhibit some 
antimicrobial, insecticidal, and antiviral activities (Tokiwa and Ugwu, 2007). The 
antimicrobial activity of β-hydroxybutyric acid is thought to be comparable to that 
of other short-chain fatty acids (SCFA) (Defoirdt et al., 2007a). Another PHB effect 
at the level of pathogen is reported by Kiran et al. (2014), where PHB (originated 
from Brevibacterium sp.) significantly reduced biofilm formation of Vibrio sp. on 
PHB-coated glass and polystyrene plates, suggesting that PHB may potentially 
reduce the colonization capacity of Vibrio sp. in the intestine of shrimp culture and 
thus reduce the biomass establishment  a prerequisite for virulence expression  
of the pathogen. It was suggested that the use of PHB to prevent pathogen biofilm 
formation instead of inhibit its growth could serve as an alternative to conventional 
biocontrol procedures using antimicrobial compounds (Kiran et al., 2014). 
It was hypothesized earlier that PHB degradation might result in the production of 
ketone body β-HB (Jendrossek & Handrick, 2002) (Chapter 2 and 4). Defoirdt et al. 
(2009) suggested that β-HB has been reasoned to protect aquaculture animals from 
bacterial infections in two ways: (1) by decreasing the growth and/or the virulence 
of the pathogens (effect at the pathogen level), and (2) by providing energy to the 
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host intestinal mucosa, thereby increasing intestinal health and resistance to 
infections (effect at the host level). A study by Dong et al. (2012) using rats 
suggested that the increased levels of ketone body 3-HB in plasma of rats with 
Klebsiella pneumoniae infection showed a strong increase in β-oxidation and a drop 
in glucose concentration, which could mirror the high demand of the body for 
energy in response to bacterial infection. It is known that the oxidation of fatty acid 
produces more energy per molecule than glycolysis (Trocher, 2003), therefore ATP 
generated from fatty acid oxidation is an important energy source required by the 
major organs (e.g. liver, heart, spleen and kidney) to function during severe sepsis. 
3-hydroxybutyrate is also known as keton body used as energy source in several 
tissues in fish (Willmott et al., 2005). The energy supply from the ketone body 3-HB 
is suggested as the important fuel for development and growth of Artemia culture 
(Weltzien et al., 2000), which could also be responsible for the increase in growth of 
giant freshwater prawn larvae fed with PHB-supplemented Artemia (Nhan et al., 
2010; Thai et al., 2014). It is thus hypothesized that a shared mechanism of PHB 
and/or its monomer 3-HB could have been responsible for the health as well as 
growth promotion in tilapia culture as observed in this study, by (1) providing the 
antimicrobial activity, and (2) providing energy to support body function during 
infection (sub-optimal) as well as to enhance growth during normal (optimal) 
conditions. 
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General conclusions  
Considerable efforts have been made to render aquaculture more sustainable, due 
to the fast expansion of the aquaculture production that has exerted high pressure 
on the environment. On one hand, this implies the search for (micro-)biologically 
based methods to limit the use of antibiotics as growth promoters for food animals 
and/or to control pathogenic infections. As for this, the bacterial storage compound 
poly-β-hydroxybutyrate has been proposed as an alternative to antibiotics and 
studied in several main aquaculture species. This research contributed to the 
exploration of PHB as it showed that: 
 PHB can have a growth promoting effect when supplemented to the diet of 
tilapia fingerlings  
 PHB can potentially improve the nutrient utilization, particularly in lipid 
metabolism  
 PHB is metabolized, compartmentally distributed and incorporated in different 
organs / physiological systems 
 PHB can be used in a gnotobiotic system to confirm its protective effect against 
pathogenic infection 
The exact mechanisms of action of PHB, however, require further thorough 
exploration in order to optimally apply PHB at full-scale. Further research is 
required to explore and understand the full potential of PHB as a growth and/or 
health promoting agent in wide aquaculture practices. This should focus on: 
 determining the optimal developmental stage at which PHB should/can be 
applied for each targeted animal / species 
 unravelling the mechanistic action of PHB on fish nutrient utilization, 
particularly the lipid metabolism, e.g. by applying the whole-body fatty acid 
balance method (WBFABM), an in vivo method for assessing fatty acid 
metabolism, including rates of liponeogenesis and de novo fatty acid production, 
β-oxidation and also bioconversion (elongation and desaturation) of fatty acids  
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 detecting the effect of PHB on the physiological profile of fish gut microbiota, 
including the more diverse microaerophilics, e.g. by using the Biolog GN-/GP-
MicroPlate™ method (with 95 C sources; instead of 31 C sources as in Biolog 
EcoPlate™), as well as the anaerobics, e.g. by using the Biolog AN MicroPlate™ 
method.  
 understanding the biodegradation processes and the metabolic fate of dietary 
PHB in the fish body, e.g. a complete mass balance experiment by integrating 
the compound-specific isotope analysis (CSIA) with the advanced metabolomics 
approach 
 elucidating the mode of action of PHB in its protective effect against pathogenic 
infection, e.g. by optimizing and making use of the gnotobiotic tilapia system to 
study (i) the interactions between dietary PHB and host, (ii) the interaction 
between dietary PHB and gut microbiota, (iii) the interaction between 
modulation of gut microbiota and host physiology, and (iv) to which extent 
interactions between gut microbiota and dietary PHB can affect host physiology 
and health 
 rendering PHB more cost effective through the integration into existing 
microbial control strategies, i.e. by using the bio-flocs technology / BFT for an 
economical PHB accumulation, or by applying existing PHB-degrading 
probiotics treatments  
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Summary 
 
The present study demonstrated the benefits of the application of PHB in Nile 
tilapia production. It was confirmed that PHB can significantly improve the growth 
performance of Nile tilapia fingerling (Chapter 3). PHB resulted in increasing body 
weight gain in Nile tilapia juvenile, but the difference was not significant when 
compared to the control group (Chapter 2). In the attempt to explain the growth 
promoting effect of PHB, the effect of PHB on fish digestion and metabolism, and 
also gut physiological MC profile have been elucidated (Chapter 2 and Chapter 3). 
This study showed that PHB improved the nutrient utilization by increasing the 
lipase activity of Nile tilapia juvenile, which indicates an increase in lipid digestion 
that could have been lead to the increase in the total lipids content in Nile tilapia 
juvenile. PHB also resulted in increasing total lipid content in Nile tilapia 
fingerling, but the difference was not significant when compared to the control 
group. Furthermore, PHB also seemed to alter the content of several FAs, 
particularly the total saturated, total monounsaturated and total (n-6) FAs of both 
Nile tilapia juvenile and fingerling, although the composition of these FAs in the 
total lipid remain unaltered.  
Based on these findings, we hypothesized that the growth promoting effect of 
PHB is due to an improved of nutrient utilization, particularly with the 
improvement of lipids digestion, absorption, and metabolism. Although various 
studies acknowledged the dietary modulation of fish gut microbiota, which 
seemed to alter the host metabolism and digestion, in this current study we could 
not detect any effect of PHB on either the resident or the transient gut MC 
functional physiological profile, suggesting that the growth promoting effect of 
PHB was not necessarily related to changes in the functional gut MC profile or its 
feed digestion pattern (Chapter 3). With this knowledge in mind, we hypothesized 
that the growth promoting effect of PHB is due to physiological response of the 
fish, instead of its intestinal microbiota.  
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Based on the carbon isotope tracer study, we demonstrated that PHB is digested 
and compartmentalized in different tissues at different incorporation rates 
(Chapter 4). The higher and faster isotope incorporation in the intestine and liver 
suggest that PHB are highly digested, absorbed and metabolized in these major 
metabolically active organs. Based on the general knowledge on the main functions 
of intestine and liver in fish nutrient metabolism, this again suggests the role of 
PHB in the improvement of lipids digestion, absorption and metabolism, as 
indicated in Chapter 2.  
The present research also demonstrated that the consumption of PHB by 
gnotobiotic Nile tilapia larvae resulted in higher resistance against infectious 
Edwardsiella ictaluri bacterial challenge (Chapter 5). The developed gnotobiotic Nile 
tilapia model can be used to further evaluate whether the PHB has a direct effect on 
the pathogen and/or the host. It is important to note that the magnitude of the 
expected beneficial effects of PHB on health promotion of commercial Nile tilapia 
culture (open system) should be further evaluated by considering different 
operational parameters applied in the aquaculture system.  
In conclusion, the overall results of the present research suggest that the 
application of PHB positively contributed to the growth and health promotion in 
Nile tilapia culture. To this end, it can only be hypothesized that dietary PHB 
directly affect the physiological response of the fish in term of nutrient, e.g. fatty 
acids, utilization / metabolism; possibly with the release of SCFA. It is also 
hypothesized that the degradation of PHB resulted in the release of its monomer β-
hydroxybutyric acid. It is noticed that more research is needed to elucidate the 
biodegradation processes and the metabolic fate of dietary PHB in the fish body, 
and to decipher the complex functional relationships between dietary PHB, gut 
microbiota, and fish physiology, in order to have a better understanding of how to 
extract the full potential of PHB applications as growth and health promoter in 
aquaculture production. 
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Samenvatting 
 
De huidige studie toont de voordelen aan van de toepassing van PHB bij de kweek 
van Nijltilapia. Het werd bevestiged dat PHB de groei van Nijltilapia juvenielen 
significant kan verbeteren (Hoofdstuk 3). PHB resulteerde eveneens in een 
verhoging van de toename van het  lichaamsgewicht van Nijltilapia juvenielen, 
maar het verschil was niet significant in vergelijking met de controle groep zonder 
PHB supplementatie (Hoofdstuk 2). In een poging om het groeibevorderende effect 
van PHB te verklaren, werd het effect van PHB op de vertering en het metabolisme 
van de vissen, alsook op het intestinaal fysiologisch profiel van de gastrointestinale 
microbiële gemeenschap opgehelderd (Hoofdstuk 2 en Hoofdstuk 3). Deze studie 
toonde aan dat het nutriëntgebruik door PHB werd verhoogd door toename van de 
lipase activiteit in Nijltilapia larven. Dit wees op een toegenomen vetvertering die 
mogelijks de verklaring was van het toegenomen vetgehalte in de Nijltilapia 
larven. PHB resulteerde eveneens in een toegenomen vetgehalte in Nijltilapia 
juvenielen, maar het verschil was niet significant in vergelijking met een controle 
groep zonder PHB supplementatie. Verder leek PHB het vetzuurprofiel van het 
volledige lichaam van de vissen te veranderen, vooral met toenemende trends in 
het gehalte aan verzadigde, mono-onverzadigde en n-6 vetten in zowel Nijltilapia 
larven als juvenielen. Gebaseerd op deze vindingen werd de hypothese 
vooropgesteld dat het groeibevorderende effect van PHB het gevolg is van een 
toegenomen nutriëntgebruik, vooral als gevolg van een verbeterde vetvertering, -
absorptie, en –metabolisme.   
Hoewel verschillende studies de verandering van de microbiële gemeenschap in 
de darm van vissen, en de daarbij horende metabolisering en vertering, als gevolg 
van verandering in dieet erkennen, werd in deze studie geen effect gevonden van 
PHB op het fysiologisch profiel van zowel de residente als transiënte intestinale 
microbiële gemeenschap. Dit suggereert dat het groeibevorderende effect van PHB 
niet noodzakelijk het gevolg is van veranderingen in het functionele profiel van de 
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intestinale microbiële gemeenschap of het verteringspatroon (Hoofdstuk 3). Met 
deze kennis in gedachten werd de hypothese vooropgesteld dat het 
groeibevorderende effect van PHB resulteert uit een fysiologische respons van de 
vissen in plaats van de intestinale microbiota.  
Gebaseerd op de koolstof isotoop traceerstudie hebben we aangetoond dat PHB 
wordt verteerd en verdeeld over verschillende weefsels aan verschillende 
incorporatiesnelheden (Hoofstuk 4). De hogere en snellere isotoopincorporatie in 
de darm en lever suggereert dat PHB sterk wordt verteerd, geabsorbeerd en 
gemetaboliseerd in deze hoog metabolisch actieve organen. Gebaseerd op 
algemene kennis over de functies van de darm en lever in het nutriëntmetabolisme 
van vissen, duidt dit opnieuw de rol van PHB in vetvertering, absorptie en 
metabolisme zoals aangeduid in Hoofdstuk 2.  
Het huidige onderzoek toont eveneens aan dat de consumptie van PHB door 
gnotobiotische Nijltilapia juvenielen resulteerde in een verhoogde weerstand tegen 
infecties door Edwardsiella ictaluri (Hoofdstuk 5). Het ontwikkelde gnotobiotische 
Nijltilapia model kan verder gebruikt worden om het directe effect van PHB op de 
pathogeen en/of de gastheer na te gaan. Het is belangrijk om te benadrukken dat de 
mate van de voordelige effecten van PHB op de gezondheid bij commerciële 
Nijltilapia cultuur (open systemen) verder dienen te worden geëvalueerd door de 
verschillende operationele parameters in aquacultuursystemen in beschouwing te 
nemen.  
Concluderend tonen de algemene resultaten van het huidige onderzoek aan dat 
de toepassing van PHB op positieve wijze bijdraagt tot de groei en gezondheid in 
de Nijltilapia kweek. In dit kader kan als hypothese gesteld worden dat PHB een 
directe invloed heeft op de fysiologische respons van vissen in termen van 
nutriëntgebruik en – metabolisme (bv. vetzuren); mogelijks met vrijstelling van 
kortketen vetzuren. Een alternatieve hypothese is dat de degradatie van PHB 
resulteert in de vrijstelling van zijn monomeer β-hydroxyboterzuur. Er is meer 
onderzoek nodig om de exacte biodegradatieprocessen en het metabolische lot van 
PHB gedoseerd via het dieet in het lichaam van vissen op de helderen, en om de 
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complexe functionele relaties tussen PHB, de darmbacteriën en de fysiologie van 
de vis uit te klaren. Dit zal bijdragen om het volledige potentieel vervat in PHB als 
groei- en gezondheidsbevorderend middel in de aquacultuur te verstaan en te 
gebruiken.  
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